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ABSTRACT 
 
The tetrahydroquinolines structural unit is found in a number of natural products that exhibit 
a variety of biological activities including anti-allergic, anti-inflammatory and antitumour. As 
a result there is significant interest in their synthesis. This PhD thesis describes the work 
undertaken in the development of a new synthetic route that can be applied to the asymmetric 
synthesis of structurally diverse tetrahydroquinolines. The introductory chapter outlines the 
main current synthetic strategies towards tetrahydroquinolines and their application to the 
synthesis of some biologically interesting compounds.  
 
Chapter 2 discusses work on the total asymmetric synthesis of the Galipea alkaloids. An aza-
Michael reaction was used to install the required stereochemistry. Extensive optimisation of 
the aza-Michael reaction resulted in high enantioselectivities, with optically pure material 
obtained upon recrystallisation. Various synthetic procedures were investigated for formation 
of the tetrahydroquinoline ring system and the remainder of the synthesis, with the Galipea 
alkaloids obtained from a common precursor.   
 
Work towards the formal synthesis of the Martinelline alkaloids, using the aza-Michael 
reaction to set the first stereocentre, is detailed in Chapter 3. A range of different α, β-
unsaturated carbonyl and anilines were investigated for the aza-Michael reaction, with 85% 
enantioselectivity obtained on optimisation. Formation of the tetrahydroquinoline core was 
achieved and the installation of the second chiral centre investigated.  
 
Chapter 4 describes any miscellaneous work conducted, including preliminary investigations 
towards the synthesis of levonantradol. The last Chapter contains the experimental 
procedures and characterisation data for all the compounds synthesised during the course of 
this project.   
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1.0 Biologically Interesting Tetrahydroquinolines  
Quinolines and their derivatives are an important class of benzofused nitrogen heterocycles.
1
 
The tetrahydroquinoline structural unit is found in a number of natural products
2
 that exhibit 
a variety of biological properties, including anti-allergic, anti-inflammatory
3
 and anti-tumour 
activities.
4
 They also attract attention as important synthetic intermediates.
5
 Many of these 
compounds contain substituents in the 2-, 3- and/or 4- positions of the ring (Figure 1.1), each 
constituting a stereogenic centre. 
 
Figure 1.1: Tetrahydroquinoline core structure. 
The pharmaceutical industry has a long-standing interest in compounds containing the 
tetrahydroquinoline core unit. Several libraries of substituted tetrahydroquinolines have been 
synthesised and screened for their potential as drug candidates. Some have found therapeutic 
uses, such as the 2-substituted tetrahydroquinoline oxaminiquine 1.1 (Figure 1.2), which is 
used to treat schistosomiasis, a parasitic disease.
6
 
 
Figure 1.2: 2-substituted tetrahydroquinoline Oxaminiquine. 
 
A selection of other tetrahydroquinolines with interesting biological activities is shown below 
(Figure 1.3). 
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Figure 1.3: Biologically interesting tetrahydroquinolines. 
 
2-Methyltetrahydroquinolines of type 1.2 show antiparasitic activity,
7
 whilst the compounds 
1.3-1.6 are all potent antagonists of the NMDA receptor, which plays a role in neuronal cell 
death during conditions such as stroke.
8-12
 The tricyclic family of tetrahydroquinolines with 
core structure 1.7a-c are BKCa receptor antagonist, currently under investigation as novel 
agents to treat migraines by the regulation of neuronal excitability and synaptic 
transmission.
13
 The 2-phenyltetrahydroquinoline 1.8 is a potent CETP inhibitor, which could 
have potential therapeutic uses for the treatment of high cholesterol.
14
 The tricyclic fluoro-
quinolones 1.9a-c are antimicrobial agents with high antibacterial activity,
15
 particularly 
towards gram-positive bacteria; all three quinolines show a significant difference in 
Chapter 1  Introduction 
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effectiveness between the two enantiomers, with the (S)-enantiomer 64 to 256 times more 
potent than the (R)-enantiomer.
16
  
 
Despite significant interest in tetrahydroquinolines, there are surprisingly few examples of 
their asymmetric synthesis. The following sections will be dedicated to the discussion of four 
tetrahydroquinolines of particular interest and relevance to the topic of our investigation. Two 
of these are naturally occurring alkaloids, while the others are synthetic molecules. Following 
this, the major enantioselective synthetic routes to tetrahydroquinolines will be presented. By 
far, the asymmetric hydrogenation of quinolines is the most utilised for the synthesis of 
optically pure 2-substituted tetrahydroquinolines; both metal and non-metal catalytic systems 
will be discussed. The next most commonly used synthesis for 2-, 3-, and 4-substituted 
tetrahydroquinolines is the inverse electron demand Diels-Alder reaction and this is discussed 
next. Following these will be other methodologies including: aza-Michael reactions, 
hydroamination reactions and miscellaneous examples used for the synthesis of specific 
tetrahydroquinolines. The Chapter will conclude with a discussion of the aims of the project.    
 
1.0.1 Galipea Alkaloids 
The Galipea alkaloids (Figure 1.4) are a group of four, 2-alkyl-tetrahydroquinolines, known 
to exhibit anti-malaria and cytotoxic activities, consisting of angustureine 1.10, galipeine 
1.11, cuspareine 1.12 and galipinine 1.13.
17
 Angustureine and galipeine were the first to be 
extracted from Galipea officinalis Hancock, a Venezuelan shrubbery tree, in 1999 by 
Jacquemond-Collet et al.
18
 The natural configuration of angustureine was determined to be 
(R) by Theeraladanon et al. through the construction of the (S)-enantiomer in a complete 
stereo-defined manner.
17
 The other three alkaloids where all determined to be the (S)-
enantiomer, by their total synthesis from quinolines using asymmetric hydrogenation.
19, 20
  
 
  
Figure 1.4: The Galipea alkaloids. 
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1.0.2 Martinelline Alkaloids 
Preparations made from the root bark of the Martinella species have been used by Amazon 
Indian tribes for the treatment of eye ailments. In 1995, martinelline 1.14 and martinellic acid 
1.15 (Figure 1.5) were isolated from Martinella iquitosensis by Merck scientists. They were 
found to be the first non-peptidic Bradykinnin B1 and B2 receptor antagonist,
21
 with potent 
antibiotic activity against Gram-positive and Gram-negative bacteria
22
 and have an 
unprecedented hexahydropyrrolo[3,2-c]quinolines core structure.
23
 
1
H NMR and NOE 
experiments confirmed the relative stereochemistry of the fused ring junction to be syn, 
whereas the stereochemistry of the adjacent 2-substituent was found to be anti, with respect 
to the ring junction.
21
 The absolute stereochemistry of martinelline was assigned by the total 
synthesis of both enantiomers and comparison of their optical rotation to that of the isolated 
natural product.  
 
 
Figure 1.5: Martinelline alkaloids. 
 
1.0.3 Torcetrapib 
Torcetrapib 1.16 is a 2, 4-disubstituted tetrahydroquinoline (Figure 1.6), which was 
investigated as a potential substitute for Lipitor in the treatment of coronary heart disease.  It 
inhibits the cholesteryl ester transfer protein (CETP), increasing the levels of “good” 
cholesterol and lowering the levels of “bad” cholesterol. However, development of 
Torcetrapib was stopped during phase III clinical trials, due to the increased risk of patient 
death.
24
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Figure 1.6: Torcetrapib. 
 
1.0.4 Levonantradol 
Levonantradol 1.17 is a tricyclic tetrahydroquinoline containing 5 chiral centres (Figure 
1.7).
25
 It is a synthetic cannaboid developed by Pfizer in the 80‟s, possessing analgesic and 
antiemetic properties, with 9-14 times greater potency than morphine.
26
 However, unlike 
morphine it is devoid of interactions with the opiate receptor. There has been significant 
interest in levonantradol over the last few decades, with a number of studies conducted into 
potential therapeutic uses, however, it has limited utility due to adverse effects.
27
  
 
Figure 1.7: Levonantradol. 
 
1.1 Quinoline hydrogenation 
There is significant interest in the development of catalytic asymmetric hydrogenation 
reactions to yield optically pure heterocycles.
28
 Although a variety of Rh, Ru and Ir 
complexes have been reported for the enantioselective hydrogenation of olefins, ketones and 
imines, a majority of these failed with heteroaromatic compounds.
29
 Several factors 
contribute to the increased difficulty, for example resonance stability and catalytic poisoning, 
due to binding of the heteroatom to the metal centre.
30
 However, in recent years a variety of 
examples of the asymmetric hydrogenation of quinolines have been reported. These will be 
presented in this section, in addition to their application to the synthesis of some of the 
biologically interesting compounds mentioned earlier. This Chapter concludes with a 
discussion of the mechanism. 
Chapter 1  Introduction 
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1.1.1 Metal catalysed hydrogenations 
The first asymmetric hydrogenation of quinolines was reported by Zhou in 2003, using a 
catalyst formed in situ from [Ir(COD)Cl]2 (0.5 mol%) and (R)-MeO-Biphep 1.18 (1.1 mol%), 
with I2 as an activator (Scheme 1.1).
20
 In the absence of iodine, the reaction only proceeded 
in < 5% yield.  
 
Scheme 1.1: First asymmetric hydrogenation of 2-substituted quinolines. 
The hydrogenation of a variety of 2-substituted quinolines proceeded with excellent yields 
and enantioselectivities of up to 94%. High ee‟s were achieved regardless of the length or 
nature of the side chain (Table 1.1, entries 1-3); branched (entry 4), arenethyl (entry 5), ester 
(entry 6) and alcohol functionalities (entry 7) can be tolerated. However, 2-aryl substituted 
quinolines gave lower ee values (entry 8). This system worked specifically for 2-substituted 
quinolines, with little to no enantioselectivity obtained with 3- or 4- substituted quinolines. 
Table 1.1: Asymmetric hydrogenation of various 2-substituted quinolines.
a
 
a
Reagents and conditions: Quinoline (1.0 mmol), [Ir(COD)Cl]2 (0.5 mol%), (R)-MeO-Biphep (1.1 mol%), I2 (10 
mol%), toluene (5 mL), H2 (600-700 psi). 
b
Isolated yields. 
c
Determined by chiral HPLC analysis. 
 
Entry R % Yield
b
 % ee, (Config)
c
 
1 Me 94 94 (R) 
2 Et 88 96 (R) 
3 n-Pr 92 93 (R) 
4 i-Pr 92 94 (S) 
5 CH2CH2Ph 95 93 (R) 
6 CH2OCOCH3 90 87 (S) 
7 
 
87 94 (S) 
8 Ph 95 72 (S) 
Chapter 1  Introduction 
7 
 
There are two suggested functions for the iodine additive; the first is that the iodine activates 
the substrate via complexation to the nitrogen and the second involves the formation of a new 
highly active catalyst by oxidative addition. To determine the mode of action, Wang et al. 
pre-formed the iodo-quinoline complex and also the iodo-catalyst complex. No 
hydrogenation of the iodo-quinoline occurred on addition of catalyst, however the iodo-
catalyst complex successfully hydrogenated 2-methylquinoline, suggesting that the iodine 
plays a role in catalyst activation.
31
    
 
Various other ligands have also been investigated for the hydrogenation of 2-methyl 
quinoline using the conditions developed by Zhou (Scheme 1.2, Table 1.2). Chiral bidentate 
phosphine ligands, in particular, have received much attention.  
 
 
Scheme 1.2: Hydrogenation of 2-methylquinoline. 
 
Chan et al. described a catalytic system generated in situ from [Ir(COD)Cl]2 and the 
electronically deficient biaryl phosphine ligand P-Phos 1.21 (Scheme 1.2, Table 1.2). The 
results were found to be comparable to that attained with MeO-Biphep (Table 1.2, entries 1 
vs 2). Moreover, no degradation in ee was observed on exposing the catalytic system to air 
for 24 hours.
32
 However, the partial decomposition of the catalyst, in the presence of oxygen, 
during the hydrogenation process becomes significant on lowering the catalytic loading. 
Conducting the reactions under anaerobic conditions, and decreasing the iodine levels to 
1.25-2.5%, allowed good results to be obtained at a S/C ratio as low as 50,000.
33
 The catalyst 
Chapter 1  Introduction 
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could be separated and recycled by conducting the reaction in a poly (ethylene glycol) 
dimethyl ether (DMPEG)-hexane mixture.
32
  
 
Subsequently, the use of Xylyl-P-Phos 1.22, Cl-MeO-Biphep 1.23, DifluorPhos 1.24 and 
SYNPHOS 1.25 was investigated by the same research team (Table 1.2, entries 3-6).  
Excellent conversions and comparable enantioselectivities were obtained irrespective of the 
ligand used.
34
 Using DifluorPhos as ligand, catalytic loading may be lowered to 0.01 mol% 
without significant change in enantioselectivity (entry 7).
35
 Re-use of the catalyst, however, 
resulted in a small decrease in activity after each cycle.
34
  
Table 1.2: Hydrogenation of 2-methylquinoline using various ligands.
a
 
Entry Ligand 
Catalytic 
loading/ mol % 
I2/   
mol % 
Solvent 
% 
Yield 
ee %, 
(Config)
b
 
1 (R)-1.18 0.5 10 Toluene 94 94 (R) 
2 (R)-1.21 0.5 5.0 THF 97 91 (R) 
3 (R)-1.22 1.0 10 THF 99 92 (R) 
4 (R)-1.23 1.0 10 THF 99 91 (R) 
5 (R)-1.24 1.0 10 
CH2Cl2/THF 
(1:1) 
89 99 (R) 
6 (R)-1.25 1.0 10 
CH2Cl2/THF 
(1:1) 
89 99 (R) 
7 (R)-1.24 0.01 2.5 Toluene 99 94 (R) 
a
Reagents and conditions: Quinoline (1.0 mmol), [Ir(COD)Cl]2 (0.01-1.0 mol% ), ligand (1.1-2.1 mol%), I2 (2.5-
10 mol%), solvent (See table), H2 (600-700 psi), rt, 20-24 hr. 
b
Determined by chiral HPLC. 
 
More recently, the hydrogenation of 2-substituted quinolines was achieved by Zhou, using an 
[Ir(COD)Cl]2/(S)-SegPhos (Figure 1.8), with water/silane as the hydrogen source. The 
reaction of a metal silane complex with H2O resulted in formation of an Ir-dihydride 
complex, which liberated hydrogen gas by reductive elimination (Scheme 1.3). Good 
enantioselectivities of 83-93% and yields up to 98% were obtained using this system, with 
the exception of 2-phenylquinoline, which again proceeded with lower yield and ee.
36
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Scheme 1.3: Generation of hydrogen from a silane and water. 
 
Figure 1.8: (S)-Segphos. 
 
A range of other types of ligands have also been used for the hydrogenation of 2-
methylquinoline (Figure 1.9, Table 1.3). Notably, several of these are derived from chiral 
BINOL (1.28, 1.30 and 1.31).   
 
Figure 1.9: Ligands used for the asymmetric hydrogenation of 2-substituted quinolines. 
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Table 1.3: Asymmetric hydrogenation of 2-methyl quinolines 1.19 using various ligands.
a
 
Entry Ligand (mol%) 
Cat. 
loading  
(mol%) 
Additive  
(mol%) 
Pressure/ 
Psi  
Temp/ 
ºC 
% 
Yield
b
  
% ee, 
(Config)
c
  
1 (S, Sp)-1.27 (1.1) 0.5 I2 (5.0) 600 rt 95
 d
 90 (R) 
2 (R)-1.28 (1.1) 1.0 I2 (1.0) 700 rt 100 95 (R) 
3 (R)-1.29 (0.1) 0.05 I2 (1.0) 700 rt 100 92 (R) 
4 (S)-1.30 (1.0) 0.5 I2 (1.0) 870 rt 96 92 (S) 
5 (S)-1.31 (4.0)/ 
Tri-o-tolylphosphine 
(2.0) 
1.0 
Piperidine 
HCl (10) 
725 60 100 89 (S) 
a
Reagents and conditions: Quinoline (1.0 mmol), [Ir(COD)Cl]2 (0.05-1.0 mol%), ligand, additive, H2, 20-24 hr. 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC. 
d
Isolated Yield. 
 
All five ligands catalysed the hydrogenation of 2-methylquinoline in good yield and ee 
(Table 1.3).
37-40
 These reactions were conducted using [Ir(COD)Cl]2/L*, H2 and I2, with the 
exception of ligand 1.31 (entry 5), where iodine was substituted with piperidine 
hydrochloride and the addition of an achiral ligand, tri-o-tolylphosphine, was also required to 
achieve high yields and enantioselectivities.
38
 All systems accommodate changes in the the 2-
alkyl-substituent of the quinolines, and good results were obtained even for of 2-aryl 
substituted quinolines, which has thus far proved problematic.
39
  
 
Attempts to lower the S/C ratio were met with limited success (Table 1.4). Increasing the 
ratio to 2000 for the MeO-Biphep catalysed reaction decreased the conversion to 7% (entry 1 
vs 2). Significantly lowered yields and enatioselectivities were also obtained with (R)-H8-
BINAPO 1.28, on increasing the S/C ratio to only 500 (entry 3 vs 4). The reaction with 
Spiropo 1.29, however, proved the most robust; only a slight decrease in yield was observed 
on changing the S/C ratio from 100 to 5000 (entry 5 vs 6).
39
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Table 1.4: Effect of S/C ratio on hydrogenation of 2-methylquinoline.
a 
Entry Ligand S/C ratio I2 / mol% % Yield % ee (Config)
b
 
1 (R)-1.18 200 10 94 94 (R)
c
 
2 c (R)-1.18 2000 1.0 7 -  
3 (R)-1.28 100 1.0 100 95 (R) 
4 (R)-1.28 500 1.0 48 76 (R) 
5 (R)-1.29 100 1.0 100 92 (R) 
6 (R)-1.29 5000 1.0 91 92 (R) 
a
Reagent and conditions: Quinoline (1.0 mmol), [Ir(COD)Cl]2 (see table), ligand (see table), I2 (1.0-10 mol%), 
CH2Cl2
 
(5 mL) , H2 (600-700 psi), rt, 20 h. 
b
Determined by chiral HPLC. 
c
Reaction conducted in toluene. 
 
The air-sensitivity of many of the catalysts described has driven much research into the 
development of more stable systems. To this end, three diamine-based catalysts were 
synthesised and used in the hydrogenation of 2-substituted quinolines (Scheme 1.4).
41
 
 
Scheme 1.4: Reagents and conditions: (i) 1.32, TFA, H2, MeOH, 15 °C; (ii) 1.33, HCOONa, 
pH 5 buffer solution, 40 °C; (iii) 1.34a, H2, [BMIM]PF6, 25 °C.  
 
The hydrogenation of 2-substituted tetrahydroquinolines proceeded well with 1 mol% of the 
iridium catalyst 1.32, in undegassed MeOH. The results were unaffected by exposing the 
reaction mixture to oxygen, or on stirring the catalyst under oxygen for 1 hour prior to use. 
Enantioselectivities and yields of 94-99% were consistently obtained, with the exception of 
2-phenyl quinolines, which proceed in 90% yield and 79% ee.
41
 The hydrogenation also 
proceeded well with the ruthenium catalyst 1.34a. Enantioselectivities of 96-99% and yields 
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of 87-97% were obtained, when the reaction was conducted in the ionic liquid [BMIM]PF6, 
without the need for additives. Furthermore, catalyst was found to be highly stable in the 
ionic liquid, with the same activity observed even after exposure to air for 30 days. The 
catalyst proved highly recyclable with retention of reactivity and ee observed over 6 cycles.
42
     
 
The asymmetric hydrogenation of various 2-substituted quinolines was also performed under 
transfer hydrogenation conditions using the rhodium catalyst 1.33 in water. Excellent yields 
and enantioselectivities were obtained, irrespective of the nature of the side chain, using a 
buffered system to maintain the reaction at pH 5. 96% yield and 90% ee was obtained for the 
notoriously difficult hydrogenation of 2-phenyl quinoline. The hydrogenation of 2, 3-
disubstituted quinolines was also achieved in excellent yields, ee‟s and d.r‟s., giving the syn 
disubstituted product as the major diastereoisomer (Scheme 1.5).
43
  
 
Scheme 1.5: Hydrogenation of 2, 3-disubstituted quinolines. 
 
In summary, the first asymmetric hydrogenation of quinolines was developed by Zhou, using 
a Ir[COD)Cl]2/(R)-MeO-Biphep catalytic system and I2 as activator. A range of 2-alkyl 
substituted tetrahydroquinolines were formed in excellent ee‟s and yields. In contrast, the 
reduction of 2-phenylquinoline proceeded with lower enantioselectivity. Subsequently, a 
variety of different diphosphine ligands have been reported. The use of P-Phos as ligand 
created an air stable catalyst, which afforded comparable enantioselectivities to MeO-Biphep. 
This catalyst could also be recycled and reused in the reaction with comparable ee. Very good 
results were achieved with the ligand 1.29 at low catalytic loadings. To date, there is only one 
example where 2, 3- tetrahydroquinolines were successfully formed in good yields, ee‟s and 
dr‟s, using a Ph catalyst. 
 
In the next section, the hydrogenation of quinolines using non-metal, phosphoric acid 
catalysts will be presented.           
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1.1.2 Non-metal catalysed hydrogenations 
The non-metal catalysed asymmetric hydrogenation of various 2-substituted quinolines can 
be achieved using chiral phosphoric acids 1.36a and 1.37 as catalyst and the Hantzsch ester 
1.35a as the hydrogen source (Scheme 1.6).
29, 44  
 
 
Scheme 1.6: Phosphoric acid-catalysed hydrogenation of 2-substituted quinolines. 
 
Table 1.5: Hydrogenation of 2-substituted quinolines using chiral phosphoric acids.
a
 
Entry 
Chiral phosphoric acid 
(mol%) 
R Temp/ °C % Yield % ee, (Config)
b
 
1 (R)-1.36a (2.0 mol%) n-Bu 60 91 87 (R) 
2 (R)-1.36a (2.0 mol%) n-pent 60 88 90 (R) 
3 (R)-1.36a (2.0 mol%) Ph 60 92 98 (S) 
4 (R)-1.37 (0.2 mol%) n-Bu 35 99 94 (R) 
5 (R)-1.37 (0.2 mol%) n-pent 35 99 92 (R) 
6 (R)-1.37 (0.2 mol%) Ph 35 99 96 (S) 
a
Reagents and conditions: Quinoline (0.1 mmol), 1.35a (2.4 eq), phosphoric acid (see table), 20 h. 
b
Determined 
by chiral HPLC. 
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Changing the length of the side chain from an n-butyl group to an n-pentyl group, had little 
effect on the results obtained (Table 1.5, entry 1 vs 2 and 4 vs 5). Good enantioselectivities 
and yields were also obtained for the hydrogenation of 2-phenylquinoline (entries 3 and 6). 
Thus, this appears to be a complementary methodology to the metal catalysed reactions.   
 
Unusually, the hydrogenation of 3-substituted quinolines was also attempted using the chiral 
phosphoric acid catalyst 1.38a, with the allyl-substituted 1.35b as the hydrogen source 
(Scheme 1.7). The reaction proceeded to give the tetrahydroquinolines in moderate ee (77-
86%) and variable yields (30-76%).
45
 
 
Scheme 1.7: Hydrogenation of 3-substituted quinolines. 
 
In summary, chiral phosphoric acids catalyse the hydrogenation of 2-substituted quinolines, 
with Hantzsch esters as the hydrogen source, to give optically pure tetrahydroquinolines. The 
hydrogenation of 2-phenylquinoline, which often proves difficult for metal-catalysed 
processes, was achieved in good ee‟s and yields with both phosphoric acids 1.36a and 1.37. 
The rarely reported hydrogenation of 3-substituted tetrahydroquinolines was achieved with 
the chiral phosphoric acid 1.38a in moderate ee‟s and variable yields.   
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1.1.3 Applications to natural product synthesis 
The Galipea alkaloids precursors 1.39-1.42 have all been synthesised by asymmetric 
hydrogenation of quinolines. The Galipea alkaloids are easily obtainable from the reduced 
product, by the methylating of the nitrogen (Scheme 1.8).
29
  
  
Scheme 1.8: Synthesis of the Galipea Alkaloids via asymmetric hydrogenation. 
 
A large number of the systems previously described have been applied to the synthesis of the 
angustureine precursor 1.39, in excellent enantioselectivities of 90-96%.
33-35, 38, 39
 Fewer 
systems, however, were used for the synthesis of the other Galipea alkaloids (Table 1.6). The 
original [Ir(COD)Cl]2/MeO-Biphep system developed by Zhou
20
 was applied to the 
synthesise of angustureine, cuspareine and galipinine precursors 1.39, 1.41 and 1.42, 
respectively, in good yields and enantioselectivities (Table 1.6, entries 1-3). In comparison, 
hydrogenation using the [Ir(COD)Cl]2 system with Segphos 1.26
36
 proceeded in lower yields 
and enantioselectivities (entries 4-6). This was also the case with the ferrocenyloxazoline 
ligand 1.27,
40
 which proceeded to give two of the tetrahydroquinolines 1.39 and 1.41, in 
lower enantioselectivities of 92% and 87% (entries 7-8). On the other hand, the use of the air 
stable diamine iridium and ruthenium catalysts 1.32
41
 (entries 9-11) and 1.34a
42
 (entries 14-
16) proceeded to give the precursors 1.39, 1.41 and 1.42 in excellent yields and 
enantioselectivities, whilst the Rh complex 1.33
43
 afforded 1.39 and 1.42 with similar results 
(entries 12 and 13). Last but not least, the phosphoric acid catalysts 1.36a
29
 and 1.37
44
 were 
used for the synthesis of 1.39, 1.41 and 1.42, with the reactions proceeding to give the 
tetrahydroquinolines in excellent yields but somewhat lower enantioselectivities (entries 17-
22).  
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Table 1.6: Synthesis of Galipea alkaloids via asymmetric hydrogenation reactions.
a
 
Entry Product Cat. System 
Cat. 
Loading/ 
mol% 
% 
Yield 
% ee, 
(Config)
b
 
1 1.39 [Ir(COD)Cl]2/(R)-1.18, H2, I2 0.5 92 94 (R)  
2 1.41 [Ir(COD)Cl]2/(R)-1.18, H2, I2 0.5 86 96 (R) 
3 1.42 [Ir(COD)Cl]2/(R)-1.18, H2, I2 0.5 88 93 (R) 
4 1.39 [Ir(COD)Cl]2/(S)-1.26, H2, H2O, 
Et3SiH 
1 96 88 (S) 
5 1.41 [Ir(COD)Cl]2/(S)-1.26, H2, H2O, 
Et3SiH 
1 84 83 (S) 
6 1.42 [Ir(COD)Cl]2/(S)-1.26, H2, H2O, 
Et3SiH 
1 94 86 (S) 
7 1.39 [Ir(COD)Cl]2/(S, S)-1.27, H2, I2 0.5 94 92 (R) 
8 1.41 [Ir(COD)Cl]2/(S, S)-1.27, H2, I2 0.5 82 87 (R) 
9 1.39 (S, S)-1.32 0.2 98 96 (S) 
10 1.41 (S, S)-1.32 0.2 96 96 (S) 
11 1.42 (S, S)-1.32 0.2 97 97 (S) 
12 1.39 (S)-1.33 1 92 97 (S) 
13 1.42 (S)-1.33 1 85 97 (S) 
14 1.42 (S, S)-1.34a 1 96 98 (S)  
15 1.41 (S, S)-1.34a 1 96 97 (S) 
16 1.39 (S, S)-1.34a 1 97 98 (S) 
17 1.39 (R)-1.36a/1.35a 2 88 90 (R) 
18 1.41 (R)-1.36a/1.35a 2 95 90 (R) 
19 1.42 (R)-1.36a/1.35a 2 94 91 (R) 
20 1.39 (R, R)-1.37/1.35a 0.2 99 92 (R) 
21 1.42 (R, R)-1.37/1.35a 0.2 99 95 (R) 
22 1.41 (R, R)-1.37/1.35a 0.2 99 90 (R) 
a
Reagent and conditions: Quinoline (1.0 mmol), catalyst (see table). 
b
Determined by chiral HPLC. 
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There is only one reported total synthesis of (-)-galipeine, which was achieved by asymmetric 
hydrogenation (Scheme 1.9).
19
       
 
Scheme 1.9: Reagents and conditions: (i) BnCl, NaHCO3, KI, MeCN, 89%; (ii) NaBH4, 
MeOH, 96%; (iii) PBr3, Et2O/pyridine, 85%; (iv) Quinaldine, n-BuLi, Et2O, 
86%; (v) [Ir(COD)Cl]2/ (S)-MeO-Biphep, I2, H2 (500 psi), toluene, 94%, (vi) 
HCHO, AcOH, NaBH3CN, MeCN, 96%; (vii) 5% Pd/C, EtOAc, AcOH, 95%. 
The benzyl bromide 1.43 was synthesised from the commercially available isovanillin in 
three steps.  Lithiation of quinaldine with n-BuLi, followed by the addition of 1.43 gave the 
2-substituted quinoline 1.44. Asymmetric hydrogenation, using the [Ir(COD)Cl]2/(S)-MeO-
Biphep system developed by Zhou, proceeded to give the tetrahydroquinoline 1.45 in 94% 
yield and 96% ee. Finally, methylation of the tetrahydroquinoline nitrogen and removal of the 
benzyl protecting group gave (-)-galipeine in 7 steps with 54% overall yield.  
 
The total synthesis of flumequine 1.9a, has also been achieved by asymmetric hydrogenation 
as the key step (Scheme 1.10). Using the chiral phosphoric acid catalyst 1.38a, the THQ 1.47 
was formed in 83% yield and 95% ee. Alkylation of 1.47 with diethyl(ethoxymethylene) 
malonate 1.48 gave 1.49, which was subjected to electrophilic cyclisation and hydrolysis to 
form the tricyclic fluoroquinoline in 5 steps with an overall yield of 61%.
46
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Scheme 1.10: Reagent and conditions: (i) 1.38a, 1.35a, benzene, 60°C, 95%; (ii) 125 °C then 
10 mbar; (iii) PPA, 110 °C; (iv) H2O, H
+
, 100 °C.  
 
1.1.4 Mechanism 
The hydrogenation of various 2-substituted tetrahydroquinolines by the Ru-hydride catalyst 
1.34b has been investigated very recently (Scheme 1.11).
47
 
 
Scheme 1.11: Hydrogenation system investigated for mechanistic studies. 
Activation of the quinoline by binding to the catalyst is required prior to the hydrogenation 
step. The subsequent additions of H2 may proceed via two possible pathways (Scheme 1.12).  
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 Scheme 1.12: Two possible hydrogenation mechanisms. 
To determine the operating mechanism, the N-benzoyl protected 1.53b was prepared and 
subjected to the hydrogenation conditions. No conversion to the product was observed 
(Scheme 1.13). In contrast, the hydrogenation of the imine 1.52b proceeded to give the 
desired tetrahydroquinoline in comparable ee and yield to that obtained on hydrogenation of 
the quinoline. In addition, the presence of the imine intermediate 1.52b was detected in the 
reaction mixture by 
1
H NMR and ESI-HRMS. This confirmed that the hydrogenation 
proceeds along pathway 1, through the imine.
47
 Therefore, the key step in the mechanism is 
proposed to take place via enantioselective hydride transfer to the imine, catalysed by the 
(re)coordination of the catalyst to the nitrogen of the dihydroquinoline intermediate (Scheme 
1.12).    
 
 
Scheme 1.13: Determination of reaction pathway 
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Although the hydrogenation of 2-substituted tetrahydroquinolines proceeded smoothly, 
allowing for the synthesis of some biologically interesting tetrahydroquinolines, there are 
very few examples where asymmetric hydrogenation has been applied to the synthesis of 3-
substituted tetrahydroquinolines and, as yet, there are no examples of the asymmetric 
hydrogenation of 4-substituted quinolines. This limits the application of the methodology to 
the synthesis of more complex natural products. In the next section we will discuss the 
formation of tetrahydroquinolines using aza-Diels-Alder reactions, often used for the 
synthesis of highly substituted tetrahydroquinolines.     
 
1.2 Diels-Alder reaction 
The aza-Diels-Alder reaction known as the Povarov reaction,
48
 describes a [4+2] 
cycloaddition reaction between N-arylimines and electron rich dienophiles. It is one of the 
most popular and powerful synthetic methods for the synthesis of 1, 2, 3, 4-substituted 
tetrahydroquinolines (Scheme 1.14).  
 
Scheme 1.14: General aza-Diels-Alder reaction for the formation of tetrahydroquinolines. 
These cyclisations are also described as „inverse electron demand‟ (IED) reactions, where the 
HOMO of the dienophile reacts with the LUMO of the diene. They occur when the aza-diene 
is very electron poor and the dienophile contains electron donating groups (Scheme 1.15).
49
 
 
 
Scheme 1.15: Normal and inverse electron demand aza-Diels-Alder reactions.
4
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Lewis acid catalysts are widely used for IED aza-Diels-Alder reactions, during which, up to 
three chiral centres can be created. The catalyst acts by coordination to the aza-diene, 
enhancing the interaction between the HOMO and LUMO orbitals.
50
  
 
In this section, the synthesis of 2, 4-substituted tetrahydroquinolines and 2, 3, 4-substituted 
tetrahydroquinolines via IED Diels-Alder reactions will be described. The mechanism of the 
reaction will be discussed initially, followed by examples of metal-catalysed reactions. This 
will be followed by non-metal catalysed IED Diels-Alder reactions, and finally the chapter 
concludes with examples where these Diels-Alder reactions have been applied to the 
synthesis of some biologically interesting tetrahydroquinolines.    
 
1.2.1 Mechanism 
Whilst the Diels-Alder reaction is generally believed to proceed with retention of the alkene 
geometry, the BF3.OEt2 catalysed reaction of N-arylimines with trans 1, 4-disubstituted 
dienes gave the syn 2, 3, 4-substituted tetrahydroquinoline exclusively, i.e. the 
stereochemifstry of the diene was not conserved in the product (Scheme 1.16).
51
  
 
Scheme 1.16: Diels-alder reaction of an imine with a 1-mono substituted diene. 
 
Based on these observations, an ionic mechanism was proposed, where the diene approaches 
the activated imine along the least hindered pathway to create a cationic intermediate 
(Scheme 1.17). Attack by the aromatic ring, after C-C bond rotation, yielded the 
tetrahydroquinoline derivative.  
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Scheme 1.17: Ionic pathway for the aza-Diels-Alder reaction.
51
 
1.2.2 Metal catalysed aza-Diels-Alder reactions 
The first catalytic asymmetric aza-Diels-Alder reaction of N-benzylidiene-2-hydroxyaniline 
with cyclopentadiene was reported by Kobayashi and co-workers, using a chiral ytterbium-
BINOL complex (Scheme 1.18).
52
  
 
 
Scheme 1.18: Diels-Alder reaction of cyclopentadiene with N-benzylidiene-2-
hydroxyaniline. 
 
Without any additives, the reaction between 1.56 and cyclopentadiene proceeded to give the 
syn isomer, as shown in 1.57, almost exclusively (>98:2) in 62% ee. The use of N- 
benzylideneaniline gave no chiral induction, so it was suggested that the presence of the 
phenol group on 1.56 allowed for the bidentate binding of the catalyst, leading to 
enantioselective control. The addition of 2, 6-di-tert-butylpyridine to interact with the 
phenolic hydrogen, improved the results, giving the cycloadduct in 92% yield and 71% ee. 
The phenolic hydrogen-additive interaction is believed to fix the aza-diene in place (Figure 
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1.10). In addition, the BINOL-ligated Yb complex is believed to form two hydrogen bonds 
with DBU, transferring the axial chirality of the ligand into the reaction sphere and shielding 
the top face of the imine from attack.  
 
Figure 1.10: Binding of chiral Lewis acid and additive to the aza-diene. 
 
Recently, Xie et al. reported the synthesis of fused tetrahydroquinolines using a Sc(OTf)3 
complex with a chiral N,N’-dioxide ligand (Scheme1.19). 53  
Scheme 1.19: Sc(OTf)3 catalysed synthesis of THQ. 
 
A range of aromatic aldehydes were reacted with 2-hydroxyaniline and cyclopentadiene to 
produce the tetrahydroquinolines with preferential formation of the syn isomer 1.61 (>90:10), 
in excellent enantioselectivities (>90%). Aliphatic aldehydes were also suitable substrates, 
giving the tetrahydroquinolines with enantioselectivities between 94-99%. The reaction is 
both air- and moisture- tolerant, and catalytic loading can be reduced to 2.5 mol% without 
loss of selectivity. Although the reaction can tolerate a range of aldehydes, the choice of 
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aniline is limited to those containing a hydroxyl group in the 2-position, and attempts to use 
other dienophiles were also unsuccessful.    
 
 
In 2001, Sundererjan et al. reported the asymmetric synthesis of tetrahydroquinolines using a 
chiral titanium complex generated from a mixture of di-isopropoxide titanium dichloride with 
the amino diol ligand 1.63.
50
 The cycloadditions of several dienophiles with benzylidene 
aniline were examined in the presence of this titanium complex (Scheme 1.20). The reaction 
gave mixtures of the syn- and anti- isomers in varying ratios and enantioselectivities (Table 
1.7). 
 
Scheme 1.20: Titanium catalysed Diels-Alder reaction of N-aryl imines. 
Table 1.7: Results of Ti catalysed IED Diels-Alder reaction of various dienophiles.
a
 
Entry Dienophile T/ 
o
C 
% 
Conversion 
Ratio of 
syn/anti 
% ee of syn
b
 % ee of anti
b
 
1 Dihydropyran 0 60 0.25 92 10 
2 Ethylvinyl ether 35 65 0.67 90 50 
3 Dihydrofuran 0 50 2.33 82 90 
4 Cyclopentadiene 35 58 1 51 - 
a
Reagents and conditions: 1.63-TiCl2 (0.6 mmol), benzylidene aniline (2.0 mmol), dienophile (2.0 mmol), 
CH2Cl2/toluene (2:1) (5 mL). 
b
Determined by chiral HPLC. 
 
The reaction of benzylidene aniline with dihydropyran or ethylvinyl ether proceeded to give 
the anti isomer as the major product in low ee, while a higher ee was obtained for the minor 
syn isomer (Table 1.7, entries 1 and 2). Conversely, the syn isomer was preferentially formed 
when dihydrofuran was used, and both isomers were produced in good enantioselectivities 
(entry 3). With cyclopentadiene as the dienophile, the syn isomer was formed exclusively in 
moderate ee (entry 4).  
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1.2.3 Non-metal catalysed Diels-Alder reactions 
Several reports of the synthesis of tetrahydroquinolines using chiral phosphoric acids of type 
1.36 have been published (Scheme 1.21 and Scheme 1.22).   
 
Scheme1.21: Phosphoric acid catalysed reaction of aldimine and ethyl vinyl ethers.
 
 
The reaction of imines of type 1.64 with enol ethers of type 1.65, catalysed by 1.36a, resulted 
in the formation of THQ‟s 1.66 in a syn /anti ratio of 99:1, with up to 97% ee and 95% yield. 
A range of aromatic groups and a variety of different enol ethers, both cyclic and acyclic, 
were well tolerated. However, the presence of the OH group on the N-aryl again proved 
essential for the attainment of high enantioselectivities. The reaction is believed to proceed 
through a 9-membered cyclic intermediate (Figure 1.11), where the chiral catalyst binds to 
the phenolic hydrogen and nitrogen of the imine by hydrogen bonds. This hydrogen bonding 
encases the imine within a chiral environment, leading to the selectivity observed.
4
   
 
Figure 1.11: Suggested 9-membered cyclic intermediate in the reaction of 1.64 and 1.65. 
 
Vinylindoles 1.68 and 1.69 have also been successfully adopted as dienophiles with 1.36b as 
catalyst (Scheme 1.22).  
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Scheme 1.22: Chiral phosphoric acid catalysed Diels-Alder reaction with vinylindole. 
All tetrahydroquinoline products were produced in excellent d.r. of >90:10 and 
enantioselectivies of >90%, regardless of the steric or electronic nature of the aromatic 
imine.
54
 
 
These chiral phosphoric acid catalysed reactions have been used for the synthesis of more 
complex structures, such as tricyclic Julolidine derivatives of type 1.74 (Scheme 1.23).
55
  
Scheme 1.23: Synthesis of Julolidines. 
In these reactions the aniline 1.71 first condenses with the aldehyde 1.72 to form the imine 
intermediate I in situ. Activation of the imine by the binding of the phosphoric acid catalyst 
1.36a initiates the reaction with the enamide 1.73, producing the intermediate II, which 
subsequently undergoes a hydroamination reaction catalysed by the gold complex to give the 
intermediate III. Reduction of the imine proceeds to give syn-1.74 as the major product. 
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A range of Julolidine derivatives were synthesised in good yields (60-72%) and excellent 
enantioselectivities (92-99%) (Table 1.8). The use of both electron-donating and withdrawing 
aldehydes had no effect on the enantioselectivities obtained in the reaction (Table 1.8, entry 3 
vs 2 and 4) and the presence of electron-withdrawing groups in the R
1
 and R
2
 positions were 
also well tolerated (entries 5 and 6).
55
     
Table 1.8: Formation of Julolidine derivatives by Diels-Alder reactions.
a
 
Entry R
1
 R
2
 R
3
 % Yield
b,d
 % ee
c,d
 
1 H Ph Ph 67 (12) 92 (92) 
2 H Ph 4-Cl-Ph 70 (15) 96 (97) 
3 H Ph 4-MeO-Ph 61 (7) 94 (92) 
4 H Ph 4-CN-Ph 70 (14) 97 (97) 
5 H 4-F-Ph 4-Br-Ph 61 (16) 97 (96) 
6 4-Cl Ph 4-Br-Ph 62 (20)  99 (99) 
a
Reagents and conditions: Aniline (0.1 mmol), aldehyde (1 eq), enamine (3 eq), (Ph3P)AuMe (10 mol%), 3 Å 
MS, 1.36a (15 mol%), -40 °C, 24 h. 
b
Isolated yield. 
c
Determined by Chiral HPLC. 
d
The data in parentheses are 
the values corresponding to the minor diastereoisomer of 1.74. 
 
The synthesis of Torcetrapib 1.16 can be achieved in four steps, employing a three 
component Diels-Alder reaction with N-vinyl carbamates as the dienophile (Scheme 1.24).  
 
Scheme 1.24: Reagent and conditions: (i) ClCO2Et, py., 88%; (ii) Pd/C, H2, ClCO2Me, py., 
81%; (iii) KH, 3,5-di-CF3-benzyl bromide, 79%.  
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The two chiral centres were installed using an IED Diels-Alder reaction in the presence of 10 
mol% of the BINOL-derived phosphoric acid 1.38b. The reaction furnished the 
tetrahydroquinoline in 57% yield and 93% enantioselectivity. Torcetrapib was obtained from 
the cycloadduct 1.75 in three further synthetic steps with 56% overall yield, by removal of 
the Cbz protecting group, followed by alkylation of the heteroatoms (Scheme 1.25).
56
  
  
There are other literature reports for the diastereoselective formation of tetrahydroquinolines 
using aza-Diels-Alder reactions.
13, 57-63
 However, these racemic compounds will not be 
discussed here, likewise for reactions with limited substrate scope.  
 
Miscellaneous reports of the enantioselective synthesis of biologically interesting 
tetrahydroquinolines will be discussed in the next section, all involving the addition of a X-H 
across an unsaturated C-C bond.    
   
1.3 Heterofunctionalisation of alkenes and alkynes 
The addition of amines to C-C unsaturated bonds is atom-economical and as a result is a 
highly topical research area.
64, 65
 Addition of the amine to the C-C bond can either occur in an 
intermolecular or intramolecular manner, and both have been utilised in the synthesis of 
optically active tetrahydroquinolines.   
 
1.3.1 Intermolecular reactions 
There are three examples where the intermolecular aza-Michael reactions have been used for 
the synthesis of tetrahydroquinolines. The first two examples involve the addition of an 
aniline to an α, β-unsaturated carbonyl compound (Scheme 1.25). This forms a chiral centre 
which will become the C-2 position of the tetrahydroquinoline. 
Scheme 1.25: Tetrahydroquinoline synthesis using an aza-Michael reaction. 
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The core structure of the Martinelline alkaloids has been synthesised in good 
enantioselectivity, using an asymmetric tandem Michael-aldol reaction.
66
   
Scheme 1.26:  Synthesis of the core structure of the Martinelline alkaloids. 
The reaction of the requisite α, β-unsaturated carbonyl 1.78 with the 2-amino benzaldehydes 
derivatives 1.77 was conducted in the presence of the organocatalyst (S)-diphenylprolinol 
triethyl silyl ether 1.79 (Scheme 1.26). Interestingly, the nature of the substituent R
1
 was 
found to have a dramatic effect on the ee obtained. When an O-TBDMS group was present, 
the reaction proceeded to give the 2-substituted dihydroquinoline 1.80a as a racemic mixture, 
however, on changing to an O-benzyl group, 86% ee was obtained. With extensive 
optimisation of the reaction conditions, the dihydroquinoline was produced in 92% yield and 
97% ee. 
66
 
 
Further functional group manipulation of the alkene allowed for the synthesis of the 
pyrroloquinoline core (Scheme 1.27). It was envisioned that the stereochemistry set at the C-
2 position would direct bond formations at the C-3 and C-4.
66
 
Scheme 1.27: Application of the tandem Michael aldol reaction to the synthesis of 
Martinelline alkaloids. 
 
Previously, our research group have been working on the development of an asymmetric aza-
Michael reaction, between anilines and α, β-unsaturated di-carbonyl compounds, using a 
chiral Pd-complex catalyst (Scheme 1.28).
67, 68
 Previous work has shown the best 
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enantioselectivities and yields are obtained when N-carbamates
69
 are used in combination 
with C2-symmetrical biaryl diphosphine ligands.
70
 
 
Scheme 1.28: Asymmetric aza-Michael reaction. 
This reaction has been applied to the synthesis of Torcetrapib 1.16, which contains 2 chiral 
centres at the C-2 and C-4 positions. The addition of 4-trifluoromethylaniline to the α, β-
unsaturated carbamate 1.84 was investigated (Scheme 1.29). The asymmetric aza-Michael 
reaction was used to set the stereochemistry at the C-2 position, which directed the formation 
of the second chiral centre in a stereospecific ring cyclisation.  
Scheme 1.29: Aza-Michael reaction used in the synthesis of Torcetrapib. 
The chiral palladium catalyst was formed in situ from Pd(OTf)2 and the diphosphine ligand. 
(S)-BINAP and (S)-P-Phos 1.21 proved to be the best ligands giving yields of ca. 80% and 
90% ee. Optically pure aza-Michael product 1.85 was obtained upon recrystallisation from 
cyclohexane/toluene. Torcetrapib was then synthesised in three further steps (Scheme 1.30); a 
Lewis acid catalysed reductive cyclisation reaction proceeded to give the 2, 4-disubstituted 
tetrahydroquinoline 1.86, as a single diastereoisomer, in 92% yield. Derivatization of both 
nitrogens gave Torcetrapib 1.16. The overall synthetic sequence comprises of 7 steps and 
proceeded in 26% overall yield.
24
 
 
Scheme 1.30: Synthesis of Torcetrapib: (i) NaBH4, MgCl2, 92%; (ii) ClCO2Et, py., 82%; (iii) 
3,5-bis(trifluoromethyl) benzyl bromide, KO
t
Bu, 52%. 
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The tandem conjugate addition/cyclisation reaction of the homochiral lithium amide 1.88 
(98% ee) with α, β-unsaturated esters of type 1.87 produced the densely substituted 4-
aminotetrahydroquinoline 1.89 as a single diastereoisomer in 98% enantioselectivity and 75% 
yield, after N-Boc protection (Scheme 1.31).    
 
Scheme 1.31: Enantioselective tetrahydroquinoline formation utilising optically pure starting 
materials. 
The reaction proceeds via the conjugate addition of the amide, which installs the first 
stereocentre at the C-4 position and produces the (Z)-lithium enolate 1.90. The cyclisation 
reaction proceeds through a boat transition state, with the Re face of the enolate is directed 
towards the imine as a result of the lithium-chelation (Scheme 1.32), producing the 
tetrahydroquinoline as the 2, 3-syn, 3, 4-anti isomer.     
Scheme 1.32:  Stereochemical pathway for the cyclisation reaction 
A range of addition/cyclisation precursors were synthesised, with the phenyl group at C-2 
replaced by various other aryl functionalities, including furan-2-yl. In all cases the 2, 3-syn 3, 
4-anti tetrahydroquinoline was formed selectively in excellent yields (73-98%).
71
   
 
1.3.2 Nucleophilic cyclisations 
The asymmetric intramolecular aza-Michael reaction of tert-butyl ester activated α, β-
unsaturated ketones of type 1.91, proceeded to give optically active tetrahydroquinolones in 
the presence of a chiral phosphoric acid 1.92 (Scheme 1.33).
72
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Scheme 1.33: Intramolecular aza-Michael cyclisation. 
A range of different substrates were subjected to the cyclisation (Table 1.9), with different 
aryl groups accommodated at C-2. The tetrahydroquinolones were obtained in excellent 
yields after removal of the tert-butyl carboxylate group, post cyclisation. The 
enantioselectivity was found to be highly dependent on the nature of the substrate. The 
presence of an electron withdrawing group, such as a bromide or nitro, on the aromatic R
1
 led 
to a decrease in ee (Table 1.9, entry 1 vs 2 and 3). The highest enantioselectivity of 82% was 
obtained when a 4-tolyl substitutent was present (entry 4). Surprisingly, the location of the 
substituent on the phenyl ring also appeared to have a significant effect on the 
enantioselectivity; 60% ee was obtained when a methoxy group was present at the para 
position of the phenyl ring, whereas a methoxy group on the ortho position afforded near 
racemic material (entry 5 vs 6).       
 
    Table 1.9: Substrate scope for intramolecular aza-Michael reaction.
a
 
Entry R
1
 Yield %
b
 ee %
c,d
 
1 Ph 95 72 (-) 
2 4-Br-C6H4 90 58 (-)-(S)
e
 
3 4-NO2-C6H4 77 20 (-) 
4 4-Me-C6H4 98 82 (-) 
5 4-MeO-C6H4 94 60 (-) 
6 2-MeO-C6H4 95 4 (+) 
a
Reagents and conditions: 1.92 (10 mol%), aniline (0.1 mol/L in toluene). 
b
Isolated yields. 
c
Determined by chiral 
HPLC. 
d
Optical rotation. 
e
Absolute configuration was determined by X-ray analysis. 
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In 2007, Yamamoto et al. showed that anilino-alkynes cyclise upon treatment with Pd(PPh3)4 
and (R,R)-RENORPHOS, in the presence of benzoic acid, to give 2-substituted 
tetrahydroquinolines as a single E-isomer. Enantioselectivities of up to 78% and yields of 61-
73% were obtained. The method was used to prepare (-)-angustureine in two steps from 1.94 
with 48% yield and 52% ee (Scheme 1.34).
73
  
 
Scheme 1.34: Intramolecular cyclisation reaction to form angustureine. 
The proposed catalytic cycle involves the initial formation of a hydridopalladium species, 
created by reaction of Pd
0
 with benzoic acid (Scheme 1.35). This inserts into the alkyne to 
give a vinylpalladium intermediate 1.95, which undergoes β-hydride elimination to give an 
allene 1.96. The π-allyl moiety 1.97 then forms from the re-insertion of Pd-H and the product 
is produced by an intramolecular nucleophilic attack of the amine.
73
  
 
Scheme 1.35: Proposed mechanism for cyclisation of aniline-alkynes. 
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An intramolecular palladium-catalysed asymmetric allylic substitution reaction has been 
utilised by Hamada et al. for the synthesis of optically active tetrahydroquinolines (Scheme 
1.36).
74
 
 
Scheme 1.36: Cyclisation of ortho-substituted aniline sulfonamides. 
The cyclisation proceeded using Pd(dba)2 and the bicyclic phosphine ligand 1.98a or 1.98b, 
in the presence of bis(trimethylsilyl)acetamide and lithium acetate. The tetrahydroquinoline 
products were obtained in good enantioselectivities of up to 92% but, in relatively low yields 
(55-68%). This cyclisation proceeded through a π-allyl palladium species, formed by 
displacement of the acetate group with palladium. Nucleophilic attack of the deprotonated 
amine onto the π-allyl species gave the tetrahydroquinoline.     
 
This methodology was applied to the synthesis of the Martinelline alkaloids in 9 steps and 
43% yield from commercially available starting materials (Scheme 1.37).
75
  
 
Scheme 1.37: Synthesis of Martinelline alkaloid core. 
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The cyclisation of racemic 1.99 using (-)-9-PBN 1.98a, in the presence of LiOAc, gave the 
tetrahydroquinoline 1.100 as a 68:32 mixture of syn:anti isomers, in 60% ee (Scheme 1.37). 
The alkene geometry of the starting material had no effect on the diastereoselectivity 
obtained.  However, changes in the nature of the alkoxy protecting group R
2
 were found to 
have a significant effect. Oxidation of 1.100 gave the ketone 1.101, from which the 
pyrroloquinoline core structure was synthesised in 5 steps with only 9% overall yield.
75
  
 
In summary, a number of different heterofunctionalisation reactions have been used for the 
synthesis of tetrahydroquinolines. These reactions have been applied to the synthesis of 
several biologically interesting tetrahydroquinolines. Three intermolecular aza-Michael 
reactions were discussed, with the synthesis of 2, 3, 4-trisubstituted tetrahydroquinolines 
achieved by the tandem conjugate addition/cyclisation reaction of a chiral lithium amide. The 
reaction proceeded to give the 2, 3-syn, 3, 4-anti isomer only. In addition 2, 4-syn 
disubstituted tetrahydroquinolines were formed using the aza-Michael reaction of anilines 
with α, β-unsaturated carbamates, followed by a stereospecific cyclisation reaction. This 
methodology was applied to the synthesis of the 2, 4-disubstituted natural product 
Torcetrapib 1.16. The core structure of the Martinelline alkaloids 1.14-1.15 was successfully 
synthesised in good yields and enantioselectivity using a tandem aza-Michael/aldol reaction.  
 
In addition, synthesis of the core structure of the Martinelline alkaloids was achieved in 
moderate yield and enantioselectivity but low diastereoselectivity, via the intramolecular 
addition of aniline to a π-allyl palladium species. Also, angustureine was formed by an 
intramolecular cyclisation reaction in excellent yield but very poor enantioselectivity. Despite 
the application of these addition reactions to the synthesis of a number of natural products, 
the reactions were highly specific, with variations often proceeding to give poor results.  
 
1.4 Miscellaneous approaches 
1.4.1 Metal catalysed cyclisation 
In the presence of 10 mol% of an optically active thiolate-bridged diruthenium complex 
1.104 and 20 mol% of NH4BF4, the acyclic substrate 1.103 reacted to give the 3, 4-
disubstituted tetrahydroquinolines 1.105 (Scheme 1.38).
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Scheme 1.38: Ruthenium catalysed formation of 1, 2, 3, 4-tetrahydroquinolines. 
The reaction proceeded in the good syn/anti ratio of 13/1, and the syn isomer was formed 
with up to >95% ee, regardless of the nature of the Ar group. This cyclisation reaction is 
believed to proceed via Ru-alkylidene intermediates, which rearrange to give the 
tetrahydroquinoline core (Scheme 1.39).
77
  
 
Scheme 1.39: Tetrahydroquinoline formation via cyclisation of propargylic alcohols bearing 
allylic amines.
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The potent CETP inhibitor 1.8 has been synthesised using an intramolecular cyclisation, 
under Fukuyama conditions (copper iodide and caesium carbonate in hot DMSO) (Scheme 
1.40). Asymmetric reduction of the prochiral ketone 1.106 proceeded in 91% ee and the 
resultant alcohol was converted to the amine 1.108 in 4 steps. Synthesis of the 
tetrahydroquinoline was achieved using a copper-mediated cyclisation reaction. Cross-
coupling to attach the aryl group in the 6 position was achieved by a Suzuki-Miyaura 
reaction, followed by alkylation of the tetrahydroquinoline nitrogen to give 1.8 
predominantly as the syn isomer in 73% yield.
79
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Scheme 1.40: Reagent and conditions: (i) (R)-Me-CBS, Me2S·BH3, 82-90%; (ii) MsCl, 
triethylamine, 100%; (iii) NaN3, DMF, 95%; (iv) Me2S·BHCl2, 95%; (v) 
NaCl, triethylamine, 95%; (vi) CuI, Cs2CO3, 96%; (vii) HSCH2CO2H, LiOH, 
88%; (viii) Pd(PPh3)4, m-CF3OC6H4B(OH)2, K2CO3, 91%; (ix) Yb(OTf)3, 1, 1, 
1-trifluoroepoxypropane, DCE, 50 °C, 73%.  
 
1.4.2 1,4-Addition reactions 
The 1, 4-addition of phenylzinc chloride to 2, 3-dihydro-4-pyridone, catalysed by a BINAP-
Rh complex, with chlorotrimethylsilane as an additive, proceeded to give 2-aryl substituted 
tetrahydroquinolines (Scheme 1.41). It is believed that the additive activates the substrate 
towards 1, 4-addition, by acting as a Lewis acid, and/or stabilises the product, by forming a 
silyl enol ether.
80
 
 
 
Scheme 1.41: Asymmetric 1, 4-addition reaction. 
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Table 1.10: Synthesis of 2-substituted tetrahydroquinolines using 1, 4-addition reactions.
a
 
Entry R Ar % Yield  % ee, (Config)
b
 
1 H Ph 88 98 (R) 
2 H 3,5-Me-Ph 100 98 (R) 
3 H 2-Tol 74 86 (R) 
4 4-Cl Ph 89 99 (R) 
5 4-Cl 4-Tol 82 88 (R) 
6 3,5-OMe Ph 87 99 (R) 
7 3,5-OMe Nap 92 98 (R) 
a
Reagent and conditions: [RhCl(C2H4)2]2 (7.5 mol%), (R)-BINAP (8.2 mol%), Me3SiCl (3.0 eq), THF, 20 °C, 20 
h. 
b
Determined by chiral HPLC. 
 
Excellent yields and enantioselectivities were obtained for the addition of a range of different 
arylzinc reagents. The reaction proceeded well with tolyl zinc reagents (Table 1.10, entries 2 
and 3), although 2-tolyl zinc chloride gave a slightly lower ee and yield than the reaction with 
4-tolyl zinc, probably as a result of steric congestion. The presence of both electron-
withdrawing and donating groups on the 4-quinolone had little effect on the results obtained, 
(entries 4 and 6) and the reaction proceeded smoothly with napthyl-zinc chloride to give the 
2-substituted tetrahydroquinolone in 98% ee.   
 
The 1, 4-addition of cyano groups to quinolines, catalysed by a chiral aluminium 
phosphonate complex 1.110 proceeded to give 2-substituted tetrahydroquinolines in good 
yields and enantioselectivities (Scheme 1.42).  
 
Scheme 1.42:1, 4-addition reaction of the cyano group catalysed by 1.110. 
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The presence of electron-donating groups on the quinoline, increased both the yield and 
enantioselectivity obtained (Table 1.11, entries 2-4), while the presence of electron 
withdrawing groups, gave less satisfactory results (entry 5).
11
  
 
Table 1.11: 1, 4-addition reaction of TMSCN.
a
 
Entry R
1
 % Yield
b
 % ee, (Config)
c
 
1 H 91 85 (R) 
2 4-MeO 74 89 
3 3,4-MeO 99 91 
4 4-NH2 72 89 
5 4-Cl 57 67 
a
Reagents and conditions: Catalyst 1.110 (9.0 mol%), TMSCN (2.0 eq), 2-furoyl chloride (2.0 eq), -40 °C. 
b
Isolated yield. 
c
Determined by chiral HPLC. 
 
This catalytic reaction was used for the synthesis of L-689,560 a potent NMDA receptor 
antagonist (Scheme 1.43). 
          
Scheme 1.43: Reagents and conditions: (i) 1 mol% 1.110, TMSCN, 2-furoyl chloride, CH2Cl2, 
-40 °C, (ii) NaBH3CN, AcOH, MeOH, 91%; (iii) HCl, MeOH, 93%; (iv) NaOH, 
EtOH; (v) HCl, MeOH; (vi) recrystallisation, 81%; (vii) Pd(PPh3)4 (5 mol%), 
1,3-dimethyl-barbituric acid; (viii) HCl, 92%; (ix) PhNCO, NEt3, 87%; (x) 
LiOH; (xi) H3O
+
, 85%.   
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Reaction of the di-chloroquinoline with TMSCN produced the dihydroquinoline 1.113 in 
91% yield and 93% ee. Enamine reduction proceeded to give the tetrahydroquinoline 
selectively as the anti isomer. Conversion of the cyano group to the carboxylic ester, 
followed by removal of the N-furoyl group gave 1.115; at this juncture, the enantioselectivity 
of the compound was enhanced to 99% by recrystallisation. Removal of the allyl groups, 
followed by formation of the urea at the C-4 position and hydrolysis of the ester, gave 
L,689,560.
11
               
 
1.5 Aim 
The aim of this project is the development of a new synthetic route to structurally diverse 
tetrahydroquinolines using a catalytic asymmetric aza-Michael reaction, previously 
developed in our group (Scheme 1.44).
81
  
 
 
Scheme 1.44: Palladium BINAP catalysed aza-Michael reaction. 
This work will focus on applying the strategy for the asymmetric synthesis of interesting 
tetrahydroquinolines including; the Galipea alkaloids, as well as more complex structures 
such as the Martinelline alkaloids and levonantradol. The key to these latter targets is to 
utilise the stereogenic centre at C-2 to direct the introduction of further substituents at C-3 
and C-4. This is guided by several examples of diastereoselective ring syntheses, where chiral 
centres already installed can be used to direct the formation of a second or third chiral 
centre.
11, 24, 82-85
 
 
  
 
 
 
 
 
 
 
 
 
 
CHAPTER TWO 
SYNTHESIS OF THE GALIPEA 
ALKALOIDS 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2  Synthesis of the Galipea alkaloids 
41 
 
2.0 Synthesis of the Galipea alkaloids  
This project was initiated with an investigation into the asymmetric total synthesis of the 
Galipea alkaloids (Figure 1.4). It would be advantageous to synthesise all four of the 
alkaloids from a common precursor, allowing for a more divergent route. We envisioned that 
2.1 would be an appropriate common precursor as all four alkaloids could be easily obtained 
by attachment of the appropriate side chain. Retrosynthetic analysis of the 
tetrahydroquinoline 2.1 led to the tetrahydroquinolone 2.2 (Scheme 2.1). This in turn should 
be accessible from 2.3, formed by the asymmetric aza-Michael reaction of aniline with 
Michael acceptors of type 2.4. This will be used to install the required stereochemistry of the 
alkaloids, starting from pro-chiral reagents.   
 Scheme 2.1: Retrosynthetic analysis of 2.1. 
 
Prior work in our research group investigated the enantioselective aza-Michael reaction of 
primary aromatic amines with α, β-unsaturated compounds. The addition of anilines to N-
alkenoyl oxazolidinones,
67
 N-alkenoyl carbamates
69
 and α, β-unsaturated N-imides86 occurred 
readily in very high selectivity, using a dicationic [(BINAP)Pd(solvent)2]
2+
 [TfO]
-
2 catalyst 
1.117 (Scheme 2.2, Table 2.1).  
Scheme 2.2: Palladium-catalysed addition of anilines to N-alkenoyl oxazolidinones, 
carbamates and imides. 
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Table 2.1: Aza-Michael reaction of N-alkenoyl oxazolidinones, N-alkenoyl carbamates and α, 
β-unsaturated N-imides.a 
Entry Product Cat. (mol%) R
1
 R
2
 % Yield
b
 % ee
c
 
1 2.5 10 H Me 93 93 
2 2.5 10 4-Me Me 85 73 
3 2.5 10 4-OMe Me 89 37 
4 2.5 10 4-Cl Me 96 90 
5 2.5 10 H Et 66 41 
6 2.5 10 H Pr 72 27 
7 2.6 2.5 4-Cl Me >99 >99 
8 2.7 5 4-Cl Me 84 73 
a
Reagent and conditions: ArNH2 (1 eq), alkene (1 eq), Cat. (x mol%), toluene, 25 °C, 18 h. 
b
Determined by 
1
H 
NMR. 
c
Determined by chiral HPLC. 
Similar reactivity trends were observed in each system, where the presence of an electron 
donating group on the aromatic amine (e.g. OMe) led to a decrease in the ee (Table 2.1, entry 
1 vs entries 2 and 3). However, the presence of an electron-withdrawing group, such as a 
chloride, had little effect on the results compared to using aniline (entry 1 vs 4). Increasing 
the chain length of R
2
 resulted in a significant decrease in the enantioselectivity (entry 1 vs 
entries 5 and 6). The highest enantioselectivities were obtained with N-alkenoyl carbamates 
(entry 7 vs 4 and 8).  
 
In this Chapter, the synthesis of the prochiral Michael acceptors from readily available 
starting materials will be described. Four different α, β-unsaturated carbamates were 
synthesised, using various alkene forming reactions, to investigate the effect the nature of the 
carbamate group has on the aza-Michael system. The optimisation of the reaction between 
aniline and the Michael acceptors is detailed next. On obtainment of optically pure aza-
Michael adducts, the formation of the tetrahydroquinolone ring was investigated, from which 
the common precursor 2.1 was obtained. Finally, the chapter concludes with the formation of 
the Galipea alkaloids via attachment of the side chains.     
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2.1 Synthesis of α, β-unsaturated carbamates 
In this work, N-alkenoyl carbamates were chosen as Michael acceptors for the synthesis of 
the Galipea alkaloids, as these previously gave the best results. Firstly, a range of α, β-
unsaturated carbamates, with general structure 2.8, were prepared. These were accessible 
from the Horner-Wadsworth-Emmons (HWE) reaction of phosphonate carbamates and 
protected -hydroxyl aldehydes (Scheme 2.3).    
 
Scheme 2.3: Retrosynthesis of the α, β-unsaturated carbamates. 
 
Synthesis of the protected α-hydroxy acetaldehydes was achieved by oxidation of a mono-
protected ethylene glycol (Scheme 2.4). Benzyl and tert-butyldiphenyl silyl were chosen as 
O-protecting groups.  
 
 
Scheme 2.4: Reagents and conditions: (i) BnBr, NaH, reflux, 16 h; (ii) TBDPSCl, imidazole, 
rt, 24h; (iii) Oxalyl chloride, DMSO, NEt3, CH2Cl2, -78°C. 
The desymmetrised alcohol 2.9 was obtained using published procedures, by the reaction of 
ethylene glycol with sodium hydride and benzyl bromide.
87
 The reaction gave a mixture of 
2.9 and the diprotected ethylene glycol in a 9:1 ratio, which separated by distillation to give 
the desired 2.9 in 83% yield. Alternatively, ethylene glycol was reacted with tert-
butyldiphenylsilyl chloride and imidazole to give 2.10 in a 78% yield, after purification by 
column chromatrography.
88
 In this case, there is no evidence of any disilylated product in the 
reaction mixture.   
 
The next step involved the oxidation of the protected alcohols to the corresponding 
aldehydes. Swern oxidation conditions
87, 89
 were used to produce the aldehydes 2.11 and 2.12. 
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Product formation was confirmed, in both cases, by the presence of an aldehyde proton 
resonance in the 
1
H NMR spectrum at 9.7 ppm. As these aldehydes were found to be unstable 
to isolation and storage, they were immediately employed in the HWE reaction without 
purification.  
 
Adopting published procedures,
24
 the phosphonate carbamates were prepared by the reaction 
of chloroacetyl chloride with the required carbamate at 100 °C to yield 2.13a and 2.13b 
(Scheme 2.5). These were subsequently heated with triethyl phosphite in an Arbuzov 
reaction, to afford 2.14a and 2.14b in 87% and 80% yields, respectively.  
 
 Scheme 2.5: Reagents and conditions: (i) 100 °C; (ii) P(OEt)3, 80 °C; (iii) 2.11 or 2.12, DBU, 
THF, 5 °C.  
The HWE reaction was attempted in accordance with previous precedence,
86
 by the treatment 
of the aldehyde with DBU and the phosphonate carbamate in THF at 5 °C. However, this 
produced the desired Michael acceptors 2.15, 2.17 and 2.18 in low isolated yields of 20-23% 
(Table 2.2, entries 1, 2 and 5). Formation of the Michael acceptor was identified by the 
presence of characteristic olefinic proton resonances in the 
1
H NMR spectrum: For the 
benzyl-protected Michael acceptor 2.15 these appear at 7.06 ppm as a doublet and at 7.15 
ppm as a double triplet with a mutual 
3
J coupling constant of 15.5 Hz. For the tert-
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butyldiphenylsilyl protected Michael acceptors the olefinic protons appear as a triplet at 7.16 
ppm and a doublet at 7.23 ppm, also with a mutual 
3
J coupling of 15.5 Hz. These 
3
J coupling 
constants confirmed the exclusive formation of the E-isomer in both cases.  
 
Table 2.2: Conditions for Horner-Wadsworth-Emmons reaction.
a
 
Entry Product Base LiCl /eq % Yield
b
 
1 2.17 DBU 0 20 
2 2.18 DBU 0 21 
3 2.17 i-Pr2NEt 7.43 32 
4 2.18 i-Pr2NEt 7.43 45 
5 2.15 DBU 0 23 
6 2.15 i-Pr2NEt 7.43 44 
7 2.16 i-Pr2NEt 7.43 42 
a
General reaction conditions: Aldehyde (6.6-19 mmol, 1.1 eq), phosphonate carbamate (7.9-23 mmol, 1.3 eq), 
LiCl (44-130 mmol, 7.4 eq), i-Pr2NEt (5.9-17.5 mmol, 1.0 eq), MeCN, rt, 12 h. 
b
% Isolated yield calculated over 
2 steps. 
The low yields obtained for the HWE reaction were attributed to the limited stability of the 
aldehydes under basic conditions. Hence, the olefination reaction was attempted under 
Masamune-Roush conditions.
90
 In this protocol LiCl is used as an additive, and the chelation 
of the phosphonate to the cation increases the acidity of the methylene proton (Scheme 2.6). 
This allows for the use of a weaker base, e.g. i-Pr2NEt. Using the modified procedure, a 
moderate improvement in yield was obtained (Table 2.2, entries 3, 5 and 6). 
Scheme 2.6: Mechanism of the Masamune-Rousch modified HWE reaction. 
The order of reagent addition was varied to determine if this affected the yield of the reaction. 
The base was stirred with an excess of phosphonate carbamate for 30 minutes, prior to the 
addition of the aldehyde, to allow for complete consumption of the base. Unfortunately, no 
improvement was achieved and degradation of the aldehyde was still a competitive process. 
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In light of these results, it was believed that formation of the Michael acceptors under neutral 
conditions, utilising a Wittig reaction, would be advantageous. Following a literature 
procedure,
91
 the phosphonium salts 2.19a and 2.19b were prepared, in 78% and 76% yield 
respectively, by the reaction of 2.13a and 2.13b with triphenylphosphine in THF under 
refluxing conditions (Scheme 2.7). The ylid salt formation was confirmed by the presence of 
a broad doublet 
1
H resonance signal at 5.45 ppm, corresponding to the CH2 group adjacent to 
the phosphorus (
2
JPH = 14 Hz). Reaction of these chloride salts with KO
t
Bu gave the yilds 
2.20a and b, causing the shift of the broad doublet from 5.45 ppm to 4.59 ppm. The ylids 
were isolated as white solids in 85% and 70% yield respectively, and used without further 
purification in a Wittig reaction with the aldehyde 2.11. This afforded the Michael acceptors 
2.15 and 2.16 with improved yields of 53% and 75% respectively, as a 3.5:1 mixture of E- 
and Z- isomers. The E-isomer was identified by the presence of the trans-olefinic protons 
with a 
3
J coupling constant of 15.5 Hz, whereas the minor Z-isomer olefin protons displayed 
a smaller 
3
J coupling of 11.7 Hz. The isomers were separable by column chromatography.    
 
Scheme 2.7: Reagents and conditions: (i) PPh3, reflux, 16 h, 77%; (ii)  KO
t
Bu, THF, 1 h, 
84%; (iii) 2.11, CH2Cl2, rt, 16 h.    
A tandem Swern/Wittig reaction has been reported by Ireland, where the ylid was added to 
the Swern reaction mixture, on complete formation of the aldehyde.
92
 This would obviate the 
need to isolate the unstable aldehyde. Accordingly, the ylid 2.20a was added to the Swern 
reaction mixture containing 2.11, and the Michael acceptor 2.16 was isolated in the lower 
yield of 30%, with a slightly decreased E:Z ratio of 2:1.  
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It is possible that the low yields obtained for the synthesis of the Michael acceptors were a 
result of aldehyde degradation under the Swern conditions, where a large excess of NEt3 was 
used. Thus the neutral Dess-Martin periodinane (DMP) and IBX reagents were employed for 
the oxidation-olefination reactions (Table 2.3).    
Table 2.3: Results for the oxidation of 2.9 to the aldehyde.
a
 
Entry Conditions Time/h Temp/°C % Yieldb 
1 IBX 60 70 10 
2 DMP 12 Rt 100 
a
General reaction conditions: Entry 1: Alcohol 2.9 (1.3 mmol, 1.0 eq), IBX (1.7 mmol, 1.3 eq) , EtOAc (5 mL), 
reflux; Entry 2: Alcohol 2.9 (1.1 mmol, 1.0 eq), DMP (1.2 mmol, 1.1 eq), CH2Cl2 (5 mL), rt. 
b
Yields 
determined by 
1
H NMR. 
The oxidation using IBX (Table 2.3, entry 1) gave low conversion to the aldehyde, with 
starting material persisting in the reaction mixture. In contrast, the oxidation using DMP 
(entry 2) proceeded well with full conversion. However, significant decomposition occurred 
upon workup and the aldehyde was obtained as a complex mixture. This degradation could be 
prevented by performing the oxidation and Wittig reactions in a tandem one-pot protocol, 
removing the need to isolate the aldehyde.
93
 Accordingly, the Michael acceptor 2.16 was 
formed in 78% yield as the E-isomer exclusively. Oxidation of the alcohol was also 
attempted in a mild tandem oxidation process (TOPs), in which MnO2 is used as oxidant and 
the resultant aldehyde is immediately reacted with a ylid.
94
 However, no product or aldehyde 
was observed after 72 hours and starting material persisted.  
 
An alternative synthesis of the Michael acceptors involves the allylic oxidation of an alkene, 
using selenium dioxide (Scheme 2.8).
95
    
 
Scheme 2.8: Michael acceptor formation by allylic oxidation. 
Formation of the Michael acceptors via this method is attractive as it avoids the use of 
unstable aldehydes. 2.21 was easily synthesised, in good yield, by the HWE reaction of the 
phosphonium carbamates 2.14a with acetaldehyde.
24
 The mechanism of the allylic oxidation 
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proceeds as shown (Scheme 2.9). The selenium dioxide reacts with the alkene to give an 
allylic selenine acid. This undergoes a [2,3] sigmatropic rearrangement to produce an 
unstable selenium ether, which rapidly decomposed to give the desired allylic alcohol.   
 
Scheme 2.9: Mechanism of the selenium dioxide mediated allylic oxidation. 
The allylic oxidation was attempted on the alkene 2.21, which was refluxed with the selenium 
dioxide in ethanol for several days.
95
 However, only starting material was recovered from the 
reaction mixture.     
 
In summary, the instability of the aldehydes proved problematic for the synthesis of the aza-
Michael acceptors. The HWE reactions proceed to give the desired Michael acceptors in the 
desired E-isomer exclusively, however the yields are low. Using a weaker base in the 
Masamune-Roush modified HWE reaction had little effect. Changing to the neutral Wittig 
reaction increased the yield significantly, but gave a mixture of E- and Z- isomers. Finally, a 
tandem oxidation/Wittig reaction using DMP proved to be the most successful method, 
giving an overall yield of 78% over 2 steps. The next section details the optimisation of the 
aza-Michael reaction of aniline with these α, β-unsaturated carbamates.     
 
2.2 Aza-Michael reactions 
The asymmetric aza-Michael reaction was the key step in the synthesis of the Galipea 
alkaloids, as it was used to install the stereochemistry. Significant optimisation of the aza-
Michael reaction was undertaken to allow for the obtainment of material with high optical 
purity. The addition of aniline to Michael acceptors 2.15-2.18 catalysed by 1.117 was 
investigated to determine if the nature of the protecting group R
1
 or the nature of the 
carbamate R
2
 had any significant effect (Scheme 2.10).    
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Scheme 2.10: Aza-Michael reaction of aniline with Michael acceptors 2.15-2.18. 
The palladium-BINAP complex 1.117 was used in the initial screening, as it was found to be 
the best general catalyst for the addition of anilines to α, β-unsaturated carbonyls.81 The 
catalyst was prepared in two steps. Following a literature procedure, palladium nitrate was 
treated with triflic acid to generate palladium triflate as a hygroscopic purple solid (Scheme 
2.11).
96
 The catalyst 1.117 was then generated by reaction of the palladium triflate with (R)-
BINAP in acetonitrile under anhydrous conditions, followed by recrystallisation from 
CH2Cl2/ether. The palladium-BINAP catalyst formed was air stable and identifiable by 
31
P 
NMR, which shows a characteristic broadened singlet at +33.0 ppm.
97
 
 
Scheme 2.11: Palladium BINAP catalyst synthesis.  
 
Previously, it has been shown that the solvent used in the aza-Michael reaction has a 
significant effect on the enantioselectivity, toluene was found to be optimal for most of the 
reactions of α, β-unsaturated 1,3-dicarbonyl compounds.67, 69, 86 Accordingly, aniline was 
added to a mixture of the catalyst 1.117 and Michael acceptor 2.15-2.18 in toluene. The 
reaction was initially conducted at room temperature. However, starting materials persisted in 
the mixture after 16 h, as significant levels of both the catalyst and alkene were insoluble. 
Subsequently, the reaction temperature was increased to 50 °C (Table 2.4). 
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Table 2.4: Results of the aza-Michael reaction of 2.15-2.18 with aniline.
a
 
Entry Michael acceptor Aniline Time /h % Yield
b
 % ee
c
 
1 E-2.17 PhNH2 71 93 ND 
2 E-2.18 PhNH2 71 78 ND 
3 E-2.15 PhNH2 16 100 69 
4 Z-2.15 PhNH2 16 100 25 
5 E-2.16 PhNH2 16 100 61 
6 E-2.16 PhNHMe 48 63 ND 
a
General reaction conditions: For entries 1-5: Michael acceptor (0.2-0.4 mmol, 1.0 eq), 1.117
 
(5.0 mol%), 
aniline (0.2-0.4 mmol, 1.0 eq), toluene (1 mL), 50 °C. Entry 6:
 
Michael acceptor (0.4 mmol, 1.0 eq), 1.117 
 
(5 
mol%), N-methylaniline (0.4 mmol, 1.0 eq), toluene (1 mL), 50 °C. 
b
Determined by 
1
H NMR. 
c
Determined by 
chiral HPLC using a Daicel Chiralpak AD-H column. 
Even at the elevated temperature, the additions of aniline to the silyl-protected 2.17 and 2.18 
proceeded very sluggishly and conversions were incomplete after 3 days (Table 2.4, entries 1 
and 2). In comparison, the addition to E-2.15 and E-2.16 proceeded with quantitative 
conversions within 16 h (entries 3 and 5). In all cases, the formation of the aza-Michael 
product was confirmed by loss of the olefin protons and the appearance of an ABX pattern in 
the 
1
H NMR spectra, corresponding to the formation of the stereogenic centre and the 
diastereotopic methylene group. Separation of the enantiomers of E-2.17 and E-2.18 was not 
possible by chiral HPLC, preventing the determination of their enantiomer excesses. 
However, encouraging enantioselectivities of 69% and 61% were obtained for the products 
from the E-isomers of 2.15 and 2.16 (entries 3 and 5). Performing the reaction with the Z-
isomer of 2.15 led to a significantly lower enantioselectivity of 25% (entry 4). As a result, it 
is important to ensure that the E-isomer is used in the conjugate additions, in order not to 
compromise the enantioselectivities.     
 
The use of N-methylaniline in the aza-Michael reaction would install the methyl group 
present on the tetrahydroquinoline nitrogen of all four of the Galipea alkaloids. This would 
remove the need to methylate this nitrogen at a later stage, reducing the total number of steps 
in the synthesis. However, the reaction of E-2.16 with N-methylaniline proved to be slow, 
attaining only 63% conversion after 2 days at 50 °C (Table 2.4, entry 6). Additionally, 
separation of the two enantiomers by chiral HPLC was unsuccessful and thus determination 
of the enantioselectivity was not possible. For this reason, it was decided that the methyl 
group should be installed later in the synthesis.  
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Previously, the assignment of the stereochemistry of the aza-Michael products was achieved 
by the synthesis of the known β-amino acid 2.27.81 It was established that the use of (R)-
BINAP led to formation of the (S)-isomer of the β-amino acid. Thus we expect the aza-
Michael reaction of our α, β-unsaturated carbamates to also proceed with the same 
stereodifferentiation, i.e. using the (R)-isomer of the catalyst 1.117, we would expect the (R)-
isomer of 2.23-2.26 (Figure 2.1). This assumption will be confirmed by the synthesis of the 
natural products (vide infra). 
 
Figure 2.1: β-amino acid synthesised for the assignment of the stereochemistry. 
 
For the synthesis of the Galipea alkaloids, high enantioselectivities were required. As better 
yields and shorter reaction times were achieved with the benzyl protected substrates, these 
were adopted in the subsequent optimisation studies. The next three sections detail the 
optimisation of the reaction, to obtain optically pure aza-Michael adducts.          
 
2.2.1 Dilution study 
The effect of dilution on the aza-Michael reaction of 2.15 catalysed by 1.117 was 
investigated. Changing the dilution of the reaction had very little effect on the reaction yield, 
however significant changes to the enantioselectivity can be observed (Table 2.5). Decreasing 
the concentration of the reactant from 600 to 200 mM, led to further increase in the 
enantioselectivity (Table 2.5, entry 4 vs entries 2 and 3). Conversely, by increasing the 
concentration to 1 M, a large decrease in ee to 39% was observed (entry 1), whilst further 
dilution below 200 mM exerted little effect on the enantioselectivity (entries 4, 5 and 6). All 6 
reactions remained homogeneous at 50 °C, suggesting this is not a solubility effect.   
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Table 2.5: Dilution results.
a
 
Entry Dilution/ mM Time /h % Yield
b
 % ee,
c
 (Config) 
1 1000 16 96 39 (R) 
2 600 16 98 58 (R) 
3 300 16 98 67 (R) 
4 200 16 95 74 (R) 
5 150 16 91 74 (R) 
6 75 16 97 76 (R) 
a
General reaction condition: Michael acceptor (0.3 mmol, 1.0 eq), (R)-1.117
 
(5 mol%), aniline (1.0 eq), toluene, 
50 °C, 16 h. 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using Daicel Chiralpak AD-H column. 
Previous mechanistic studies
98
 revealed that a single equivalent of aniline binds to the 
catalyst 1.117 reversibly. However, the addition of the second equivalent leads to the 
formation of a diamine complex (Scheme 2.12), which is kinetically stable and catalytically 
inactive. Therefore, a high concentration of aniline in the reaction mixture can cause catalyst 
deactivation. The increase in ee with dilution is thus attributed to a reduction in the effective 
concentration of aniline, resulting in slower inhibition of the catalytic activity. This could be 
achieved more efficiently by the slow addition of aniline to a solution of the Michael acceptor 
and catalyst.
98
 
 
Scheme 2.12: Consecutive binding of aniline to 1.117. 
Slow addition of aniline to 2.15 and 2.16 was conducted over 20 hours using a syringe pump. 
This further improved the ee obtained to 81% and 84% respectively (Table 2.6).   
 
Table 2.6: Slow addition results.
a
 
Entry Product Time/ h % Yield
b
 % ee
c
, (Config) 
1 2.23 17 96 81 (R) 
2 2.24 18 96 84 (R) 
a
Slow addition conditions: Entry 1: Michael acceptor 2.15 (0.15 mmol, 1.0 eq), (R)-1.117
 
(5 mol%), aniline 
(0.15 mmol, 1.0 eq) , toluene (2.5 mL), 50 °C, 48 h. Entry 2: Michael acceptor 2.16 (0.4 mmol, 1.0 eq), (R)-
1.117 (5 mol%), aniline (0.4 mmol, 1.0 eq), toluene (4.5 mL), 50 °C, 48 h. 
b
Determined by 
1
H NMR.
 
c
Determined by chiral HPLC using Daicel Chiralpak AD-H column. 
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2.2.2 Ligand screen 
Axial chirality was previously shown to be the most effective for the enantioselective aza-
Michael reactions.
70
 Thus, range of chiral biaryl diphosphines were examined as chiral 
ligands in the reaction of 2.15 and 2.16 with aniline (Figure 2.2). In these experiments, the 
[P2Pd(sol)2]
2+
 [TfO]
-
2 complexes (where P = biaryl phosphine ligand) were generated  in situ, 
by stirring 5.5 mol% of the ligand with 5.0 mol% of Pd(OTf)2.2H2O in toluene for 30 
minutes, prior to addition of the reactants. 
Figure 2.2: Various ligands used in the screening reactions. 
 
Table 2.7: Results of ligand screen with Michael acceptors 2.15 and 2.16.
a
  
Entry Michael acceptor Ligand Time/ h % Yield
b
 % ee
c
, (Config) 
1 2.15 R-BINAP 19 100 69 (R) 
2 2.16 R-BINAP 16 100 58 (R) 
3 2.15 R-Tol-BINAP 19 95 69 (R) 
4 2.16 R-Tol-BINAP 16 98 53 (R) 
5 2.15 R-MeO-Biphep 19 100 66 (R) 
6 2.16 R-MeO-Biphep 
 
 
30 93 77 (R) 
7 2.16 R-MeO-Cl-Biphep 16 93 72 (R) 
8 2.15 R-Synphos 19 97 69 (R) 
9 2.16 R-Synphos 30 85 40 (R) 
10 2.15 R-P-Phos 19 100 64 (R) 
11 2.16 R-P-Phos 30 74 11 (R) 
12 2.15 R-Xylyl-P-Phos 19 94 72 (R) 
13 2.16 R-Xylyl-P-Phos 19 94 41 (R) 
a
General reaction conditions: For Michael acceptor 2.15: Pd(OTf)2.2H2O (5.0 mol%), ligand (5.5 mol%), 2.15 
(0.3 mmol, 1.0 eq), aniline (1.0 eq), toluene (1.5 mL), 50 °C; For Michael acceptor 2.16: Pd(OTf)2.2H2O (5.0 
mol%), ligand (5.5 mol%), 2.16 (0.4 mmol, 1.0 eq), aniline (1.0 eq), toluene (1.5 mL), 50 °C. 
b
Yields 
determined by 
1
H NMR. 
c
Enantioselectivity determined by chiral HPLC using Daicel Chiralpak AD-H column. 
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Comparable results were obtained for the [Pd(R-BINAP)(OH2)2]
2+
[OTf]
-
2
 complex generated   
in situ, compared to the use of the preformed catalyst 1.117 (Table 2.7 entries 1 and 2 vs. 
Table 2.4 entries 3 and 5). Generally, changes in the biaryl diphosphine ligand structure had 
little effect on the ee or yield for additions to the CBz-protected 2.15, with the ee varying 
from 64 to 72% and yields from 94 to 100% (entries 3, 5, 8, 10 and 12). In contrast, the 
ligand structure had a very significant effect on the ee values obtained with the Moc-
protected 2.16. (R)-MeO-Biphep and (R)-Cl-MeO-Biphep complexes proceeded to give the 
highest ee of 77% and 72% respectively, and good yields of over 90% (entries 6 and 7), while 
(R)-P-Phos, (R)-Synphos and (R)-Xylyl-P-Phos gave moderate to good yields but low ee 
(entries 9, 11 and 13). (R)-Tol-BINAP gave similar results to those obtained with (R)-BINAP 
(entry 2 vs 4), suggesting that the size of the phosphine groups has little bearing on the 
results.  
 
From this study, the highest enantioselectivity was obtained for the aza-Michael reaction of 
2.16, with (R)-MeO-Biphep. As the slow addition of aniline to the reaction mixture was 
previously shown to be beneficial for enantioselectivity (Table 2.6), this protocol was also 
adopted for the reaction of 2.16 with the (R)-MeO-Biphep catalyst. Unfortunately, no 
improvement in yield or ee was observed (66% yield and 77% ee).  
 
Despite testing a range of biaryl-phosphine ligands for the aza-Michael reaction, no 
improvement in enantioselectivity was achieved. However, it is interesting to note that the 
enantioselectivities obtained with the various ligands were higher dependent on the nature of 
the terminal carbamate group.   
 
2.2.3 Recrystallisation (enrichment of optical purity) 
Good enantioselectivities (up to 84%) have been achieved for the aza-Michael reaction. 
However, for the total synthesis of the Galipea alkaloids, optically pure material was 
required. Previously, the optical purity of similar Michael adducts was shown to improved 
upon recrystallisation from cyclohexane-toluene.
24
 For these compounds, racemic products 
are more crystalline and so precipitate more readily, leaving optically enriched compound in 
the mother liquors. Thus, the Michael adduct 2.24 was similarly recrystallised using a range 
of solvent conditions. Recrystallisation from EtOAc-hexane was found to be the most 
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effective - after several recrystallisations the initial mixture of 86% ee deposited crystals with 
an ee of 27%, leaving the mother liquor containing 2.24 in 77% recovered yield with 99% ee 
(Figure 2.3). 
 
                                             
        MOTHER LIQUOR                                         PRECIPITATE  
Figure 2.3: HPLC traces of mother liquor and precipitated solid after recrystallisation of a 
sample of 2.24 with 86% ee. 
 
In conclusion, optimisation of the aza-Michael reaction allowed for the increase in ee from 
the initial 61% and 69% to the 84% and 81%, respectively, by the slow addition of aniline to 
the catalyst and alkene. Subsequently, optically pure material was obtained via 
recrystallisation of the aza-Michael adducts.   
 
2.3 Electrophilic ring cyclisation 
The next step in the synthesis of the Galipea alkaloids was the formation of the 
tetrahydroquinoline core structure. This section details our attempts at the cyclisation of the 
aza-Michael derivatives.  
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2.3.1 Friedel-Crafts type cyclisations 
Several methods have been reported for the formation of tetrahydroquinolone ring systems, 
via the electrophilic cyclisation of β-amino acids. The first uses dehydrating reagents such as 
PPA
99
 and Eaton‟s reagent (7% P2O5 in CH3SO3H)
100
 to facilitate the ring cyclisation 
(Scheme 2.13).      
 
 
Scheme 2.13:  Electrophilic ring cyclisation using dehydrating reagents. 
The second method involves the formation of an acid chloride from the β-amino acid, which 
can then undergo a Friedel-Crafts reaction in the presence of a Lewis acid, such as AlCl3. Ma 
et al. have used this method for the synthesis of a tetrahydroquinolone in 62% yield (Scheme 
2.14).
101
 
 
Scheme 2.14: Friedel-Crafts cyclisation of an amino acid. 
First, methylation of 2.24 was attempted using a large excess of MeI and 2.5 equivalents of 
Ag2O, however low yields of 2.28 were obtained. In comparison, reductive alkylation 
proceeded under literature conditions
19
 to give 2.28 in 88% yield (Scheme 2.15). Hydrolysis 
of the carbamates proceeded to give the N-aryl -amino acids 2.29 and 2.30 in 70% and 88% 
yield, respectively. The loss of the methyl carbamate group was confirmed by 
1
H NMR and 
the appearance of a 
13
C signal at 175.8 ppm corresponding to the carboxylic acid moiety. In 
addition, the characteristic broad OH stretch between 3000 and 2800 cm
-1
, accompanied by a 
C=O absorption at 1709 cm
-1
, were observed in the infrared spectrum.  
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Scheme 2.15: Reagents and conditions: (i) Formaldehyde, NaCNBH3, AcOH, MeCN, 5 °C, 1 
h; (ii) 1 M KOH, MeOH, rt, 2 h; (iii) Eaton‟s reagent 7% P2O5 in CH3SO3H, 
rt-60 °C; (iv) (COCl)2, DMF, CH2Cl2, AlCl3, 0 °C-rt, 15 h; (v) PPA, 65-90 °C.  
With the acyclic precursors 2.29 and 2.30 in hand, the electrophilic ring cyclisation using 
Eaton‟s reagent100 or PPA99 was investigated (Table 2.8).  
Table 2.8: Results of the electrophilic ring cyclisation using Eaton reagent and PPA.
a
 
Entry Stating material Reagent Temp/
o
C Time/h % Yield 
1 2.29 Eaton‟s 60 3 - 
2 2.29 Eaton‟s Rt 4 - 
3 2.24 Eaton‟s 60 3 - 
4 2.30 Eaton‟s Rt 5 - 
5 2.30 PPA 90 2 - 
6 2.30 PPA 65 2 - 
7 2.30 PPA 90 1 - 
8 2.24 PPA 65 2 - 
9 2.23 PPA 90 2 - 
10 2.35 PPA 90 2 - 
a
General reaction conditions: For entries 1-4: Cyclisation precursor (1.0 eq), Eaton‟s reagent (4.0 eq); For 
entries 5-10: Cyclisation precursor (0.16 mmol, 1.0 eq), PPA (8.0 mmol, 50 eq). 
b
Determined by 
1
H NMR. 
 
None of the desired tetrahydroquinolone was obtained when the electrophilic ring cyclisation 
of 2.29 was attempted using Eaton‟s reagent (Table 2.8, entry 1). Instead, complete 
degradation of the starting material occurred. It was hoped that this degradation could be 
suppressed by lowering the reaction temperature (entry 2), or by subjecting the carbamate 
2.24 to the reaction (entry 3). However, neither of these attempts were successful; complex 
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reaction mixtures were obtained, with signals observed in the 
1
H NMR spectra relating to 
aniline and an alkene, suggesting a retro-aza-Michael reaction had occurred. It was postulated 
that the methylated 2.30 would be more resistant to the retro-aza-Michael reaction. However, 
2.30 was still inherently unstable to the strongly acidic conditions and although none of the 
retro aza-Michael products were observed, complete degradation of the starting material to 
unidentifiable compounds occurred (entry 4). 
 
As the cyclisation with Eaton‟s reagent proved unsuccessful, the reaction was attempted with 
PPA, in the hope that the carboxylic acid would prove more stable against these reaction 
conditions. Unfortunately, no product was obtained when the reaction was conducted under 
described conditions (entry 5),
99
 with lowered temperature (entry 6) or with shortened 
reaction time (entry 7). Complex mixtures were obtained in all three cases, from which an 
unknown compound can be isolated in low yields (~ 30%). This was subsequently identified 
as 2.34 (Scheme 2.16), characterised by a strong carbonyl stretch at 1770 cm
-1
 in its infrared 
spectrum typical of a γ-lactone moiety, further supported by a 13C NMR resonance signal at 
175.7 ppm and the observation of a M
+
 ion peak of 191 (EI).  The presence of the lactone 
implies that the benzyl protecting group in 2.30 was unstable under the reaction conditions, 
and on cleaving formed the -hydroxy acid intermediate 2.33, which cyclise spontaneously to 
form 2.34. 
 
Scheme 2.16: Formation of the lactone ring. 
The direct cyclisation of carboxylic esters to produce tetrahydroquinolones is known in the 
literature.
99
 Thus, the PPA cyclisation was attempted with the methyl carboxylic ester 2.35, 
formed from 2.24 in 60% yield (Scheme 2.17),
102
 and also the carbamate derivatives 2.23 and 
2.24. In these cases, the formation of the γ-lactone 2.34 was not observed, but neither was 
any tetrahydroquinolone – once again, complete degradation of the precursors occurred 
(Table 2.8, entries 8-10).      
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Scheme 2.17: Reagent and conditions: (i) CaCl2, NaOMe, MeOH, 60%; (ii) PPA, 120 °C. 
  
Due to the lack of success with acid-catalysed electrophilic cyclisations, it was hoped the 
formation of the cyclised material may be achieved under the milder Friedel-Crafts 
conditions. To this end, the amino acid 2.29 was converted into the acid chloride 2.36, which 
was then subjected to the Friedel-Crafts reaction (Scheme 2.18).  
Scheme 2.18: Formation of tetrahydroquinolone using a Friedel-Crafts reaction. 
Complete consumption of starting material occurred but, once again, the reaction proceeded 
to give the γ-lactone 2.34 (23% yield) i.e. cleavage of the benzyl protecting group by the 
strong Lewis acid occurred under these conditions.    
 
Up to this juncture, despite a large number of attempts, none of the desired heterocycle was 
obtained by the electrophilic cyclisation of acid derivatives. Complete degradation occurred 
via a retro-aza-Michael reaction when Eaton‟s reagent was employed, due to the strongly 
acidic reaction conditions. When using PPA or a Lewis acid, competitive debenzylation, 
leading to the formation of a lactone, prevented obtainment of the tetrahydroquinoline. In 
other cases, degradation of the starting material occurred.        
 
The formation of tetrahydroquinolone rings by the Fries rearrangement of an N-arylated β-
lactams had been reported (Scheme 2.19).
103, 104
 
 
Scheme 2.19: Fries rearrangement of β-lactams to give tetrahydroquinolones. 
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Accordingly, the required β-lactam 2.37 was obtained from the methyl ester 2.35 by 
cyclisation with LHMDS (Scheme 2.20).
105
 On subjecting 2.37 to the Fries rearrangement 
conditions, none of the tetrahydroquinolone was formed, and starting material persisted in 
solution. Increasing the reaction time led to complete degradation of the starting material.    
 
Scheme 2.20: Reagent and Conditions: (i) LHMDS, THF, -20 °C; (ii) CF3SO3H, DCE, 0 °C. 
The instability of these aza-Michael products, their corresponding carboxylic acid and β-
lactams to strongly acidic conditions, renders the formation of the tetrahydroquinolone ring 
system impossible via electrophilic cyclisation reactions. As a result, alternative, milder 
methods were sought.  
 
2.3.2 Lewis acid mediated reduction/cyclisation reaction 
Previous work in our group reported the formation of 2, 4-disubstituted tetrahydroquinolines 
from aza-Michael adducts in the synthesis of a CETP inhibitor, Torcetrapib 1.16 (Scheme 
2.21).
24
 
 Scheme 2.21: Synthesis of Torcetrapib 1.16. 
The cyclisation step was facilitated by MgCl2, which acted as a Lewis acid forming a chelate 
with the 1, 3-dicarbonyl moiety of the aza-Michael adduct, promoting the reduction of one of 
the carbonyl groups by NaBH4 (Scheme 2.22). Elimination of the resultant hydroxyl group 
produced an acyl immonium ion, which underwent electrophilic cyclisation to produce the 2, 
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4-tetrahydroquinoline as the syn isomer exclusively. Molecular modelling revealed the 
activation energy of the syn cyclisation pathway to be considerably lower than the anti 
cyclisation pathway.  
 Scheme 2.22: Lewis acid medicated reductive cyclisation of aza-Michael adducts. 
Similarly, Michael adduct 2.24 was subjected to the reductive/cyclisation conditions. 
Gratifyingly, this afforded the expected nitrogen heterocycle 2.38 in 87% yield, as a single 
compound, presumably the syn-isomer (Scheme 2.23). The formation of the desired 
tetrahydroquinoline was indicated by the loss of one of the two carbonyl stretches in the IR 
spectrum, corresponding to the imide functionality, and the emergence of the new N-
carbamate entity, with a 
13
C resonance at 156.4 ppm.  
 
Scheme 2.23: Reductive cyclisation of aza-Michael adducts. 
Formation of the tetrahydroquinoline ring was finally achieved using this mild 
reductive/cyclisation reaction, in excellent yield. This cyclisation also installed another 
stereocentre in the C-4 position of the ring, which has to be removed for the synthesis of the 
Galipea alkaloids.  
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2.4 Synthesis of the common precursor 2.1 
Synthesis of the common precursor 2.1 from the tetrahydroquinoline 2.38 requires 
methylation of the tetrahydroquinoline nitrogen, the removal of the Moc protected amine at 
C-4 and deprotection of the C-2 ether to liberate the hydroxyl group. 
  
It was decided that methylation of the tetrahydroquinoline nitrogen should be performed first, 
as an unsubstituted nitrogen could cause problems in later steps. This was easily achieved 
under reductive methylation conditions,
19
 to give the desired tetrahydroquinolines 2.39 in 
88% yield (Scheme 2.24).  
 
Scheme 2.24: Reductive methylation reaction. 
The installation of the Me group was confirmed by the presence of a singlet resonance at 2.99 
ppm in the 
1
H NMR spectrum, and a resonance signal at 31.9 ppm in the 
13
C NMR spectrum.    
 
2.4.1 Deamination 
The deprotection of the N-Moc group was attained using trimethylsilyl iodide,
106
 to afford the 
amine 2.40 in 78% yield (Scheme 2.25). The loss of the CO2Me was confirmed by 
1
H and 
13
C 
NMR spectroscopy.  
 
Scheme 2.25: Moc deprotection using TMSI. 
Several deamination procedures are known in the literature, the simplest of which involves 
the reaction of the amine with excess methyl iodide, followed by the Hofmann elimination of 
the resultant quaternary ion. This could be achieved using various bases
107
 or amberlite
108
 
(Scheme 2.26). Hydrogenation of the resultant alkene would both remove the double bond 
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created and the benzyl protecting group to give the common intermediate 2.1 in a single step. 
Unfortunately, reaction of the amine 2.40 with a large excess of MeI and K2CO3 did not 
proceed to give the desired alkene, leading only to complete degradation of the starting 
material.  
 
Scheme 2.26: Reagents and conditions: (i) MeI, K2CO3, MeOH; (ii) Amberlite, MeOH; (iii) 
Base. 
 
In a Barton deamination reaction, the amine is converted into an isocyanide, which undergoes 
a radical reaction with AIBN and tin-n-butyl hydride to give the corresponding deaminated 
product (Scheme 2.27).
109
 Accordingly, formation of the isocyanide was attempted via 
formylation of the amine using formic acetic anhydride, followed by dehydration with 
toluene-p-sulphonyl chloride in pyridine.
109
 However, only a complex mixture was obtained. 
 
Scheme 2.27: Barton deamination reaction: (i) Formic acid, acetic anhydride, reflux, 12 h; 
(ii) Py., TsCl, rt, 2 h (iii) AIBN, HSnBu3. 
 
Deamination reactions have been achieved using hydroxyl-amine-O-sulfonic acid and sodium 
hydroxide. Initially the amine is converted to the hydrazine under basic conditions and then 
elimination of nitrogen gives the alkane (Scheme 2.28).
110
 
 
Scheme 2.28: Deamination using hydroxyl-amine-O-sulfonic acid. 
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Under the literature conditions,
110
  none of the desired deamination product 2.43 was 
obtained, with 2.40 persisting in the reaction solution, even when the reaction was performed 
under reflux.
111
  
 
Although these deamination reactions would provide a direct route to the Galipea alkaloids, 
the instability of the amine to the harsh reaction conditions proved problematic.  
 
2.4.2 Transamination 
A number of methods for the transformation of amines into ketones are known in the 
literature, whereby amines are converted into imines, which hydrolyse to give the 
corresponding ketones. Removal of a ketone group from the C-4 position should be facile, 
with a large number of procedures known to facilitate this, including the Wolff-Kishner 
reduction.
112
 A variety of transamination reactions were attempted on the amine 2.40 
(Scheme 2.29, Table 2.9).  
 
Scheme 2.29: Transamination of amine 2.40 to the tetrahydroquinolone. 
Table 2.9: Transamination of the amine 2.40.
 
Entry Conditions Temp/ 
o
C Time/ h % Yield
b
 
1 Bz2O2, Cs2CO3, DMF 0-50 18 - 
2 Bz2O2, Cs2CO3, DMF 0 2 - 
3 Fremy‟s salt, 2% Na2CO3, Py. rt 16 - 
4 Fremy‟s salt, 2% Na2CO3 rt 5 - 
5 IBX rt 72 - 
6 IBX rt 2 < 5 
7 Rapoport‟s reagent, DBU, H
+
 rt 18 44 
8 Corey‟s reagent rt  4 43 
a
Reagents and conditions: For entries 1-2: Amine (1.2 eq), Bz2O2 (0.15 mmol, 1.0 eq), Cs2CO3 (1.5 eq), DMF 
(1 mL); For entries 3-4: Amines (0.18 mmol, 1.0 eq), Fremy‟s salt (10 eq), 5% Na2CO3 (20 mL); For entries 
5-7: Amine (0.18 mmol, 1.0 eq), IBX (1.1 eq), DMSO (0.5 mL); Entry 8: Amine (0.18 mmol, 1.0 eq), 
Rapoport‟s reagent (1.0 eq), DBU (2.0 eq), sat. oxalyic acid (2 mL), DMF (1 mL), CH2Cl2 (1 mL); Entry 9: 
Amine (0.18 mmol, 1.0 eq), Corey‟s reagent (1.0 eq). bYields determined by 1H NMR. 
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The reaction of amines with benzoyl peroxide and caesium carbonate leads to the formation 
of hydroxylamines. These can decompose on heating to give imines, which hydrolyses to 
form ketones (Scheme 2.30).
113
 Unfortunately, only degradation products were observed in 
the reaction mixture when 2.40 was subjected to the literature conditions (Table 2.9, entry 
1).
113
 Failure to isolate the intermediate hydroxylamine implies that the decomposition 
occurred at the onset of the reaction (entry 2).  
 
Scheme 2.30: Conversion of amines into ketones using benzoyl peroxide. 
Using Fremy‟s salt, (KO3S)2NO· a stable radical,
114
 an electron can be extracted from the 
amine to form a radical cation, which produces an alkyl radical after loss of a proton. 
Addition of the Fremy‟s salt gives a neutral quaternary species, which immediately 
elimination ON(SO3
-
)2 to give an imine (Scheme 2.31).  
 
 
Scheme 2.31:  Conversion of amines to ketones using Fremy‟s salt. 
The reaction was attempted using Fremy‟s salt with Na2CO3 in pyridine. Unfortunately, 
degradation of the amine starting material was facile under these conditions (Table 2.9, entry 
3). The reaction was also attempted in the absence of pyridine (entry 4), in case the presence 
of the organic base was facilitating degradation of the starting material, however, no 
improvement was observed.  
 
IBX has been shown to convert a variety of primary amines into ketones (Scheme 2.32).
115
 
  Scheme 2.32: Mechanism of ketone formation using IBX. 
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Once again, only extensive degradation was observed when the amine was reacted with IBX 
at room temperature for 72 hours (Table 2.9, entry 5). On reducing the reaction time, only 
trace levels of the ketone were observed by 
1
H NMR (entry 6).     
 
Finally, 4-formyl-1-methylpyridinium benzenesulfonate, Rapoport‟s reagent 2.45116 and 3,5-
di-t-butyl-1,2-benzoquinone, Corey‟s reagent 2.46,117 were investigated as transamination 
reagents (Figure 2.4).  
 
Figure 2.4: Transaminating reagents. 
The Rapoport‟s reagent 2.45 mimics the pyridoxal phosphate co-factor responsible for 
transamination of amino acids.
116
 It reacts with the amine to form an imine intermediate 
(Scheme 2.33). Upon the addition of a base (DBU), deprotonation occurred and an 
equilibrium is established between the resonance structures A, B and C. Upon the addition of 
an aqueous acid, protonation of these resonance structures proceeded to give an imine. 
Protonation of the resonance structure A would reform the starting material, whereas 
protonation of the resonance structure B would lead to the formation of product, upon 
hydrolysis. Therefore the success of the reaction is dependent on this equilibrium.  
Scheme 2.33: Mechanism of transamination using 2.45. 
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Condensation of amines with Corey‟s reagent 2.46 also produces an imine. In this case, the 
addition of base is unnecessary. The imine intermediate undergoes a spontaneous 1, 5-
prototropic rearrangement, with aromatisation of the ring the driving force. The resultant 
imine hydrolyses to produce the desired ketone (Scheme 2.34).  
 
 
 
Scheme 2.34: Transamination with Corey‟s reagent. 
The transamination of the amine 2.40 with Rapoport‟s reagent proceeded to give the ketone 
in a moderate yield (Table 2.9, entry 7).  A clean mixture of product and starting material was 
obtained; the latter could be recovered and reused. It was thought that the transamination of 
the amine with Corey‟s reagent could proceed to give higher levels of conversion, as the 
quinine/aromatic redox system thermodynamically favours the 1, 5-protrotpic rearrangement. 
However, this proved not to be the case, and a comparable yield to that obtained with 
Rapoport‟s reagent was achieved, however, none of the starting material was recovered (entry 
8). Thus, the Rapoport‟s transamination reagent was chosen for the synthesis of the Galipea 
alkaloids.  
 
A variety of different conditions were investigated for the transamination using 2.45, in an 
attempt to optimise the yield of the ketone (Table 2.10).  
Table 2.10: Transamination of 2.40 with 2.45.
a
   
Entry 2.45 (eq) DBU (eq) % Isolated yield 
1 1 2 44 
2 2 2 47 
3 2 2 35
b
 
4 2 3 67 
5 10 10 75 
a
Reagents and conditions: Amine (0.18 mmol, 1.0 eq), 2.45 (1-10 eq), CH2Cl2 (1 mL) and DMF (1 mL). 
b
Conducted at twice the concentration. 
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The original procedure employed one equivalent of the transamination reagent and 2 
equivalents of DBU, to afford an iolated yield of 44% (Table 2.10, entry 1). It was thought 
the low yield could be due to a problem with formation of the imine, prior to addition of base, 
with the equilibrium favouring the precursors 2.40 and 2.45. Thus, the amount of 
transaminating reagent was increased (2 equivalents), in an attempt to drive the equilibrium 
towards the imine. However, little difference in the yield was observed (entry 2). Next, the 
reaction was performed at a higher concentration, whereupon the yield decreased to 35% 
(entry 3). This is attributed to the poor solubility of transamination reagent.  
 
The effect of base on the reaction was explored. By increasing the equivalents of DBU from 
2 to 3, an increase in the yield to 67% was observed (Table 2.10, entry 4). This suggests that 
an excess of DBU is required to ensure deprotonation occurs to establish the equilibrium 
between the resonance structures. Finally, a good yield of 75% was obtained when a large 
excess of both reagents was used (entry 5). 
 
The amine group at C-4 may be converted into a hydroxyl group via an acetate. Reaction of 
the amine with sodium nitrite produced a diazonium ion, which was immediately substituted 
by an acetate group. Hydrolysis of the acetate gave the desired alcohol.
118
 Conversion of the 
amine 2.40 into the alcohol 2.48 was attempted under the described conditions (Scheme 
2.35), however degradation of the starting material occurred, even when the reaction was 
conducted at -5 °C. 
Scheme 2.35: Conversion of the amine into a hydroxyl group. 
It was noted that the literature examples contained an electron-withdrawing group on the 
tetrahydroquinoline nitrogen. In this case, it is possible that the unprotected nitrogen was 
interfering with the reaction, leading to degradation of the starting material. With this in 
mind, 2.50 was prepared with a benzoyl protecting group on the nitrogen (Scheme 2.36).  
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Scheme 2.36: Reagents and conditions: (i) BzCl, NEt3, Et2O; (ii) TMSI, MeCN; (iii) 2M 
NaOH, EtOH, reflux.  
 
Protection of the nitrogen was required to take place prior to removal of the N-Moc group 
from the amine in the C-4 position, to ensure selective protection of the tetrahydroquinoline 
nitrogen. 2.49 was prepared in 84% yield, with the formation confirmed by the appearance of 
an additional carbonyl signal at 169.9 ppm in the 
13
C
 
NMR. Removal of the N-Moc 
protecting group was initially attempted using TMSI. The reaction proceeded to give the 
amine 2.50, in the low yield of 43%. This prompted us to attempt a different N-Moc 
deprotection using 2M NaOH at reflux, but this did not lead to any improvement in yield.  
 
With the protected amine 2.50 in hand, conversion of the amine to the alcohol was attempted. 
Disappointingly, this led to a complex mixture, which appeared to contain only trace levels of 
the alcohol. The significant levels of decomposition made this method unattractive.  
 
Direct substitution of an NH2 by an OH has also been reported to occur using KOH.
119
 
Following this procedure, the amine 2.40 was heated to 120 °C in ethylene glycol with KOH. 
On leaving the reaction for 16 hours, complete degradation of the starting material occurred. 
The reaction time was consequently reduced. After 3 hours, trace amounts of the alcohol was 
observed by 
1
H NMR, however, this was accompanied by a significant level of degradation.  
No reaction occurred upon lowering the reaction temperature to 50 °C. 
 
The formation of the alcohol proved unsuccessful and large levels of decomposition occurred 
under all the reaction conditions. As a good yield was obtained for the transamination of the 
amine 2.40 into the ketone 2.44 using Rapoport‟s reagent, 2.44 was chosen as the 
intermediate for the synthesis of the Galipea alkaloids.  
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2.4.3 Ketone removal and benzyl deprotection 
There are a wide range of conditions reported for the removal of ketone groups. The 
reduction of ketones to alkyls has previously been reported using AlCl3 and LiAlH4 (Scheme 
2.37).
120
  
 
Scheme 2.37: Ketone removal from the tetrahydroquinolone. 
 
Reduction of our ketone 2.44 using LiAlH4 and AlCl3 produced a mixture of the 
tetrahydroquinoline 2.43 and the partially reduced 2.48 in a 2:1 ratio (Table 2.11, entry 1). 
The major component was confirmed as 2.43, by the presence of its M
+
 ion at 267 (EI) and 
two multiplets between 2.83-2.64 ppm and 2.19-1.96 ppm in the 
1
H NMR spectrum, 
corresponding to the adjacent methylene groups in the heterocycle. The alcohol 2.48, 
obtained as a 1:1 mixture of diastereoisomers, was identified as the minor component by the 
observation of the M
+ 
ion at 283 (EI) and an OH stretch in the IR spectrum at 3410 cm
-1
. On 
extending the reaction time to 16 hours, the yield of 2.43 was improved, however complete 
formation was still not obtained (entry 2). Eventually, on increasing the equivalents of 
LiAlH4 and the reaction time, complete conversion to the desired product occurred, and 2.43 
was isolated in 87% yield (entry 3).  
 
Table 2.11: Ketone removal from the tetrahydroquinolone.
a
 
Entry Total LiAlH4 (eq) AlCl3 (eq) Time/h 2.43 : 2.48
b
 
1 2.5 2 2 2:1 
2 2.5 2 16 5:1 
3 3.5 2 18 100:0 
a
General reaction conditions: Tetrahydroquinolone 2.44 (0.36 mmol, 1.0 eq); AlCl3 (0.71-1.42  mmol); LiAlH4 
(0.89-1.78  mmol). 
b
Ratio determined by 
1
H NMR. 
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Formation of the common precursor 2.1 was now achievable by cleavage of the benzyl 
protecting group (Scheme 2.38).  
 
Scheme 2.38: Removal of the benzyl group. 
Classically, the removal of benzyl protecting groups is achieved by hydrogenation over 
activated Pd/C.
121
 When the tetrahydroquinoline 2.43 was subjected to hydrogenation 
conditions (5% Pd/C in ethanol under an atmosphere of hydrogen, at ambient temperature 
and pressure), none of the desired alcohol was obtained and starting material was recovered. 
No improvement was achieved on the addition of acetic acid. Turning to other non-reductive 
methods, some success was achieved by the use of TMSI, which afforded a mixture of the 
starting material 2.43 and the alcohol 2.1 in a 1:1 ratio. Increasing the reaction time, the 
amount of TMSI and the temperature had no effect on the product distribution. In all cases 
starting material persisted, and increasing the temperature for prolonged periods resulted in 
complex mixtures.    
 
It was postulated that removal of the benzyl group could be facile at an earlier stage in the 
synthesis (Scheme 2.39). Hence, deprotection of the 2, 4-disubstituted tetrahydroquinoline 
2.39 was attempted under a range of conditions (Table 2.12 and 2.13).  
 
Scheme 2.39: Removal of the benzyl group from the tetrahydroquinoline 2.39. 
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Initally, hydrogenation was attempted using palladium on charcoal (Table 2.12). It was 
postulated that removal of the Moc protected amine could also occur under these conditions, 
as it resides in the activated benzylic position.  
Table 2.12: Hydrogenation of the tetrahydroquinoline 2.39.
a
 
Entry Conditions Temp/ °C Pressure/psi Time/ h % Yield
b
  
1 5 % Pd/C, H2, AcOH rt 14.7 5 - 
2 10 % Pd/C, H2 50 14.7 7 - 
3 10 % Pd/C, H2 50 14.7 72 - 
4 10 % Pd/C, H2 rt 30 72 - 
5 10 % Pd/C, H2 50 30 72 - 
6 
10% Pd/C, 1,4-
cyclohexadiene 
rt - 72 - 
a
Reagents and conditions: Entry 1: THQ (100 mg, 0.3 mmol), Pd/C (100 mg), AcOH (cat.), H2, EtOH (2 mL); 
For entries 2-3: THQ (50 mg, 0.14 mmol), Pd/C (50 mg), THF (2 mL), H2; For entries 4-5: THQ (50 mg, 0.14 
mmol), Pd/C (50 mg), THF (2 mL), H2 (30 psi); Entry 6: THQ (100 mg, 0.3 mmol), Pd/C (100 mg), 1,4-
cyclohexadiene (0.3 mL), EtOH (1.5 mL). 
b
Yields determined by 
1
H NMR. 
No reaction occurred on attempting the hydrogenation with 5% Pd/C at room temperature 
under an atmosphere of hydrogen, even with the addition of acid (Table 2.12, entry 1). 
Changing the catalyst to 10% Pd/C and increasing the temperature to 50 °C had no effect 
(entry 2), even at extended reaction times (entry 3). As a result, the hydrogenation was 
conducted under 30 psi of hydrogen at room temperature, to see if increasing the pressure 
would allow for deamination. None of the desired product was obtained; starting material was 
recovered, even when the reaction was left exposed to the hydrogenative conditions for 72 
hours at 50 °C (entries 4 and 5), although the onset of degradation was evident. Transfer 
hydrogenation was attempted under literature conditions,
122
 using Pd/C as catalyst and 1, 4-
cyclohexadiene as the hydrogen source. This hydrogenation process also proved unsuccessful 
with benzyl protecting group remained in place (entry 6), suggesting it is surprisingly stable. 
 
As hydrogenation with Pd/C did not proceeded to remove the benzyl group a number of other 
methods for debenzylation were investigated (Table 2.13). 
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Table 2.13: Results for benzyl deprotection of 2.39.
a
 
Entry Conditions Time/h Temperature/ °C 
% of 2.51 
obtained
b
 
% of SM 
remaining
b
 
1 
AlCl3, N,N-
dimethylaniline 
24 rt - 100 
2 FeCl3 24 rt - - 
3 Nickel sponge 16 80 90 10 
a
Reagent and Conditions: Entry 1: 2.39 (50 mg, 0.14 mmol), AlCl3 (78 mg, 0.58 mmol), N,N-dimethylaniline 
(55 μL, 0.44 mmol), CH2Cl2 (1 mL);  Entry 2: 2.39 (50 mg, 0.14 mmol), FeCl3 (71 mg, 0.41 mmol), CH2Cl2 (3 
mL); Entry 3: 2.39 (50 mg, 0.14 mmol), nickel sponge (500 mg), EtOH (2 mL), THF (1 mL). 
b
Determined by 
1
H NMR. 
The removal of benzyl ethers using AlCl3 and N,N-dimethylaniline has been reported.
123
 This 
reaction is believed to proceed via coordination of the AlCl3 to the ether oxygen. 
Nucleophilic attack of the dimethylaniline at the benzylic carbon liberates the alcohol upon 
acidic work up. Unfortunately, when 2.39 was subjected to these conditions no reaction was 
obtained and starting material was recovered (Table 2.13, entry 1). Benzyl deprotection can 
also occur in the presence of FeCl3 in dichloromethane, believed to proceed in a similar 
manner to the AlCl3 reaction.
124, 125
 In this case, complete degradation of the starting material 
to unknown compounds occurred (entry 2). Finally, cleavage of the benzyl group was 
achieved using Nickel sponge in a mixture of ethanol/THF.
126, 127
 Under refluxing conditions, 
the reaction proceeded to give 2.51 with 90% conversion after 16 hours (entry 3). 
Furthermore, the reaction progressed cleanly to give an easily separable mixture of starting 
material and product. 
 
 
The debenzylation procedure was also applied successfully to the deaminated 
tetrahydroquinoline 2.43.  In contrast to the debenzylation of 2.39, the reaction was extremely 
slow requiring 5 days to proceed to 80% conversion, giving the alcohol 2.1 in 71% yield. 
Attempts to reduce the reaction time by increase the pressure gave complex reaction 
mixtures, with significant degradation of the starting material. The formation of the 
deprotected 2.1 was confirmed by the presence of an OH stretch in the IR spectrum and the 
M
+
 ion 177.1 (EI).  
  
Hence, the common precursor 2.1 was formed from ethylene glycol in 9 steps with 12% 
overall yield (Scheme 2.40). The aza-Michael reaction afforded 2.24 in good 
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enantioselectivity, and optically pure material was obtained upon recrystallisation. The 
formation of the N-heterocycle was achieved under reductive cyclisation conditions to give 
the 2, 4-disubstituted tetrahydroquinoline 2.38. Methylation, followed by N-Moc deprotection 
produced the amine 2.40 in good yield. This amine was the subjected to a transamination 
reaction using Rapoport‟s reagent. Finally, 2.1 was obtained from the tetrahydroquinolone by 
reductive removal of the ketone and benzyl deprotection.  
 
Scheme 2.40: Reagent and conditions: (i) PhNH2, 1.117, toluene, 50 °C; (ii) NaBH4, 
MgCl2.6H2O, EtOH/THF, HCl, -10 °C; (iii) HCHO, NaCNBH3, AcOH, 
MeCN, 0 °C; (iv) TMSI, MeCN, rt; (v) 4-formyl-1-methyl pyridinium 
benzenesulfonate 2.45, DBU, oxalic acid, CH2Cl2/DMF, rt; (vi) AlCl3, LiAlH4, 
Et2O, THF, rt; (vii) Nickel sponge, EtOH, THF, reflux. 
 
2.5 C-2 Side chain attachment 
With 2.51 in hand, an attempt was made to attach the requisite C-2 substituents at this stage. 
This could be achieved by oxidation of the alcohol to the corresponding aldehyde, followed 
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by a Wittig reaction (Scheme 2.41). However, oxidation of 2.51 under Swern conditions did 
not proceed to give the aldehyde, but only led to complete degradation of the starting 
material.  
 
Scheme 2.41: Attachment of the C-2 side chain to 2.51. 
Thus, attachment of the C-2 substituent was attempted with 2.1. Two potential methods were 
identified; The conversion of the C-2 alcohol into a leaving group, followed by the reaction 
with a suitable organometallic reagent (Scheme 2.42), or the tandem oxidation/Wittig 
sequence, followed by hydrogenation of the resultant double bond (Scheme 2.43).    
 
Scheme 2.42: Formation of the Galipea alkaloids by a SN2 reaction. 
 
Scheme 2.43: Formation of the Galipea alkaloids using a tandem oxidation-Wittig-reduction 
sequence.  
The first strategy has been previously adopted for the synthesis of racemic angustureine and 
various analogues. 2.54 and 2.55 were treated with a cuprate, to produce angustureine in 18% 
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yield. The main side products of this reaction were the anilines 2.61 and 2.62, formed by 
competitive elimination (Scheme 2.44).
128
 
 
Scheme 2.44: Attempted Galipea alkaloid synthesis. 
In the reported work, the addition of allyl, phenyl and methyl groups to the iodide proceeded 
to give the substituted products in moderate to good yields, using a cuprate formed from 
Li2CuCl4 and a Grignard reagent (Scheme 2.45).
128
  
 
Scheme 2.45: Extension of C-2 side chain by SN2 substitution. 
 
The alcohol of 2.1 was converted into a good leaving group, either an iodide or bromide, 
following literature conditions (Scheme 2.46).
128
 These compounds are unstable, and were 
used immediately on formation. Attempts to convert the alcohol into a tosyl or mesyl group 
led to extensive degradation. The bromide and iodide were reacted with n-butylmagnesium 
chloride under a number of reaction conditions (Table 2.14).    
 
Scheme 2.46: Reagents and conditions: (i) I2, PPh3, imidazole, toluene, MeCN, 0 °C; (ii) 
MsCl, NEt3, LiBr, THF, -40 °C.   
Chapter 2  Synthesis of the Galipea alkaloids 
77 
 
Table 2.14: Attempted attachment of the C-2 side chain via SN2 substitution.
a
  
Entry Starting material Reagents Grignard/eq Time/h % Yield
b
 
1 2.55 CuCl 6.25 18 30 
2 2.54 CuCl 6.25 18 - 
3 2.55 CuI 6.25 72 - 
4 2.54 CuI 6.25 72 < 5 
5 2.55 CuCl2, LiBr 1.05 18 - 
6 2.54 CuCl2, LiBr 1.05 18 < 5 
7 2.55 AgNO3 1.3 18 - 
8 2.54 AgNO3 1.3 18 - 
a
Reagent and conditions: For entries 1-2: Alkyl halide (1.0 eq), CuCl (2.7 eq), n-BuMgCl (6.25 eq), THF, 
NMP, -78°C-rt; For entries 3-4: Alkyl halide (1.0 eq), CuI (1.44 eq), n-BuMgCl (6.25 eq), THF, -78°C-rt; For 
entries 5-6: Alkyl halide (1.0 eq), CuCl2 (cat.), LiBr (cat.), n-BuMgCl (1.05 eq), THF, NMP, -78°C-rt; For 
entries 7-8: Alkyl halide (1.0 eq), AgNO3 (cat.), n-BuMgCl (1.3 eq), Et2O, rt. 
b
Yield calculated by 
1
H NMR. 
Reaction of the bromide 2.55 with the Grignard reagent, in the presence of CuCl, proceeded 
to give 1.10 as a mixture containing large amounts of starting material (Table 2.14, entry 1). 
Characteristic signals corresponding to alkene protons could be seen in the 
1
H NMR 
spectrum, suggesting degradation of the bromide via elimination of HX. Conversely, none of 
the desired 1.10 was obtained when the iodo 2.54 was subjected to the same reaction 
conditions; a majority of the iodide decomposing (entry 2). No product was formed when the 
bromide was reacted with the cupurate generated from the Grignard reagent and CuI (entry 
3). On the other hand, trace levels of product were observed when the iodide was reacted with 
this cupurate, but a significant level of starting material was recovered (entry 4). Finally, no 
reaction occurred between 2.55 and the Grignard reagent with CuCl2 and LiBr,
129
 while the 
iodide gave trace quantities of 1.10, with recovery of starting material (entries 5 and 6).   
 
Recently silver salts have been reported to efficiently catalyse the cross coupling reaction of 
alkyl halides with Grignard reagents.
130
 Accordingly, the cross coupling reaction of the iodide 
2.54 and bromide 2.55 with butyl magnesium chloride was attempted in the presence of 
AgNO3. Unfortunately only starting material was recovered from the reaction mixture.  
 
Failing to synthesise angustureine, in good yield, by cross-coupling with organometallic 
reagents, we started to investigate the second strategy involving redox transformations. 
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Namely, the oxidation of 2.1 to the aldehyde, followed by a Wittig reaction and 
hydrogenolysis of the C=C bond (Scheme 2.47). The preparation of the aldehyde was 
attempted using several different oxidising reagents (Table 2.15).  
 
Scheme 2.47: Formation of the Galipea alkaloids via redox transformations. 
Table 2.15: Oxidation of 2.1.
a
    
Entry Oxidation conditions Temp/
o
C Time/h % Conversion
b
 
1 TEMPO, NaOCl, KBr rt 20 - 
2 TPAP, NMO rt 16 10 
3 DMP rt 18 30 
4 DMP, H2O 5 3 30 
5 DMP, TFA rt 18 100 
6 Swern -78 to rt 1.5 100 
a
Reagents and conditions: Entry 1: Alcohol (0.17 mmol, 1.0 eq), TEMPO (10 mol%), NaClO (0.19 mmol, 1.1 
eq), potassium bromide (0.17 mmol, 1.0 eq), CH2Cl2 (1 mL); Entry 2: Alcohol (0.06 mmol, 1.0 eq), NMO (0.12 
mmol, 2.0 eq), TPAP (10 mol%), CH2Cl2 (0.5 mL); For entries 3-5: Alcohol (0.16 mmol, 1.0 eq), DMP (0.16 
mmol, 1.0 eq), CH2Cl2 (1 mL); Entry 6: Alcohol (0.17 mmol, 1.0 eq), oxalyl chloride (0.19 mmol, 1.1 eq), 
DMSO (0.34 mmol, 2.0 eq), NEt3 (0.85 mmol, 5.0 eq), CH2Cl2 (1 mL). 
b
Determined by 
1
H NMR.  
Formation of the aldehyde under mild reaction conditions would prove advantageous, as this 
could help minimise degradation of the aldehyde. Initially the mild oxidation of the alcohol 
was attempted using TEMPO, but starting material was recovered (Table 2.15, entry 1). Only 
10% conversion was obtained when TPAP was employed (entry 2). A DMP oxidation 
procedure was next attempted, which proceeded with 30% conversion (entry 3). The addition 
of water has been shown to improve DMP oxidation reactions,
131, 132
 however it had no effect 
in this instance (entry 4). The result contradicts am earlier report, where DMP oxidation of a 
similar alcohol to 2.1 has been achieved, when the nitrogen was protected with a deactivating 
group.
133
 This implies that the presence of the N-methyl substituent could be the cause of our 
failure. Hence, trifluoroacetic acid (1.5 eq) was added to the reaction mixture, in the hope of 
protonating and deactivating the nitrogen. Indeed, this led to a complete consumption of the 
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alcohol, but the aldehyde was not formed cleanly. Finally, Swern conditions were used for 
the oxidation to afford complete conversion to the aldehyde in a much cleaner reaction (entry 
6), confirmed by the observation of an aldehyde resonance at 9.8 ppm in the 
1
H NMR 
spectrum. Due to the instability of the aldehyde, it was used immediately in the following 
step without purification.    
 
There are several examples where the Swern oxidation of similar alcohols proceeded with 
epimerisation or racemisation of their chiral centres. An example is the Swern/Wittig reaction 
of alcohol 2.63, where the epimerisation of the C-2 chiral centre was attributed to the 
presence of the large excess of triethylamine used in the Swern reaction, to give the more 
stable 2, 3-anti isomer (Scheme 2.48).
82
 To ensure no racemisation occurred during the 
oxidation of 2.1, it is necessary to perform careful removal of the triethylamine during the 
workup, by multiple washes with sat. NH4Cl.    
 
Scheme 2.48: Epimerisation of a C-2 chiral centre under Swern oxidation conditions. 
 
The phosphonium salts required for the addition of the side chain, were prepared from 
commercially available alcohols in excellent yields (Scheme 2.49).  
 
Scheme 2.49: Reagent and conditions: (i) K2CO3, BnBr, acetone, reflux, 71%; (ii) PBr3, 
CH2Cl2; (iii) PPh3, toluene.   
 
The Wittig reactions were subsequently performed, with the ylid salts stirred for 1 hour with 
the base, prior to addition of the aldehyde.
134
 A variety of different reaction conditions were 
examined (Scheme 2.50, Table 2.16). 
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Scheme 2.50: Wittig reaction for the formation of 2.60. 
Table 2.16: Optimisation of the Wittig reaction.
a
   
Entry Base Base eq Ylid  eq Temp/°C Time/ h Yield %
b
 
1 n-BuLi 1.1 1.2 -78 to 5 18 38 
2 n-BuLi 1.1 1.2 -78 to -25 18 33 
3 n-BuLi 1.5 1.2 -78 to 5 18 40 
4 n-BuLi 2.0 1.2 -78 to 5 18 33 
5 n-BuLi 1.5 1.6 -78 to 5 18 44 
6 n-BuLi 2.0 2.2 -78 to 5 18 69 
7 KO
t
Bu 1.1 1.2 0 18 43 
8 KO
t
Bu 1.1 1.2 -78 to rt 18 33 
9 KO
t
Bu 2.0 2.2 0 18 65 
10 NaHMDS 1.1 1.2 -78 to 5 18 41  
11 NaHMDS 2.0 2.2 -78 to 5 18 69 
a
Reagent and conditions: Aldehyde (0.28 mmol, 1.0 eq), ylid (1.2-2.2 eq), base (1.1-2.0 eq), THF (3 mL). 
b
Yields over 2 steps after column chromatography, as a mixture of E/Z iosmers. 
Initially n-BuLi was used as base in a slight excess,
134
 to ensure complete consumption of the 
aldehyde (Table 2.16, entry 1). This afforded a low yield of product. To minimise the 
degradation of the aldehyde, the reaction temperature was maintained at -25 °C after addition 
of the aldehyde (entry 2), but this did not lead to any improvement in yield. The amount of 
base used in the reaction was next investigated. When a slight excess of base was used (with 
respect to the yild), there was no change in the outcome (entry 1 vs entry 3). However, the 
presence of a large excess of base led to a reduction in yield (entry 4). This result suggested 
that the aldehyde was unstable to basic conditions. In addition, the slow rate of the reaction 
could be responsible for the poor results, prompting us to employ an excess of the Wittig 
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reagent (entries 5 and 6). This led to a small increase in the product yield and thus far, the 
highest yield for the oxidation/Wittig reaction was achieved with a 2-fold excess of the ylid 
(entry 6).  
 
Other strong bases were also investigated in this study, such as KO
t
Bu (entries 7, 8 and 9) 
and NaHMDS (entries 10 and 11). The nature of the base was found to have no significant 
effect on the results and comparable yield to n-BuLi were obtained. In all cases, the highest 
yields were achieved when a 2-fold excess of the ylid was used (entries 9 and 11). The 
reaction with KO
t
Bu as base proceeded to give the best result when conducted at 0 °C (entry 
8 vs 9).     
 
In all cases the alkene 2.60 was obtained as a mixture of E- and Z-isomers, typically in a ratio 
of 2:3 (Figure 2.5). The major isomer had a 
3
J value of 11.6 Hz and so was assigned as the Z-
isomer, while the minor E-isomer exhibited a 
3
J value of 15.8 Hz.  
 
Figure 2.5: NMR of 2.60 showing the E- and Z-isomers. 
 
In addition to the Wittig reaction, a HWE reaction was also attempted in the hope of 
improving the yield of the alkene. The formation of the alkene as a single E-isomer would 
also allow for easier analysis. The phosphonate HWE reagent was prepared from the alcohol 
2.65, via the bromide, in quantitative yields (Scheme 2.51).    
 
Scheme 2.51: Reagent and conditions: (i) PBr3, CH2Cl2, 0 °C; (ii) P(OMe)3, 90 °C, quant. 
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The HWE reaction of the aldehyde 2.56 and the phosphonate 2.71, was investigated under a 
variety of different conditions (Scheme 2.52, Table 2.17).  
Scheme 2.52: HWE reaction of the aldehyde 2.56 with the phosphonate 2.71. 
 
Table 2.17: HWE reaction of the aldehyde 2.56 under various conditions.
a
 
Entry Base/additive Temp/ 
o 
C Time/h % Yield 
1 NEt3 rt 72 - 
2 KO
t
Bu rt 16 - 
3 KO
t
Bu -78
o
C 16 - 
4 DBU/LiCl rt 16 - 
a
Reagents and conditions: Entry 1: Aldehyde (0.28 mmol, 1.0 eq), 2.71 (0.28 mmol, 1.0 eq), NEt3 (0.28 mmol, 
1.0 eq), THF (1 mL), rt; Entry 2: Aldehyde (0.28 mmol, 1.0 eq), 2.71 (0.28 mmol, 1.0 eq), KO
t
Bu (0.37 mmol, 
1.3 eq), DMF (1 mL), rt; Entry 3: Aldehyde (0.28 mmol, 1.0 eq), 2.71 (0.30 mmol, 1.1 eq), KO
t
Bu (0.32 mmol, 
1.1 eq), THF (1 mL), -78 °C; Entry 4: Aldehyde (0.28 mmol, 2.0 eq), 2.71 (0.14 mmol, 1.0 eq), DBU (0.42 
mmol, 3.0 eq), LiCl (0.42 mmol, 3.0 eq), MeCN (1 mL), rt. 
Initially triethylamine was used,
135
 as it was deemed advantageous to use a milder base to 
minimise the base catalysed degradation of the aldehyde. Unfortunately, none of the desired 
alkene was formed and starting material persisted (Table 2.17, entry 1). Using the stronger 
KO
t
Bu
136, 137
 led to complete degradation of the aldehyde, even at -78 °C (entries 2 and 3). 
Finally, a Masamune-Roush modified reaction
138
 also proved unsuccessful, due to 
competitive degradation of the starting material (entry 4).  
 
Telescoping the oxidation/Wittig reaction with the hydrogenation would produce the natural 
products 1.10-1.13 in a single synthetic sequence. Hence, the final synthesis of the Galipea 
alkaloids was achieved using the optimum conditions developed for the alkene formation 
followed by immediate hydrogenation to give 1.10, 1.11 and 1.13 (Scheme 2.53, Table 2.18).  
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Scheme 2.53: Reagent and conditions: (i) Aldehyde 2.56, KO
t
Bu, Ylid, THF, 0 °C; (ii) Pd/C,   
H2, EtOH, THF, reflux.  
Table 2.18: Application of optimised Wittig reaction conditions for the synthesis of the other 
Galipea alkaloids.
a
 
Entry Ylid Product Yield %
b
 [α]D
25 
 [α]D
25
 (lit.) 
1 n-BuPPh3Cl 
 
44 +7.5 -7.16
18
 
2 2.69 
 
26
c
 - - 
3 2.70 
 
32 -27.0 
-26.1
19
 
-13.6
18
 
4 2.68 
 
31 - -33.4
139
 
a
Reagent and conditions: For entries 1-2 and 4: Aldehyde (0.28 mmol, 1.0 eq), KO
t
Bu (0.57 mmol, 2.0 eq), 
Ylid (2.2 eq), THF, 0 °C, then Pd/C (50 mg), EtOH (1 mL), THF (0.5 mL). Entry 3: Aldehyde (0.28 mmol, 1.0 
eq), KO
t
Bu (0.85 mmol, 3.0 eq), Ylid (2.2 eq) THF, 0 °C, then Pd/C (50 mg), EtOH (1 mL), THF (0.5 mL).  
b
Yield determined by 
1
H NMR over 3 steps. 
c
No hydrogenation performed, yield based on formation of the 
alkene. 
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The reaction proceeded to furnish angustureine in 44% yield over three steps, which recorded 
an [α]D
25 
value of
 
+7.5° (Table 2.18, entry 1). In comparison, the natural product was reported 
to have a specific rotation of -7.16°. This confirms we have achieved the synthesis of the 
unnatural (S)-(+)-enantiomer of angustureine, as expected from the assumption of the aza-
Michael product stereochemistry (section 2.2).  
 
For the reaction with the ylid 2.69, an additional equivalent of base was needed to take into 
account the presence of the free phenolic group.
140
 As a result, the alkene 2.58 was obtained 
in a very low yield (entry 2) and so the hydrogenation was not attempted. To overcome this 
problem, it was decided to employ the benzyl protected ylid 2.70. This afforded 1.11 in 32% 
yield after hydrogenation (entry 3), with the [α]D
25 
of -27.0°, this compares well to the 
reported optical rotation, -26.1° (96% ee), of a synthetic sample of the (S)-isomer.
19
 
Interestingly the natural product has a lower optical rotation of -13.6°, suggesting that it was 
not isolated as a single enantiomer. A third Galipea alkaloid galipinine 1.13 was also 
synthesised in 31% yield over the three steps (entry 4). Due to the limited amount of the 
alcohol 2.1 available, formation of galipinine was only achieved racemically and the 
formation of cuspareine was not attempted.  
 
In summary, this Chapter has detailed the synthesis of three Galipea alkaloids (two optically 
pure and one racemic), achieved in 12 steps with 4-5% yield. Although this route is not the 
shortest, nor the highest yielding for the synthesis of these molecules, it allows for the 
divergent synthesis of a range of tetrahydroquinolines from a common precursor. 
Furthermore, the overall synthetic route proceeds through a number of optically pure 
intermediates, which could prove interesting for the development of other 
tetrahydroquinoline molecules. This method also proved successful for the synthesis of 
galipeine, whose total synthesis has only been reported on one other occasion.
19
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3.0 Synthesis of the Martinelline Alkaloids 
This Chapter details the work towards the formal synthesis of the Martinelline alkaloids, 
martinelline 1.14 and martinellic acid 1.15. These alkaloids are substituted in the 2-, 3- and 4-
positions of the tetrahydroquinoline core and therefore have three stereogenic centres. We 
aim to use the methodology detailed in the previous chapter, to form the 2-substituted 
tetrahydroquinolone 3.1, from which both Martinelline alkaloids should be accessible 
(Scheme 3.1). The aza-Michael reaction developed previously by our group will be used to 
install the first of the chiral centres in the 2-position, which will be used to direct the 
formation of further stereogenic centres.  
Scheme 3.1 : Retrosynthetic analysis of the Martinelline alkaloids. 
 
Previously, a similar approach has been adopted for the racemic synthesis of the martinelline 
core structure,
75
 where the installation of the 5-membered heterocyclic ring was achieved by 
treatment of the ketone 3.2 with paraformaldehyde (Scheme 3.2).  
 
Scheme 3.2: Reagents and conditions: (i) HCHO, PhMeNH.TFA, 85%; (ii) KCN, AcOH, 
71%; (iii) LiAlH4; (iv) MnO2, 9%; (v) NaBH3CN, 100%. 
 
This was followed by the 1, 4-conjugate addition of KCN to the resultant activated 
methylene, to give the nitrile 3.3, exclusively as the anti isomer. Upon reduction of the nitrile 
with LiAlH4 and re-oxidation of the benzylic alcohol, spontaneous cyclisation occurred to 
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give an imine. Finally, reduction of the imine with NaCNBH3 produced the tricyclic structure 
3.4. The tandem reduction/alcohol re-oxidation steps proceeded with only 9% overall yield. 
Other selective nitrile reduction methods were also investigated, but competitive reduction of 
the allyl alkene occurred in all cases.
75
 
 
In another report, Ma et al. detailed the diastereoselective synthesis of martinellic acid from a 
2-substituted tetrahydroquinolone intermediate 3.6, which was obtained from the optically 
pure 3.5 in 9 steps with 35% overall yield. Installation of the third ring was achieved by the 
formation of a cyclic imine using a Staudinger reaction (Scheme 3.3). Following the removal 
of the TBDMS protecting group and reduction of the imine, the tricyclic core was attained as 
a single diastereoisomer. Removal of the protecting group was required in order to give high 
stereoselectivities in the reduction reaction. This was attributed to the coordination of the free 
hydroxyl to the borohydride.
101
     
 
Scheme 3.3: Reagent and conditions: (i) LHMDS, THF then BrCH2CH2OTf; (ii) NaN3, DMF 
then PPh3, H2O, 48 %; (iii) TBAF, HOAc; (iv) NaBH4, (CF3CO)2O, 94 %. 
 
Additionally, Lei et al. have shown that formation of the pyrroloquinoline core can be 
achieved from an C-3 allyl substituted tetrahydroquinoline by ozonolysis of the allyl group, 
followed by reductive amination (Scheme 3.4).
141
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Scheme 3.4: Reagent and conditions: (i) O3, CH2Cl2, -78 °C then Me2S, 0 °C-rt; (ii) 
BnNH2.HCl, NaBH3CN, MeOH, rt.    
 
3.1 Synthesis of α, β-unsaturated carbamates 
Compared to the Galipea alkaloids, the Martinelline alkaloids have a longer C-2 side chain, 
and so Michael acceptors of type 3.9 were required. These will be synthesised from γ-
hydroxy acetaldehydes, either by a Wittig reaction with the ylid 2.20a, or a HWE reaction 
with the phosphonate carbamate 2.14a (Scheme 3.5).    
 
Scheme 3.5: Retrosynthetic analysis of the aza-Michael acceptors. 
The required γ-hydroxy acetaldehydes were synthesised from 1, 4-butanediol in two steps; 
the mono-protection of the diol and the oxidation of the free alcohol. From the work 
conducted previously, the nature of the hydroxyl protecting group has a significant effect on 
the aza-Michael reaction. As a result, four different protecting groups were used in the 
synthesis of the desymmetrised alcohol, including a benzyl ether 3.11, two silyl ethers 3.12 
and 3.13 and an acetyl 3.14 (Scheme 3.6).  
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Scheme 3.6: Reagent and conditions: (i) BnBr, NaH, THF, 0 °C, 16 h; (ii) DIPEA, 
TBDPSCl, CH2Cl2, rt, 2 h; (iii) TBDMSCl, imidazole, DMF, rt, 2 h; (iv) AcCl, 
py., CH2Cl2, 0 °C, 16 h. 
The benzyl protected alcohol 3.11 was prepared using published procedures, by the reaction 
of 1, 4-butanediol with NaH and BnBr. A mixture of the mono- and di-protected butandiol 
was formed in a 10:1 ratio, which separated by column chromatography to give the desired 
3.11 in 76% yield.
142
 On the other hand, both silyl-protected alcohols were formed as the 
mono-protected species only. The TBDPS protected alcohol was obtained in 54% yield via 
the reaction of TBDPSCl and DIPEA with 1, 4-butanediol,
143
 whereas the formation of the 
TBDMS protected alcohol proceeded smoothly with imidazole as base, to give the mono-
protected alcohol in 71% yield.
144
 Last but not least, mono-protection with the acetyl group 
was achieved using acetyl chloride and pyridine in 45% yield, which is lower than the yield 
reported in the literature (74%).
145
 The next step involved the oxidation of the alcohols to 
give the protected γ-hydroxy acetaldehyde. Due to the instability of these aldehydes, they 
were used immediately in the olefination reaction, without any further purification.  
 
It was shown in the previous chapter that the aza-Michael reaction gave higher 
enantioselectivities with the E-isomer of the α, β-unsaturated carbamates was employed. 
Therefore, formation of the alkene using a HWE reaction would be advantageous. The low 
yields previously experienced with the HWE reaction were thought to be due to degradation 
of the aldehyde mediated by base and the close proximity of the protected alcohol to the 
aldehyde moiety. It was hoped that the increased distance between the aldehyde and the 
alcohol in these γ-hydroxy acetaldehydes would help increase their stability. Consequently, 
several different oxidation and olefination methods were attempted for the formation of the 
required α, β-unsaturated carbamates 3.19-3.22 (Scheme 3.7, Table 3.1).   
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Scheme 3.7: Reagent and Conditions: (i) Oxalyl chloride, DMSO, NEt3, CH2Cl2, -78 °C-rt; 
(ii) IBX, DMSO, rt; (iii) 2.14a, DBU, THF, rt; (iii) 2.20a, CH2Cl2, rt.    
 
 
Table 3.1: Synthesis of aza-Michael acceptors.
a
 
Entry Alcohol 
Oxidation 
method 
Alkene 
Synthesis 
E:Z ratio
b
 % Yield
c
 
1 3.11 Swern HWE 100:0 40 
2 3.11 Swern Wittig 10:1 34 
3 3.11 IBX HWE 100:0 20 
4 3.11 IBX Wittig 100:0 15
d
 
5 3.12 Swern HWE 100:0 49 
6 3.12 IBX HWE 100:0 15 
7 3.12 Swern Wittig 10:1 70 
8 3.13 Swern Wittig 10:1 55 
9 3.14 Swern Wittig 10:1 45 
a
Reagent and conditions: Swern reaction: Alcohol (5.6 mmol, 1.0 eq), oxalyl chloride (12 mmol, 2.2 eq), 
DMSO (27 mmol, 4.8 eq), NEt3 (28 mmol, 5.0 eq), CH2Cl2 (15 mL); IBX oxidation: Alcohol (3.9 mmol, 1.0 
eq), IBX (4.3 mmol, 1.1 eq), DMSO (20 mL); HWE reaction:  Phosphonate carbamate (5.6 mmol, 1.0 eq), 
DBU (5.6 mmol, 1.0 eq), THF (10 mL); Wittig reaction: Ylid (5.6 mmol, 1.0 eq), CH2Cl2 (20 mL). 
b
Determined by 
1
H NMR. 
c
Isolated yield obtained over 2 steps after column chromatography. 
d
Tandem 
Oxidation/Wittig reaction. 
Formation of 3.19 was initially attempted using a Swern oxidation followed by a HWE 
reaction. The reactions proceeded to give 3.19 as the E- isomer exclusively in the low yield of 
40% (Table 3.1, entry 1). Using a Wittig reaction, a 10:1 mixture of the E- and Z-isomers was 
formed in the lower yield of 34% (entry 2). Even poorer result were obtained when IBX was 
used in the oxidation step (entries 3 and 4), while the alkene was produced in only 15% yield 
with the tandem IBX oxidation-Wittig sequence (entry 4).  
 
Synthesis of the alkene 3.20 was also attempted using a HWE reaction, where the aldehyde 
3.16 was formed under Swern or IBX oxidation conditions. In both cases, the alkene was 
formed exclusively as the E-isomer, with the Swern oxidation proving optimum (entry 5 vs 
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6). Finally, an improvement in the yield was obtained with a combination of Swern oxidation 
and Wittig reaction (entry 7), which afforded the alkene 3.20 in 70% yield, as a 10:1 
inseparable mixture of the E- and Z-isomers. Likewise, the other alkenes 3.21 and 3.22 were 
obtained in a 10:1 mixture of E- and Z-isomers, via a Wittig reaction (entries 8 and 9). Rather 
unexpectedly, the acetyl protected aldehyde remained largely unreacted, giving a very low 
yield of the Wittig product 3.22 (entry 9). Characteristic alkene peaks were observed in the 
1
H NMR spectra of 3.19-3.22, appearing as a doublet at 6.8 ppm and a double triplet at 7.1 
ppm for the major E-isomer (
3
JHH = 15.4 Hz). The alkene signals for the minor Z-isomer 
appear as a doublet at 6.5-6.6 ppm and a double triplet at 6.3 ppm (
3
JHH = 11.5 Hz).   
 
The synthesis of these α, β-unsaturated compounds proceeded in low yields in all cases 
(Table 3.1), potentially caused by the close proximity of the protected alcohol to the 
aldehyde.  Hence, the synthesis of an alternative α, β-unsaturated compound 3.26 was 
investigated. The use of this Michael acceptor would install an allyl group into the C-2 
position of the tetrahydroquinoline, giving 3.23 (Figure 3.1). The required C-2 side chain 
could then be constructed following hydroboration of the allyl group.
83
    
 
 
Figure 3.1: Potential tetrahydroquinoline intermediate in the Martinelline alkaloid synthesis. 
 
3-Buten-1-ol 3.24 was converted into the aldehyde 3.25 using a TEMPO-catalysed oxidation 
procedure.
146
 Following this, the HWE reaction with the phosphonate carbamates 2.14a, 
produced none of the desired compound, but a different α, β-unsaturated alkene 3.27 was 
isolated in 10% yield (Scheme 3.8). The formation of the diene 3.27 was confirmed by the 
presence of a doublet in the 
1
H NMR spectrum corresponding to the terminal CH3 group.  
This diene was formed by the base-catalysed migration of the terminal double bond into 
conjugation with the other unsaturated alkene.
146
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Scheme 3.8: Reagents and Conditions: (i) TEMPO, PhI(OAc)2, pentane, CH2Cl2, rt; (ii) ylid, 
2.20a, CH2Cl2; (iii) 2.14a, DBU, THF.   
   To avoid this, the formation of the desired alkene 3.26 was attempted using the neutral 
Wittig reaction with 2.20a (Scheme 3.8). In this case, the reaction proceeded to give a 
complex mixture. The desired alkene 3.26 was isolated in 15% yield, confirmed by the 
presence of the CH2 methylene group, observed as a multiplet in the 
1
H NMR at 3.05 ppm. 
An equal amount of the conjugated diene 3.27 was also isolated, even under these „neutral‟ 
conditions. This suggests the double bond easily migrates into the more conjugated position.  
 
In summary, a range of different α, β-unsaturated carbamates have been synthesised in 
moderate yields (Figure 3.2), with the Swern/Wittig protocol proving to be the most effective 
method. 
 
Figure 3.2: The α, β-unsaturated carbamates synthesised. 
The next section details the reaction of these α, β-unsaturated carbamates with a range of 
anilines, in an attempt to produce optically pure Michael adducts, that can then be used for 
the synthesis of the Martinelline alkaloids. 
 
3.2 Aza-Michael reactions  
As with the Galipea alkaloids, significant optimisation of the aza-Michael reactions were 
undertaken to allow for the obtainment of material with high optical purity. Initially the effect 
of changing the alcohol protecting group was investigated. 
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3.2.1 Screening of different protecting group 
The four aza-Michael acceptors 3.19-3.22 were reacted with aniline using the set of 
conditions proven to be optimum for the aza-Michael reaction in the Galipea alkaloids 
syntheses, i.e. the reaction was conducted at 50 °C in toluene using the [Pd(R-
BINAP)(OH2)2]
2+
[OTf]
-
2 1.117 complex as catalyst (Scheme 3.9). 
 Scheme 3.9: Reaction of various α, β-unsaturated carbamates with aniline.  
Table 3.2: Aza-Michael reaction of aniline with different acceptors.
a
 
Entry Carbamate Time/d % Yield
b
 % ee
c
 
1 3.19 2 33 8 
2 3.20 3 73 66 
3 3.21 1 65 46 
4 3.22 5 47 44 
5 3.26 7 50 61 
a
Reagent and conditions: Alkene (100 mg, 1.0 eq), aniline (1.0 eq), catalyst (5 mol%), toluene (1 mL), 50 °C. 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using either Hichrom-CHI-PGG-2759 (entries 1, 3-5) or 
Daicel Chiralpak AD-H column (entry 2 or 5). 
 
Initially the reaction was attempted using the benzyl protected alkene 3.19. Only 33% 
conversion was achieved after 2 days and the aza-Michael product was formed in very low 
enantioselectivity (Table 3.2, entry 1). This result was rather unexpected as the aza-Michael 
reaction for the Galipea alkaloids proceeded well with the benzyl-protected Michael acceptor. 
Next, the reaction was repeated using 3.20, containing the bulky tert-butyldiphenyl silyl 
protecting group. An improvement in both conversion and ee to 73% and 66% respectively 
was observed (entry 2). Using the tert-butyldimethyl silyl protected 3.21, 65% conversion of 
the starting material was obtained after 24 hours (Table 3.2, entry 3), and no further 
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improvement was observed on prolonging the reaction time. The reaction gave the aza-
Michael product 3.30 in 46% enantioselectivity. On leaving the reaction for an additional 3 
days, the conversion increased to 85%. These results suggest that increasing the steric bulk of 
the silyl protecting group on the side chain leads to increased conversions and 
enantioselectivities. In contrast, lower conversion and enantioselectivity, 47% and 44% 
respectively, was obtained with the substrate containing the acetyl protecting group, 3.22 
(entry 4).  
The results concur with our earlier observations that the nature of the substituent on the 
alkene has a significant effect on both the yield and enantioselectivity of the reaction. The 
result obtained with 3.19 was significantly lower than with the other three Michael acceptors, 
suggesting that the catalyst was somehow deactivated in this system, lowering the yield and 
ee.  
 
Reaction of aniline with the aza-Michael acceptor 3.26 was also attempted, to determine if 
the reaction would proceed better in the absence of the protected alcohol. However, only 50% 
conversion and 61% ee was obtained after 7 days at 50 °C (Table 3.2, entry 5). The low 
conversion, increased reaction time and low enantioselectivity make this unattractive for the 
synthesis of the Martinelline alkaloids.  
 
In all cases the reactions proceeded in a sluggish manner with incomplete formation of 
product. The highest conversion and enantioselectivity was obtained when the bulky tert-
butyldiphenyl silyl was used as the protecting group, in the Michael acceptor 3.20. The facile 
and selective removal of this silyl protecting group using TBAF
147
 could prove advantageous 
later in synthesis. Therefore, the tert-butyldiphenyl silyl protected alkene was used in the 
subsequent optimisation studies.     
 
3.2.2 Screening of different anilines 
The Martinelline alkaloids contain substituents on the aromatic ring, para to the nitrogen 
heteroatom. Martinelline contains a carboxylic ester, while martinellic acid contains a 
carboxylic acid (Scheme 3.1). Thus, the aza-Michael reactions of a variety of para-
substituted anilines with the Michael acceptors 3.20 and 3.21 were investigated (Scheme 
3.10).  
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 Scheme 3.10: Aza-Michael reaction of model substrates with various para-substituted 
anilines. 
Table 3.3: Aza-Michael reaction of model substrates with a range of anilines
a
 
Entry Alkene R Time/d % Yield
b
 % ee
c
, (Config) 
1 3.20 CO2Et 1.5 77 57 (S) 
2 3.20 Br 2 77 68 (S) 
3 3.21 I 7 40 33 (S) 
4 3.20 H 2 77 67 (S) 
a
Reagent and conditions: Alkene (50 mg, 1.0 eq), aniline (1.0 eq), 1.117 (5 mol%), toluene (1 mL), 50 °C. 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using  Daicel chiralpak AD-H column (entry 2 and 4) or 
Hichrom-CHI-PGG-2759 (entries 1 and 3). 
   
The use of ethyl 4-aminobenzoate in the aza-Michael reaction would give 3.34, which would 
allow for the formation of the tetrahydroquinoline ring with a carboxylic ester already in 
place. Thus, the reaction of 3.20 and ethyl 4-aminobenzoate was initially attempted at 50 °C 
in toluene. This afforded 3.34 in 78% conversion and 57% enantioselectivity (Table 3.3, 
entry 1). In the hope of obtaining better conversions and enantioselectivities, alternative 
anilines were also investigated.    
 
If a bromo or iodo group could be installed in the position para to the nitrogen, it could be 
converted into a carboxylic ester at a later stage in the synthesis. This could be achieved 
using either: (i) a palladium catalysed carbonylation reaction under a carbon monoxide 
atmosphere,
101, 148
 or (ii) via lithium halogen exchange with BuLi, followed by reaction with 
dimethyl carbonate.
149
 Alternatively, bromination at the C-7 position of tetrahydroquinolines 
is known to occur using NBS and CCl4.
150
 Thus, it was envisaged that the introduction of the 
ester group may also be performed after cyclisation of the aza-Michael adduct.  
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The reaction of the alkene 3.20 with 4-bromoaniline proceeded to give 3.33 in 77% yield and 
68% enantioselectivity (Table 3.3, entry 2), while the corresponding reaction with iodoaniline 
gave a complex mixture of inseparable products. In comparison, the reaction of the silyl-
protected 3.21 with iodoaniline gave the product in very low conversion and ee, even on 
prolonged reaction times (entry 3). The formation of 3.29 proceeded with comparable yield 
but higher enantioselectivity than the reaction with ethyl 4-aminobenzoate (entry 1 vs 4).   
 
The aza-Michael reaction of 3.20 with aniline, 4-bromoaniline and ethyl 4-aminobenzoate all 
proceeded to the similar levels of completion, with 4-bromoaniline giving the highest 
enantioselectivity (68%). Surprisingly, the reaction of 3.21 with 4-iodoaniline gave a 
significantly lower ee and yield. Further optimisation was conducted on the aza-Michael 
reaction of 3.20 with 4-bromoaniline and ethyl 4-aminobenzoate.  
 
3.2.3 Effect of catalyst loading 
Attributing the low conversions to catalyst deactivation, the reactions of 4-bromoaniline and 
ethyl 4-aminobenzoate with the Michael acceptor 3.20 were repeated with an increased 
catalyst loading of 10 mol% (Table 3.4). However, no improvement in the conversion or 
reaction time was observed in either case (Table 3.4, entry 1 vs 2 and entry 3 vs 4). As a 
consequence the enantioselectivities were not determined. 
Table 3.4: Effect of catalyst loading on the aza-Michael reaction.
a
  
Entry Product Cat loading/ mol % Time/d % Yield
b
 
1 3.33 5.0 2 68 
2 3.33 10 2 70 
3 3.34 5.0 2 77 
4 3.34 10 2 75 
a
Reagent and conditions: Alkene (0.13 mmol), aniline (0.13 mmol), 1.117 (See table), toluene (1 mL), 50 °C. 
b
Determined by 
1
H NMR. 
 
3.2.4 Effect of Alkene : Aniline ratio 
The pathways to deactivation of the palladium BINAP catalyst during aza-Michael reactions 
have been previously studied.
98
 The alkene is activated towards nucleophilic attack by the 
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formation of a chelate through the 1, 3-dicarbonyl of the α, β-unsaturated carbamate. 
Similarly, the catalyst can also bind to the product, and if this binding was stronger than the 
binding to the alkene starting material, gradual catalyst deactivation would occur over the 
course of the reaction. It was postulated that by increasing the ratio of alkene : aniline, an 
excess of the starting material would always be present in the reaction mixture, and therefore 
the competitive binding of the starting material to the catalyst would be increased.  
 
 
Table 3.5: Effect of alkene : aniline ratio on the reaction of ethyl 4-aminobenzoate with 
3.20.
a
 
Entry Alkene (eq) Time/d % Yield
b
 
1 1.0 2 77 
2 1.2 2 50 
3 1.5 2 55 
4 2.0 2 60 
a
Reagent and conditions: Alkene (50 mg, 0.13 mmol), aniline (0.06-0.13 mmol), 1.117 (5 mol%), toluene (1 
mL), 50 °C. 
b
Determined by 
1
H NMR. 
 
Initially, the reaction of 3.20 with ethyl 4-aminobenzoate was examined (Table 3.5). 
Surprisingly, increasing the equivalents of the alkene with respect to the aniline had a 
significant detrimental effect on the levels of conversion obtained. Even a slight excess of the 
alkene led to a reduction in conversion to 50% (entry 1 vs 2), however, no additional 
deprivation in yield was observed on further increasing the equivalents of alkene (entries 3 
and 4). As increasing the alkene to aniline ratio was found to have a detrimental effect on the 
yields obtained, the enantioselectivities were not determined. This data suggests that the lack 
of full conversion observed for this reaction was not a result of product inhibition.  
 
Table 3.6: Effect of alkene : aniline ratio on the reaction of 4-bromoaniline with 3.20.
a
 
Entry Alkene (eq) Time/d % Yield
b
 % ee
c
, (Config) 
1 1.0 2 68 70 (S) 
2 1.5 5 64 74 (S) 
3 2.0 2 80 85 (S) 
a
Reagent and conditions: Alkene (50 mg, 0.13 mmol), aniline (0.06 mmol-0.13 mmol), 1.117 (5 mol%), toluene 
(1 mL). 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using Chiral Daicel AD-H column. 
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 The same study was carried out on the reaction between 3.20 and 4-bromoaniline. Although 
a slight excess of the alkene did not lead to any noticeable changes (Table 3.6, entry 1 vs 2), 
doubling the equivalents of the alkene did, in this instance, lead to an increase in the yield to 
80%. Gratifyingly, this was also accompanied by an increase in the enantioselectivity to 85%. 
This suggested that product inhibition of the catalyst was an issue in this system. The 
differences observed between the reaction of 4-bromoaniline and ethyl 4-aminobenzoate 
show that the nature of the aniline has a significant effect on the catalyst deactivation process.  
3.2.5 Dilution study 
Previously, the dilution of the reaction mixture has been shown to affect the 
enantioselectivities of the aza-Michael reaction. This effect was particularly prominent in the 
synthesis of the Galipea alkaloids, where the slow addition of the aniline to the reaction 
mixture led to a significant increase in the enantioselectivity, from 61% to 84%. As a result, 
the effect of dilution on the reaction of 3.20 with 4-bromoaniline and ethyl 4-aminobenzoate 
was investigated (Table 3.7).    
 
Table 3.7: Effect of dilution on the aza-Michael reaction of 3.20 with both anilines.
a
 
Entry Product Dilution/ mM Time/d % Yield
b
 % ee
c
, (Config) 
1 3.33 260 1.5 77 67 (S) 
2 3.33 130 2 68 68 (S) 
3 3.34 260 2 78 57 (S) 
4 3.34 130 2 82 71 (S) 
a
Reagent and conditions: Alkene (0.13 mmol, 1.0 eq), aniline (0.13 mmol, 1.0 eq), 1.117 (5 mol%), toluene (See 
table). 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using Chiral Daicel AD-H column. 
 
Surprisingly, increasing the dilution of the reaction with 4-bromoaniline did not lead to any 
improvement in the enantioselectivity (Table 3.7, entry 1 vs 2). In fact, the reaction 
proceeded with higher conversion when a more concentrated solution was prepared. In 
contrast, increasing the dilution of the reaction with ethyl 4-aminobenzoate led to a 
significant improvement in the enantioselectivity obtained, with no change in the yield (entry 
3 vs 4).   
 
The slow addition of the anilines to a mixture of the catalyst and alkene was undertaken next 
(Table 3.8). 
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Table 3.8: Slow addition of the anilines to 3.20.
a
 
Entry Product Time/d % Yield
b
 % ee
b
, (Config) 
1 3.33 2 65 70 (S) 
2
d
 3.34 4 70 81 (S) 
a
Reagent and conditions: Alkene (0.13 mmol, 1.0 eq), aniline (0.13 mmol, 1.0  eq), catalyst (5 mol%), toluene (2 
mL). 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using Chiral Daicel AD-H column. 
b
10 mol% 
catalyst used. 
 
The enantioselectivity of 3.33 was not improved by the slow addition of the 4-bromoaniline 
to the reaction (Table 3.8, entry 1). However, the slow addition of ethyl 4-aminobenzoate did 
lead to an increase in the enantioselectivity observed, although the reaction was significantly 
slower (entry 2). 
 
These results show that inhibition of the catalyst is occurring in both cases. In the case of 4-
bromoaniline binding of the aza-Michael product in preference to the alkene starting material 
was causing the low conversions, whereas catalytic deactivation in the reaction of ethyl 4-
aminobenzoate was probably due to binding of the aniline.   
    
3.2.6 Effect of temperature   
Previously the aza-Michael reaction was conducted at 50 °C, due to poor solubility of the 
alkene at room temperature in toluene. This was not the case for the alkene 3.20, which is 
fully soluble at room temperature. Therefore, the reaction temperature could be lowered. The 
reaction of 3.20 with 4-bromoaniline was conducted at 30 °C and room temperature (Table 
3.9).   
Table 3.9: Effect of temperature on the aza-Michael reaction of 3.20 with 4-bromoaniline.
a
   
Entry Temp/ 
o 
C Time/d % Yield
b
 % ee
c
, (Config) 
1 rt 7 84 85 (S) 
2 30 0.5 71 85 (S) 
3
d
 30 1.5 80 87
 
(S) 
a
Reagent and conditions: Alkene (50 mg, 0.13 mmol), aniline (20 mg, 0.13 mmol), catalyst (5 mol%), toluene (1 
mL). 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC Chiral Daicel Chiralpak AD-H column. 
d
2 eq of 
alkene used. 
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The reaction conducted at room temperature proceeded to give good conversion and high 
enantioselectivity, however the reaction was very slow, taking 7 days to reach 84% 
conversion (Table 3.9, entry 1). On raising the temperature slightly to 30 °C, 71% conversion 
and 85% ee was obtained after 12 hours (entry 2). Repeating the reaction with 2 equivalents 
of the Michael acceptor, with respect to the aniline, led to a slight improvement in the yield 
and enantioselectivity (entry 2 vs 3). However, the purification of the aza-Michael product 
proved difficult in the presence of an excess of the starting alkene. As a result, an optimal 
substrate ratio of 1:1 and temperature of 30 °C were employed for the synthesis of the 
Martinelline alkaloids.  
 
High enantioselectivities were obtained for the reaction of both anilines with the Michael 
acceptor, however, the long reaction times required with the ethyl 4-aminobenzoate made this 
reaction unpractical. Therefore, 4-bromoaniline was chosen as the nucleophile for the aza-
Michael reaction. This reaction can be performed on a multigram scale.   
 
3.2.7 Recrystallisation (ee enhancement) 
Attempts to enhance the optical purity of the aza-Michael adduct 3.33 by recrystallisation 
from toluene-cyclohexane, as well as ether-pentane, were investigated, but to no avail. In 
both cases, the racemic material was insufficiently crystalline to precipitate, even when the 
process was conducted in pure cyclohexane.  
 
In summary, the nature of the alcohol protecting group on the α, β-unsaturated carbamates 
was shown to significantly affect the enantioselectivities and yields of the aza-Michael 
reactions. The use of a benzyl protecting group gave a surprisingly low yield and ee. On the 
other hand, the bulky tert-butyldiphenyl silyl was identified as the best protecting group for 
the alkene, with 3.20 giving the highest enantioselectivities and yields. Eventually, 4-
bromoaniline and ethyl 4-aminobenzoate were identified as suitable nucleophilies for the aza-
Michael reaction; good yields and enantioselectivities were obtained after extensive 
optimisation. The longer reaction times required with ethyl 4-aminobenzoate made this 
reaction less attractive and so the reaction of 3.20 with 4-bromoaniline was chosen for the 
synthesis of the Martinelline alkaloids. Unfortunately, attempts to further improve the ee of 
the Michael adduct 3.33 by recrystallisation were unsuccessful. It was decided that this will 
be attempted at a later stage.    
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3.3 Tetrahydroquinolone formation 
With the aza-Michael adducts in hand, the next step in the synthesis of the Martinelline 
alkaloids was the formation of the tetrahydroquinolone ring. 
 
3.3.1 Friedel-Crafts cyclisation 
Ma et al. reported the synthesis of a very similar tetrahydroquinolone in 62% yield, using an 
electrophilic Friedel-Crafts cyclisation of an acid chloride (Scheme 3.11).
101
  
 
Scheme 3.11: Friedel-Craft cyclisation of an amino acid. 
 
Previous attempts at the formation of the tetrahydroquinolone ring in the Galipea alkaloid 
synthesis, via electrophilic cyclisation of β-amino acids, proved unsuccessful with 
degradation of the starting material occurring in all cases (See Section 2.3.1). Some of the 
problems arose due to loss of the benzyl protecting group to produce a γ-lactone (Scheme 
3.12).   
 
Scheme 3.12: Formation of the lactone ring. 
In this case, a tert-butyldiphenyl silyl protecting group was used, which would hopefully 
prove more stable to the acidic reaction conditions. The formation of the tetrahydroquinolone 
3.36 was investigated using different reagents. First, the N-aryl β-amino acid 3.35 was 
prepared by the hydrolysis of the aza-Michael product 3.33 (Scheme 3.13).   
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Scheme 3.13: Reagent and conditions: (i) 1 M KOH, MeOH, rt, 82 %; (ii) PPA, 60 °C; (ii) 
Eaton‟s reagent, 65 °C; (iii) AlCl3, oxalyl chloride, CH2Cl2/DMF, 0 °C. 
The carboxylic acid was formed in 82% yield, with the structure confirmed by the loss of the 
methyl carbamate group from the 
1
H NMR spectrum, the appearance of a characteristic OH 
stretch at 3380 cm
-1
 and a carbonyl stretch at 1680 cm
-1
 in the infrared spectrum. It was 
envisaged that the optical purity of this intermediate may be enhanced by the formation of a 
diastereomeric salt with quinine.
151
 Consequently, the carboxylic acid 3.35 was reacted with 
(+)-quinine. However, the resultant salt did not resolve upon recrystallisation.   
 
Next, the electrophilic ring cyclisation of the carboxylic acid 3.35 was attempted under 
several different conditions (Table 3.10). 
Table 3.10: Electrophilic cyclisation of 3.35.
a
 
Entry Conditions Temp/ 
o
C Time/h % Yield
b
  
1 PPA 60 2 - 
2 AlCl3, oxalyl chloride  0-rt 16 - 
3 Eaton‟s reagent 65 3 23
c
 
a
Reagent and conditions: Entry 1: Acid (100 mg, 0.18 mmol), PPA (500 mg), CH2Cl2 (1 mL); Entry 2: Acid 
(100 mg, 0.18 mmol), oxalyl chloride (24 μL, 0.28 mmol), AlCl3 (78 mg, 0.59 mmol), DMF (cat.), CH2Cl2 (1 
mL); Entry 3: Acid (100 mg, 0.18 mmol), Eaton‟s reagent (2 mL). bIsolated yield after column 
chromatography. 
c
Tetrahydroquinolone obtained with loss of the alcohol protecting group. 
 
Initially, the cyclisation of 3.35 was attempted using PPA (Table 3.10, entry 1).
99
 None of the 
desired tetrahydroquinoline 3.36 was formed and complete degradation of the starting 
material occurred. Large levels of 4-bromoaniline were observed by 
1
H NMR, suggesting that 
a retro-aza-Michael reaction had occurred.  
 
The AlCl3-catalysed Friedel-Crafts cyclisation of an acid chloride, formed by the reaction of 
3.35 with oxalyl chloride and DMF, was attempted next (entry 2).
101
 The acid chloride 
proved to be unstable under these conditions, and degradation of the starting material was 
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observed with loss of the tert-butyldiphenyl silyl protecting group. 
1
H NMR of the reaction 
mixture showed trace levels of a side product, which is believed to be the lactone 3.37 
(Figure 3.3), as suggested by the presence of two double doublets at 3.35 ppm and 3.55 ppm 
corresponding to the CH2 group next to the lactone. Formation of the seven-membered ring 
of 3.37 would be significantly less favourable than the formation of the 5-membered lactone 
2.34, accounting for the low yield < 10%.   
 
Figure 3.3: Lactone formed under Friedel-Crafts cyclisation conditions. 
Finally, the cyclisation of 3.35 was attempted with Eaton‟s reagent.100 Again, 1H NMR 
revealed the loss of the tert-butyldiphenyl silyl protecting group; however, in this case, 
formation of the lactone 3.37 was not observed. A single product was isolated from the 
reaction mixture. IR analysis showed a carbonyl stretch at 1670 cm
-1
, which corresponds to 
an aryl ketone, suggesting that it was the deprotected tetrahydroquinolone 3.38 (Figure 3.4). 
The formation of 3.38 was also confirmed by the presence of an OH stretch at 3340 cm
-1
 in 
the IR spectrum and the observation of a MH
+
 peak of 284 (ESI).  
 
Figure 3.4: Product from electrophilic ring cyclisation with Eaton‟s reagent. 
 
3.38 was obtained in the very low yield of 23% making this route unattractive. 
Disappointingly, the silyl protecting group proved unstable to the reaction conditions, and 
complete starting material degradation occurred under the strongly acidic reaction conditions. 
As a result, an alternative method for the formation of the tetrahydroquinoline ring under 
milder conditions was required. 
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3.3.2 Lewis acid mediated reductive cyclisation 
The aza-Michael product 3.33 was reacted with MgCl2 and NaBH4 to give the 2, 4-
disubstituted tetrahydroquinoline 3.39 as a single diastereoisomer in 98% yield (Scheme 
3.14).
24
 The formation of the tetrahydroquinoline was confirmed by the loss of a carbonyl 
signal at 172.7 ppm in the 
13
C NMR spectrum and the appearance of a unique absorption 
band at 1770 cm
-1
 in the IR spectrum. 
 Scheme 3.14: Reductive cyclisation of the aza-Michael adduct. 
 
With the 2, 4-disubstituted tetrahydroquinoline in hand, the next step in the synthesis was the 
removal of the N-Moc protecting group (Scheme 3.15).  
 
Scheme 3.15: Reagent and conditions: (i) TMSI, MeCN, rt, 16 h; (ii) 2M KOH, MeOH,      
90 °C, 23 h; (iii) 4M HCl, dioxane, CH2Cl2; (iv) F3CCO2H, CH2Cl2.  
 
Previously deprotection of the amine was achieved in good yield using TMSI. Accordingly, 
the reaction was performed in MeCN at room temperature for 16 hours,
106
 which, proceeded 
to give 3.41 exclusively, as cleavage of the TBDPS group also occurred (Table 3.11, entry 1). 
The reaction was subsequently repeated with a significantly shortened reaction time of 1 hour 
(entry 2). However, the silyl group proved more labile than the carbamate under these 
conditions, with 3.42 obtained as the only product (Figure 3.5). This lack of success led us to 
investigate other methods for the removal of the Moc protecting group (Table 3.11). 
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Figure 3.5: 2, 4-disubstituted tetrahydroquinoline after loss of the TBDPS protecting group. 
 
 
Table 3.11: Various conditions attempted for the deprotection of the N-Moc group.
a
 
Entry Conditions Temp/
o
C Time/h 
% Yield of 
3.40
b
 
% Yield of 
3.41
c
 
% Yield of 
3.42
c
 
1 TMSI rt 16 - 78 - 
2 TMSI rt 1 - - 100
b
 
3 6M KOH 90 18 - 50 - 
4 2M KOH 90 23 - 80 - 
5 2M KOH rt 96 Trace - 30 
6 HCl, dioxane rt 1 - - 100
b
 
7 TMSI rt 16 - - 50 
8 TFA rt 96 - - - 
a
Reagents and conditions: For entries 1-2 and 7: Starting material (1.3 mmol, 1.0 eq), TMSI (5.2 mmol, 4.0 
eq), MeCN (15 mL); For entry 3-5: Starting material (0.4  mmol, 1.0 eq), KOH (See table), MeOH (3 mL); 
Entry 6: Starting material (0.4 mmol, 1.0 eq), CH2Cl2 (35 mL), 4M HCl in dioxane (8.6 mL, 80 eq); Entry 8: 
Starting material (0.2 mmol, 1.0 eq), TFA (2.5 mL), CH2Cl2 (2.5 mL). 
b
Yields determined by 
1
H NMR. 
c
Isolated 
yields. 
 
Removal of the N-Moc protecting group of 3.39 was attempted with KOH.
152
 Using 6M KOH 
led to the globally deprotected species 3.41 in 50% yield, when the reaction was conducted at 
90 °C (Table 3.11, entry 3). The same reaction outcome resulted using 2M KOH, where 3.41 
was formed exclusively in the significantly improved yield of 80% (entry 4). On lowering the 
temperature of the reaction, only a trace of the desired 3.40 was observed, with the tert-
butyldiphenyl silyl deprotected 3.42 isolated in 30% yield and the remainder of the starting 
material recovered. These results show that under basic conditions the deprotection of the 
silyl group is, again, quicker than the deprotection of the Moc group. 
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Next, the hydrolysis of the N-Moc group under acidic conditions was investigated. Exposing 
the tetrahydroquinoline 3.39 to 4M HCl in dioxane for 1 hour (entry 6),
153
 led to the exclusive 
removal of the TBDPS group. This is quite a significant observation as HCl was used in the 
work up of the TMSI and KOH reactions. Hence, it was possible that the observed loss of the 
tert-butyldiphenyl silyl group occurred during work up, and not during the reaction. If this 
was the case, avoiding an acidic work up should have allowed for the formation of the 
desired 3.40. With this in mind, the TMSI deprotection was repeated without an acidic work 
up. This led to a complex reaction mixture, where a significant level of the alcohol 
deprotected product was still observed (entry 7). Finally, the deprotection of 3.39 was 
attempted using the milder acid TFA.
154
 This led to complete degradation of the starting 
material to an unidentifiable mixture of products. Hence, the selective deprotection of the 
amine could not be achieved in the presence of the TBDPS protecting group, despite the 
range of methods attempted. Thus, the re-protection of the alcohol was required (Scheme 
3.16).  
 
 
Scheme 3.16: Reagent and conditions: (i) Imidazole, TBDPSCl, CH2Cl2, Quant. (ii) 
Imidazole, TBDMSCl, DMAP, CH2Cl2, 65%. 
 
Re-protection of the alcohol 3.41 with a tert-butyldiphenylsilyl group
155
 and a tert-
butyldimethyl silyl group
156
 proceeded with quantitative and 65% yields, respectively. 
Formation of the protected alcohols was confirmed by the loss of the OH peak at 3310 cm
-1
 
in the IR spectra.  
 
With the protected amines 3.40 and 3.43 in hand, their conversion into the 
tetrahydroquinolones 3.36 and 3.45 was attempted, via transamination with Rapoport‟s 
reagent
116
 (Scheme 3.17, Table 3.12).  
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Scheme 3.17: Transamination of the amines. 
 
 
 
Table 3.12: Transamination of protected amine.
a
 
Entry Amine Time/h Quench Base/eq Product % Yield
b
 
% SM 
recovered
b
 
1 3.40 3 Citric acid DBU/ 3eq 3.36 5 95 
2 3.40 18 Citric acid DBU/ 3 eq 3.36 72 28 
3 3.40 18 Oxalic acid DBU/ 3 eq 3.36 90 10 
4 3.40 18 Oxalic acid DBU/ 10 eq 3.36 Trace - 
5 3.40 18 Oxalic acid KO
t
Bu/ 3 eq 3.36 - 17
c
 
6 3.43 18 Oxalic acid DBU/ 3 eq 3.44 100 - 
a
Reagents and conditions: Amine (50 mg, 0.2 mmol), Rapoport‟s reagent (0.3 mmol, 1.5 eq), base (See table), 
CH2Cl2 (1 mL), DMF (1 mL), sat. acid (5 mL), rt. 
b
Isolated yield. 
The transamination of 3.40 was performed
157
 with oxalic acid replaced by citric acid and the 
(quenching) process reduced from 16 hours to 2 hours, to avoid decomposition of the desired 
ketone 3.36 via acid catalysed cleavage of the TBDPS group. Unfortunately, only a very low 
yield of the ketone was formed, and the majority of the starting material was recovered 
(Table 3.12, entry 1). However, no loss of the TBDPS protecting group was observed, 
showing it to be stable to these conditions. On repeating the reaction and extending the 
quench to 16 hours, a significant improvement in the yield to 72% was obtained (entry 2). A 
further improvement, to 90%, was achieved by re-adopting oxalic acid in the workup (entry 
3) and the reaction proceeded to give a clean mixture of starting material and product.  
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Next, the amount of base was increased from 3 to 10 equivalents, in the hope of pushing the 
reaction to completion. In this case, only a trace level of the desired ketone 3.36 was 
observed in the reaction mixture, accompanied by large amounts of degraded products (Table 
3.12, entry 4). KO
t
Bu was also used, to determine if a stronger base would improve the yield 
(entry 5). Again, large levels of degradation occurred and none of the desired ketone was 
obtained, although a low level of the starting material was recovered. These results show the 
reaction yield is optimal by employing DBU (3 eq) and oxalic acid for the quench; moreover, 
the time of the reaction quench proved significant.  
 
Thus, the transamination of 3.43 was attempted under the optimal conditions. However, 
TBDMS proved unstable under these conditions, as the deprotected 3.44 was isolated 
quantitatively as the only product (Table 3.12, entry 6).  
The formation of the ketone 3.45 was finally achieved in two steps, by the transamination of 
the amine 3.41 to give the ketone 3.44. Re-protection of the free hydroxyl with a TBDMS 
group at this point allowed for the synthesis of 3.45 (Scheme 3.18). The transamination of 
3.41 gave 3.44 in the good yield of 75% and the re-protection was achieved using imidazole, 
DMAP and TBDMSCl in 70% yield.  
 
Scheme 3.18: Reagent and conditions: (i) 2.45, DBU, DMF, CH2Cl2, 75%; (ii) TBDMSCl, 
DMAP, Imidazole, CH2Cl2, 70%.  
 
To summarise, the formation of the tetrahydroquinolones was achieved from the 
commercially available 1, 4-butandiol in 8 steps with 8-18% overall yield (Scheme 3.19). 
Mono-protection of 1, 4-butandiol, followed by Swern oxidation and a Wittig reaction gave 
the TBDPS-protected alkene 3.20 in 40% yield. [(BINAP)Pd(solvent)2]
2+
 [TfO]
-
2 catalysed 
the aza-Michael reaction of 4-bromoaniline in 85% yield and 85% ee. The 2, 4-disubstituted 
tetrahydroquinoline 3.39 was then synthesised by the Lewis acid catalysed reductive 
cyclisation reaction of the aza-Michael product 3.33, and global deprotection of the Moc and 
silyl protecting group using TMSI gave 3.41 in good yield. Here, the synthesis of the two 
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ketones 3.36 and 3.45 diverged, with 3.36 formed firstly by reprotection of the free hydroxyl 
and then transamination using Rapoport‟s reagent. Synthesis of 3.45 was achieved by the 
transamination of the unprotected amine 3.41 to give the ketone, followed by reprotection of 
the free alcohol with a TBDMS group. 
 
Scheme 3.19: Reagent and conditions: (i) MgCl2, NaBH4, THF, EtOH, 0 °C, 5 h, 98%; (ii) 
TMSI, MeCN, 16 h, 78%; (iii) Imidazole, TBDPSCl, CH2Cl2, 16 h, rt then 
2.45, DBU, DMF, CH2Cl2, oxalic acid, 18 h, rt, 75%; (iv) 2.45, DBU, DMF, 
CH2Cl2, oxalic acid, 18 h, rt then TBDMSCl, imidazole, DMAP, CH2Cl2, 16 h, 
rt, 35%.     
 
3.4 Work towards formation of the third ring  
The final step in the formal synthesis of the Martinelline alkaloids was the installation of the 
third ring. It was expected that the stereochemistry set at the C-2 position would direct the 
stereochemistry at the C-3 and C-4 positions. In this part of the work, alkylation of the 
ketones 3.36 and 3.45 was attempted with a range of different electrophiles (Scheme 3.20, 
Table 3.13).   
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Scheme 3.20: Alkylation of the C-3 position. 
Table 3.13: Attempted alkylation of the C-3 position.
a
  
Entry Ketone Electrophile Base/eq Time/h % Yield
b
 
1 3.45 
 
LHMDS/ 2.1 eq 3 - 
2 3.45 
 
LHMDS/ 2.1 eq 3 - 
3 3.45 
 
LHMDS/ 2.2 eq 3 - 
4 3.36 
 
LHMDS/ 3.1 eq 4 Trace 
a
Reagents and conditions: For entries 1-2: 3.45 (0.13 mmol, 1.0 eq), 1M LHMDS in THF (0.26 mmol, 2.1 eq), 
electrophile (0.28 mmol, 2.2 eq), THF (0.7 mL), -78°C - -40 °C, rt; For entry 3: 3.45 (0.13 mmol, 1.0 eq), 1M 
LHMDS in THF (0.28 mmol, 2.2 eq), electrophile (0.32 mmol, 2.5 eq), THF (0.7 mL), -78°C - -40°C; For 
entry 4: 3.36 (0.2 mmol, 1.0 eq), 1M LHMDS (0.4 mmol, 2.1 eq), electrophile (0.42 mmol, 2.2 eq), THF (1.5 
mL), -78°C - -40°C, 3 h, then 1M LHMDS (1.0 eq), -40 °C, 1 h. 
  
The alkylation of the C-3 position was first attempted using allyl bromide and LHMDS as 
base. Complete consumption of the starting material occurred to give a mixture of products 
(Table 3.13, entry 1). The major component was tentatively assigned as the quinoline 3.53, 
which was isolated in 56% yield (Figure 3.6). Formation of the quinoline was confirmed by 
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the presence of the MH
+
 peak 396 (ESI) and a singlet in the 
1
H NMR at 6.24 ppm 
corresponding to Ha.    
 
Figure 3.6: Quinoline formed during the alkylation attempt. 
LC-MS analysis of the reaction mixture identified the presence of three other components. 
The observation of a MH
+
 of 478 corresponds to the formation of a dialkylated 
tetrahydroquinoline produced in 16% isolated yield. Alkylation of the nitrogen and either the 
C-3 position of the tetrahydroquinolone or the oxygen of the enol, would give 3.54 or 3.55 
(Figure 3.7). The observation of a 
1
H resonance signal corresponding to Ha at 4.9 ppm 
supported the formation of 3.54.      
 
Figure 3.7: Two possible dialkylated tetrahydroquinolines. 
The two other components were believed to be the mono-alkylated tetrahydroquinoline 3.56 
(MH
+
 438) and 3.57 (MH
+ 
438) (Figure 3.8). No C-3 alkylation was observed, so other 
electrophiles were investigated. 
 
Figure 3.8: Two possible mono-alkylated tetrahydroquinolines. 
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Next, bromoacetonitrile was used as the electrophile (Table 3.13, entry 2). In this case, only 
starting material was recovered from the reaction mixture. Upon addition of the 
bromoacetonitrile the reaction turned black, suggesting that base-catalysed polymerisation of 
the electrophile may have occurred. To avoid this, 1-tosylaziridine was subsequently used, 
(entry 3), however, only the starting materials were recovered. Last but not least, the use of a 
masked amine electrophile N-(2-bromoethyl)phthalimide 3.52 was investigated. In this case, 
the reaction with the tetrahydroquinoline 3.36 proceeded to give trace levels of the desired 
product, but a majority of the starting material was recovered (entry 4).   
 
The lack of reaction thus far was attributed to low reactivity of the electrophiles towards 
alkylation at C-3. Previously, alkylation of the similar THQ 3.6 has been achieved with 
BrCH2CH2OTf (Scheme 3.3), and so the reaction of the tetrahydroquinolines 3.36 and 3.45 
was attempted with this electrophile (Table 3.14). 
 
Table 3.14: Alkylation with BrCH2CH2OTf.
a
 
Entry Ketone Electrophile Base/eq Time/h % Yield
b
 
1 3.36 
 
LHMDS/ 2.1 eq 3 - 
2 3.45 
 
LHMDS/ 2.1 eq 3 - 
3 3.36 
 
LHMDS/ 3.1 eq 4 - 
4 3.36 
 
LHMDS/ 4.2 eq 16 - 
5 3.36 
 
LHMDS/ 6.3 eq 16 - 
6 3.45 
 
LDA/ 2.1 eq 3 - 
a
Reagents and conditions: Ketone (0.12 mmol, 1.0 eq), electrophile (0.25 mmol, 2.2 eq), base (See table), THF 
(1 mL), -78 °C - -40°C. 
b
Yield determined by 
1
H NMR. 
None of the desired alkylated product was formed with either tetrahydroquinolines under the 
conditions reported (entries 1 and 2).
82
 Suspecting that the lack of alkylation could be due to 
incomplete deprotonation, an additional equivalent of base was added but this did not lead to 
the formation of the desired product and only starting material was recovered (entry 3). None 
of the electrophile was observed by 
1
H NMR, suggesting degradation had occurred. With this 
in mind, the enol was pre-formed and then slowly introduced into a solution of the 
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electrophile (via a cannular). Again, no alkylation was achieved even with prolonged reaction 
times and the addition of extra electrophile (entries 4 and 5). Finally LDA was used as base, 
but only the starting material persisted in the reaction mixture.  
       
To determine if deprotonation of the C-3 position was occurring, a D2O quench was 
conducted after addition of the base to 3.36 and 3.45. Deprotonation was attempted using 
LHMDS, LDA and NaHMDS – in all cases, incorporation of deuterium at C-3 was not 
observed in either the 
1
H NMR or LC-MS spectra. 
 
A range of different electrophiles were used in an attempt to achieve C-3 alkylation, however 
the formation of the third ring proved difficult, with no alkylation achieved in any of the 
cases. When allyl bromide was used as electrophile only O- and N-alkylation products were 
obtained. On the other hand, bromoacetonitrile decomposed in the presence of the strong 
base, and only starting material was recovered when 1-tosylaziridine was used. Trace levels 
of product was observed with the masked amine N-(2-bromoethyl)phthalimide 3.53, 
however, the majority of the starting material was recovered. Alkylation of the C-3 position 
was also attempted using the BrCH2CH2OTf electrophile, which was successfully used by 
Ma et al.
82
 However, no alkylation was achieved under a variety of different conditions. 
Finally, deuterium quenches of the reaction revealed that none of the bases tested were able 
to deprotonate at C-3, explaining the failure of these reactions. 
 
In summary, five different α, β-unsaturated carbamates were synthesised and assessed as 
acceptors for the aza-Michael reaction. The nature of the protecting group was found to have 
a significant effect, with variations in the enantioselectivity between 8% and 66%. The 
reaction with aniline identified the TBDPS-protected 3.20 as the best Michael acceptor. The 
aza-Michael reaction of 3.20 with four different anilines was subsequently investigated, and 
4-bromoaniline was found to give the product in the highest yield and enantioselectivity. 
 
Electrophilic cyclisation of the β-amino acid using PPA, Eaton‟s reagent and oxalyl chloride 
with AlCl3 all proved unsuccessful and as a result, the Lewis acid catalysed 
reductive/cyclisation was used to give the 2, 4-di-substituted tetrahydroquinoline. Synthesis 
of the two silyl protected tetrahydroquinolones was achieved by transamination and 
reprotection of the alcohol. Finally formation of the third ring was attempted by alkylation of 
the C-3 position. This was attempted using several different electrophiles; however, in all 
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cases no alkylation of the C-3 position was observed and additional work is required to allow 
for the formal synthesis of the Martinelline Alkaloids.      
3.5 Future Work 
For the formal synthesis of the Martinelline alkaloids, optically pure material is required. 
Improvements to the enantioselectivity by the recrystallisation of various intermediates 
should be attempted. On formation of the tetrahydroquinoline ring the material becomes more 
crystalline, thus recrystallisation of 3.39 could prove successful for the enhancement of the 
enantioselectivity. Alternatively, improvements could also be made by the formation of 
diastereomeric salts, via the reaction of the amines 3.40, 3.41 or 3.43 with a chiral acid, e.g. 
tartaric acid. Recrystallisation of the salt could allow for the separation of the 
diastereoisomers, giving optically pure material on liberation of the free amine. 
 
To achieve the formal synthesis of the Martinelline alkaloids, formation of the third ring is 
required. So far, attempts to alkylate 3.36 and 3.45 were unsuccessful. This is attributed to the 
inability of the base to deprotonate the C-3 position. Previously, alkylation of the C-3 
position of 3.6 was achieved. Thus, the presence of the bromine may be detrimental to the 
alkylation procedure and hence, the conversion of the bromide of the ketone 3.45 into the 
methoxy ester would allow for the formal synthesis, as the reaction is precedented.
158
 This 
should be achievable in two steps, by protection of the nitrogen
159
 and then reaction with 
BuLi and dimethyl carbonate (Scheme 3.21).
83
 Alternatively, the effect of protection of the 
nitrogen of 3.45 with a variety of protecting groups, i.e. Boc, benzoyl or benzyl groups, could 
be investigated in an attempt to achieve C-3 alkylation. 
 
Scheme 3.21: Reagent and conditions: (i) Boc2O, NEt3, THF; (ii) n-BuLi, CH3OCO2CH3, 
THF.     
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The reaction of 3.6 with other electrophiles including N-(2-bromoethyl)phthalimide, N-(2-
iodoethyl)phthalimide and N-tosyl aziridine should also be attempted as this stage, to provide 
a quicker route to the pyrroloquinoline core structure.  
  
 
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
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4.0 Synthesis of levonantradol  
Levonantradol 1.17 is a structurally novel analgesic drug developed by a team of Pfizer 
scientists in the 1980‟s, containing a tricyclic core structure with chiral centres in the 2-, 3- 
and 4- positions of the tetrahydroquinoline ring.
25
 In addition to these, 1.17 contains a chiral 
centre on the side chain and another on the fused carbocyclic ring. The potency of 
levonantradol‟s analgesic properties is highly dependent on the stereochemistry of all the 
chiral centres, with the 2-(S), 3-(R), 4-(R) isomer giving the highest activity. The X-ray 
structure of the diastereoisomer 4.1, containing the opposite stereochemistry on the side chain 
(Figure 4.1), was obtained. This allowed for the assignment of the absolute stereochemistry. 
This diastereoisomer showed a 10-fold decrease in activity compared to levonantradol. In 
comparison, the enantiomer of levonantradol was found to be 100 times less active, 
highlighting the importance of asymmetric synthesis for the formation of pharmaceutically 
active compounds.
25
  
 
Figure 4.1: Levonantradol 1.17 and the less active diastereoisomer. 
 
The synthesis of levonantradol was published by its inventors in a communication and also 
described in a patent, using 3, 5-dimethoxyaniline as the starting material (Scheme 4.1).
25, 160
 
The reaction of 3, 5-dimethoxyaniline with ethyl acetoacetate in the presence of acetic acid, 
followed by reduction with sodium borohydride produced the β-amino ester 4.2. Hydrolysis 
of the carboxylic ester gave the carboxylic acid 4.3. Resolution of the racemic material, to 
give optically pure acid, was conducted at this stage by recrystallisation, using the chiral 
amino alcohol 1-ephedrine as a resolving agent.
160
 Cyclisation to form the 
tetrahydroquinolone 4.4 was facilitated using 48% HBr at reflux, and was accompanied by 
the deprotection of the methoxy groups. Regiospecific attachment of the aromatic side chain 
was achieved by the addition of mesylated 5-phenyl 2-pentanol to 4.4. Formation of the third 
ring, via a Robinson annulation reaction, furnished the tricyclic core structure of; with 
stereocentre at C-3 occurring anti to the C-2 methyl group. Dissolving metal reduction was 
used to remove the C=C double bond of the cyclic enone and levonantradol was synthesised 
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in two further steps by reduction of the ketone with NaBH4, and regiospecific O-acetylation 
of the aromatic alcohol.
160
   
 
Scheme 4.1: Reagent and conditions: (i) 3, 5-dimethoxyaniline, ethyl acetoacetate, AcOH 
then NaBH4, AcOH; (ii) Hydrolysis; (iii) 1-ephedrine, CH2Cl2; (iv) Glacial 
AcOH, 48% HBr, reflux; (v) 5-phenyl 2-pentanol, NEt3, MsCl, 0 °C then 
K2CO3, DMF, 80 °C; (vi) Ethyl formate, NaH, rt; (vii) NEt3, MeOH, methyl 
vinyl ketone, rt; (viii) K2CO3, MeOH, rt; (ix) NH3, Li, -78 °C - rt; (x) NaBH4 
THF, -78 °C; (xi) DMAP, NEt3, Ac2O, 0 °C.     
 
We envisioned the asymmetric synthesis of the key intermediate tetrahydroquinolone 4.4 to 
be achievable using the methodology developed in the previous chapters. The aza-Michael 
reaction would install the C-2 stereocentre, with the tetrahydroquinolone formed by 
electrophilic ring cyclisation (Scheme 4.2). The synthesis of levonantradol from 4.4 would 
then be achievable following literature conditions. 
Scheme 4.2: Retrosynthetic analysis of 4.4. 
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4.1 Synthesis of aza-Michael precursors 
For the synthesis of levonantradol, the installation of a methyl group into the C-2 position 
requires the Michael acceptor 2.21. Following the published procedure, the HWE reaction of 
acetaldehyde with the phosphonate carbamate 2.14a proceeded in 78% yield (Scheme 4.3).
98
 
The formation of the alkene was confirmed by the presence of the olefinic protons, appearing 
as a multiplet at 7.18 ppm and a double doublet at 6.88 ppm in the 
1
H NMR spectrum.   
 
Scheme 4.3: Synthesis of the aza-Michael acceptor.  
The required tetrahydroquinolone 4.4 is substituted with hydroxyl groups in the meta 
positions (relative to the amine). Ideally, 4.4 would be formed from the aza-Michael product 
4.7, which in turn would be synthesised via reaction of 2.21 with 3,5-dimethoxyaniline 
(Scheme 4.4).  
 
Scheme 4.4: Ideal aza-Michael reaction for levonantradol synthesis. 
 
However, the aza-Michael reaction of electron rich anilines is known to proceed with low 
yields and enantioselectivities (see section 2.0), due to catalyst deactivation by irreversible 
binding of the amine to the catalyst, and also the operation of a background, uncatalysed aza-
Michael reaction.
70
 Thus, an alternative approach was required.  
 
The presence of electron-withdrawing groups on the aniline was found to be well tolerated in 
previous work (see section 2.0), and so 3, 5-dibromoaniline was chosen as the nucleophile for 
the conjugate addition. The tetrahydroquinolone 4.4 should be obtainable via conversion of 
the aryl bromides into the required hydroxyl groups (Scheme 4.5). There are a number of 
literature examples, where aryl bromides have been converted into phenols and ethers. For 
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example, by employing Pd2dba3/bulky phosphine as catalyst, KOH can be used as a 
nucleophilic reagent.
161
 
 
Scheme 4.5: Reagent and conditions: (i) [Pd(R-BINAP)(OH2)2]
2+
[OTf]
-
2, toluene; (ii) PPA; 
(iii) Pd2dba3, KOH, PR3, 100 °C. 
 
The 3, 5-dibromoaniline 4.8 is not commercially available, thus it was synthesised from 4-
nitroaniline 4.11 in 3 steps (Scheme 4.6). Bromination of 4.11 with Br2 and acetic acid gave 
4.12 in the excellent yield of 95%. Removal of the amine was achieved, via the formation of 
an intermediary diazonium salt, using NaNO2 in sulfuric acid. The diazonium salt 
decomposed on heating, releasing nitrogen to afford 4.13 in 96% yield, confirmed by the 
appearance of a triplet resonance at 8.03 ppm in the 
1
H NMR spectrum. Reduction of the 
nitro group using tin(II) chloride gave the 3, 5-dibromoaniline 4.8 in 81% yield. The 
reduction of the electron-withdrawing NO2 to a electron-releasing NH2 was indicated by an 
upfield shift of the aromatic proton resonances from 8.36 ppm and 8.03 ppm to 7.05 ppm and 
6.77 ppm, as well as the presence of the MH
+
 ion peak at 251 (ESI).   
 
Scheme 4.6: Reagents and conditions: (i) AcOH, Br2, 65 °C, 95%; (ii) NaNO2, H2SO4, 
EtOH, 90 °C, 96% (iii) SnCl2, THF/EtOH, rt, 81%. 
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4.2 Aza-Michael reaction 
At room temperature, no reaction was observed when a mixture of 3, 5-dibromoaniline, the α, 
β-unsaturated carbamate 2.21 and [Pd(R-BINAP)(OH2)2]
2+
[OTf]
-
2 1.117 (5 mol%) was 
stirred in toluene for 24 hours (Scheme 4.7). Upon raising the temperature to 50 °C, the 
formation of the product 4.9 in 80% conversion and 75% ee was achieved (Table 4.1, entry 
1). However, full conversion was unobtainable, even with prolonged reaction time. 
Formation of the product was confirmed by loss of the alkene signals at 7.18 ppm and 6.88 
ppm, and the appearance of an ABX pattern in the 
1
H NMR spectrum, with resonances 
between 2.95 ppm and 3.14 ppm corresponding to the CH2 group adjacent to the chiral 
centre.  
 
Scheme 4.7: Aza-Michael reaction of 2.21 with 3, 5-dibromoaniline. 
 
In an attempt to improve the conversion obtained for the aza-Michael reaction, further 
optimisation was carried out (Table 4.1).  
Table 4.1: Effect of solvent and aniline : alkene ratio on the aza-Michael reaction.
a
 
Entry Solvent Alkene (eq) Temp/ 
o
C Time/h % Yield
b
 % ee
c
, (Config) 
1 Toluene 1.0 50 36 80 75 (S) 
2 CH2Cl2 1.0 40 24 50 56 (S) 
3 Toluene 1.0 50 16 75 ND
d
 
4 Toluene 1.5 50 16 50 ND
d
 
5 Toluene 2.0 50 16 23 ND
d
 
a
Reagents and conditions: Alkene (0.35 mmol, 1.0-2.0 eq), aniline (0.17-0.35 mmol, 1.0 eq), 1.117  (5 mol%), 
solvent (1 mL). 
b
Determined by 
1
H NMR. 
c
Determined by chiral HPLC using Hichrom-CHI-PGG-2759 column. 
d
Enantioselectivities were not determined as the conversions were too low. 
The lack of reaction observed at room temperature for the aza-Michael reaction was the result 
of poor solubility of both the catalyst and α, β-unsaturated carbamate. It was hoped that 
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changing the solvent would increase the solubility of both reagents and thus give improved 
results. Previously, CH2Cl2 was shown to be an effective solvent for similar aza-Michael 
reactions, offering comparable results to toluene.
81
 In this case, the reaction in CH2Cl2 
proceeded to give the product in a lower yield and enantioselectivity (Table 4.1, entry 1 vs 2), 
despite the increased solubility of the alkene.  
 
Next, the effect of varying the aniline to alkene ratio was investigated. Previously, in the 
synthesis of the Martinelline alkaloids, this led to improved enantioselectivites (see section 
3.2.4). In this case, increasing the equivalents of the alkene from 1.0 to 1.5 led to a decrease 
in yield from 75% to 50% (Table 4.1, entry 3 vs 4). A further decrease to 23% was observed 
on using two equivalents of alkene (entry 4 vs 5).  
 
In the synthesis of the Galipea alkaloids, a significant improvement in the enantioselectivity 
was obtained on the slow addition of the aniline to the reaction mixture (see section 2.2.1).
98
 
Replicating this procedure, the reaction proceeded to give 4.9 with the improved 
enantioselectivity of 85%, although full conversion was still not obtained and the aza-
Michael product was isolated in only 68% yield.    
 
In the previous synthesis of levonantradol, resolution of the racemic acid was achieved using 
the chiral amino alcohol 1-ephedrine, where recrystallisation of the ion pair gave optically 
pure material (Scheme 4.1).
25
 An attempt was made to employ this procedure to enrich the 
optical purity of the aza-Michael adduct 4.9. Hydrolysis of the carbamate to give the 
corresponding carboxylic acid proceeded in 77% yield (Scheme 4.8). The formation of the 
carboxylic acid was confirmed by the appearance of a 
13
C signal at 176.4 ppm and the M
+
 ion 
peak of 337 (ESI). 
 
Scheme 4.8: Hydrolysis of the aza-Michael product. 
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The carboxylic acid 4.14 was reacted with (1R, 2S)-(-)-ephedrine to form a diastereomeric 
salt. Recrystallisation of the ion pair was attempted with ethyl acetate/n-hexane and 
toluene/n-hexane mixtures. In both cases, oiling of the compound occurred and the process 
did not give any improvement in enantioselectivity.  
 
An enhancement in the enantioselectivity of the aza-Michael product 4.9 was eventually 
achieved by recrystallisation (Table 4.2).   
Table 4.2: Recrystallisation of 4.9 from various solvents.
a
 
Entry Solvent conditions 
% ee of mother liquor
b
, 
(Config) 
% ee of solid
b
, (Config) 
1 EtOAc/n-Hexane - 85 (S) 
2 Et2O/n-Pentane - 85 (S) 
3 Toluene/n-Hexane - 85 (S) 
4 EtOAc 85 (S) - 
5 Et2O 85 (S) - 
6 Toluene 91 (S) 69 (S) 
a
Reagents and conditions: Entries 1-3 and 6: 4.9 (0.9 g, 2.3 mmol), total solvent (10 mL), reflux; Entry 4: 4.9 
(0.4 g, 1.0 mmol), EtOAc (1.5 mL), reflux; Entry 5: 4.9 (0.4 g, 1.0 mmol), Et2O (21 mL), reflux. 
b
Determined 
by chiral HPLC using Hichrom-CHI-PGG-2759 column. 
Recrystallisation of 4.9 from an ethyl acetate/n-hexane mixture did not lead to any 
improvement in the enantioselectivity (Table 4.2, entry 1). There was no solubility difference 
between the racemic and optically pure compound in this solvent system, as the material was 
extremely crystalline. Similar results were obtained with the ether/n-pentane and toluene/n-
hexane systems, with no change in enantioselectivity observed upon recrystallisation (entries 
2 and 3).  
 
It was thought the use of the anti-solvent in the above systems could have been the cause of 
the problem. As a result the recrystallisation was tried in neat EtOAc and Et2O, however, in 
both cases, oiling occurred and no enhancement in enantioselectivity was observed (entries 4 
and 5). Finally, the recrystallisation was attempted in neat toluene and gratifyingly the 
enantioselectivity of the material remaining in the mother liquor was enhanced to 91% ee. 
Correspondingly, the solid precipitate was obtained in 62% recovered yield with 69% ee. 
Repeating the recrystallisation process allowed for the obtainment of optically pure 4.9.     
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Thus, the aza-Michael reaction of 3, 5-dibromoaniline with 2.21 proceeded to give the 
product 4.9 in 80% conversion and 74% enantioselectivity. The ee was increased to 85% via 
the slow addition of the aniline, although the reaction still did not proceed to completion. 
Finally, optically pure material was obtained by recrystallisation from toluene.  
 
4.3 Work towards the synthesis of 4.4     
The next step in the synthesis of levonantradol was the formation of the tetrahydroquinolone 
ring, from the optically pure aza-Michael product 4.9. The cyclisation of the carboxylic acid 
4.14 under several different conditions was thus attempted (Scheme 4.9, Table 4.3).  
 
Scheme 4.9: Reagent and conditions: (i) PPA, 90 °C; (ii) Oxalyl chloride, AlCl3, CH2Cl2; 
(iii) Eaton‟s reagent, 65 °C.  
Table 4.3: Electrophilic cyclisation reactions.
a 
 
Entry Reaction Conditions % Yield
b
 
1 Eaton's reagent 32 
2 (COCl)2, AlCl3, DMF 42 
3 PPA 64 
4 PPA, Toluene 25 
5 PPA, CH2Cl2 50 
a
Reagents and conditions: Entry 1: Acid (0.26 mmol, 1.0  eq), oxalyl chloride (0.4 mmol, 1.5 eq), AlCl3 (0.83 
mmol, 3.2 eq), DMF (cat.), CH2Cl2, 0 °C; Entry 2: Acid (0.26 mmol, 1.0 eq), Eaton‟s reagent (2 mL); Entry 3: 
Acid (0.26 mmol, 1.0 eq), PPA (1.0 g), 90 °C; Entry 4: Acid (2.5 mmol, 1.0 eq), PPA (2.0 g), toluene (10 mL), 
90 °C; Entry 5: Acid (0.4 mmol, 1.0 eq), PPA (0.5 g), CH2Cl2 (1 mL), 90 °C. 
b
Isolated yields. 
 
In the previous syntheses, formation of the tetrahydroquniolone ring using an electrophilic 
ring cyclisation was unsuccessful, which was attributed to the proximity of an oxygen atom. 
In this case, the absence of a heteroatom in the side chain permits the use of Eaton‟s reagent, 
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PPA and (COCl)2 with AlCl3, leading to the formation of 4.10 in all cases (Table 4.3). The 
cyclisation using Eaton‟s reagent or under Friedel-Crafts conditions proceeded in low yields 
(entries 1 and 2), whilst the cyclisation with PPA gave the tetrahydroquinolone in 64% yield 
(entry 3). In an attempt to produce a more homogenous reaction mixture, the cyclisation was 
attempted in various solvents. The yield obtained in toluene was very low (entry 4), which 
was due to the formation of a significant level of side product (as observed by 
1
H NMR). On 
the other hand, the reaction performed in CH2Cl2 did not lead to any improvement in yield 
(entry 3 vs 5).     
 
With the cyclised product in hand, we investigated the formation of 4.4 by the substitution of 
the bromides in a hydroalkoxylation reaction. Previously, Anderson et al. have demonstrated 
the conversion of aryl bromides to phenols using Pd2dba3 and a bulky phosphine ligands, such 
as 
t
Bu-X-Phos 4.15 or tetramethyl di-
t
Bu-X-Phos 4.16 (Scheme 4.10). A range of different 
Ar-Br and Ar-Cl were found to undergo the reaction with KOH to give the phenol derivatives 
in 79-99% yield.
161
 
 
 
Scheme 4.10: Synthesis of phenols. 
Formation of the desired tetrahydroquinolone 4.4 from 4.10 was attempted using the 
described conditions (Scheme 4.11). The tetrahydroquinolone 4.10 was reacted with KOH, 
using a catalyst generated in situ from Pd2dba3 (5 mol%) and X-Phos, at 100 °C for 16 hours. 
However, none of the desired 4.4 was obtained, and only the starting material was recovered 
from the reaction mixture. Upon the addition of the X-Phos to the solution of 4.10, KOH and 
Pd2dba3, the reaction turned black, which suggested catalyst deactivation. To prevent this, the 
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catalytic complex was pre-formed, prior to addition to the tetrahydroquinolone. 
Unfortunately, no improvement was observed, and the starting material was again recovered.  
 
Scheme 4.11: Hydroalkoxylation reaction of 4.10. 
 
Surveying the literature, there are several other examples of cross coupling reactions with 
aryl bromides and aliphatic alcohols. Niu et al. reported the reaction of aryl bromides with a 
wide range of aliphatic alcohols, catalysed by copper iodide (Scheme 4.12). This reaction 
proceeded to give the ethers in the good yields of 78-92%. The reaction was tolerant to both 
electron withdrawing and donating groups on the aryl ring.
162
       
 
Scheme 4.12: Cross coupling of aryl bromides with aliphatic alcohols. 
 
It was envisaged that this copper catalysed reaction could be used to convert the aryl bromide 
4.10 into the tetrahydroquinolone 4.4. Reaction of 4.10 with benzyl alcohol, catalysed by 
CuI, would produce 4.17, from which the required tetrahydroquinolone 4.4 could be 
synthesised by hydrogenation of the benzyl groups (Scheme 4.13).  
 
Scheme 4.13: Postulated formation of 4.4 using a Cu-catalysed coupling reaction. 
The reaction of 4.10 with benzyl alcohol, was attempted under the literature conditions, with 
CuI as catalyst in the presence of an excess of benzyl alcohol (10 eq) without solvent, in a 
sealed pressure tube at 110 °C. Initial evaluation of the reaction suggested that 4.10 was 
being consumed. However, removal of the excess benzyl alcohol proved difficult, preventing 
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analysis of the reaction mixture. The reaction was subsequently repeated using only 2 
equivalents of benzyl alcohol. Unfortunately, the starting material was recovered and time 
constraints prevented further investigation into this coupling reaction.   
 
In summary, the α, β-unsaturated carbamate 2.21 and the 3, 5-dibromoaniline required were 
formed in good yields of 79% and 74% respectively. These were subsequently used in the 
aza-Michael reaction, which proceeded to give the desired product in 4.9 80% conversion 
and 75% ee after 36 hours. Further optimisation led to an improvement in the 
enantioselectivity to 85% by the slow addition of the aniline, and optically pure material was 
obtained by recrystallisation from toluene.  
 
Hydrolysis of the aza-Michael adduct using KOH and MeOH proceeded to give the 
carboxylic acid in 77% yield, and the electrophilic cyclisation to the tetrahydroquinolone 4.10 
was achieved in 64% yield using PPA. Two different cross coupling reactions were attempted 
for the synthesis of the desired intermediate 4.4. The direct formation of 4.4 by reaction of 
4.10 with KOH using a Pd2dba3 and X-Phos complex was unsuccessful. Subsequently the 
coupling with benzyl alcohol, catalysed by CuI was attempted; however, no product was 
obtained. 
 
4.4 Future work 
To complete the formal synthesis of levonantradol, further investigation into the CuI, 8-
hydroquinoline coupling reaction of 4.10 with benzyl alcohol is required. In addition, a 
number of other coupling procedures should also be investigated. Gowrisankar et al. have 
reported the coupling of various alcohols with aryl bromides using a complex generated from 
Pd(OAc)2 and 4.18 - a bulky phosphine based on a bis-pyrazole backbone (Figure 4.2).
163
 
Also, the direct conversion of aryl bromides to phenols has been reported using an iron-
catalysed reaction (Scheme 1.14).
164
  
 
Scheme 4.14: Two coupling reaction of aryl bromides. 
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Figure 4.2: New ligand used for cross coupling reaction. 
 
Although formation of the third ring system of levonantradol from 4.4 has been reported 
(Scheme 4.1), the synthetic scheme is long. It would be advantageous if this ring could be 
synthesised using a more direct route, thereby reducing the overall number of steps in the 
synthesis. In 2000, Bui et al.
165
 reported a proline catalysed Robinson annulation reaction, 
which proceeded to form the bicyclic ring system in a single transformation (Scheme 
4.15).
166, 167
 Therefore, the reaction of 4.10 with methyl vinyl ketone in the presence of L-
proline could allow for the introduction of the third ring, into the C-3, C-4 position in a single 
step.  
 
Scheme 4.15: Robinson annulations reaction. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
CHAPTER FIVE 
EXPERIMENTAL 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5  Experimental 
126 
 
5.0 General remarks 
Anhydrous acetonitrile and DMF were purchased from Sigma-Aldrich in SureSeal
®
 bottles 
and stored under nitrogen. All other anhydrous solvents were dried in a solvent purification 
system, by passing through columns of molecular sieves. Commercially available reagents 
were used as received. Palladium salts and Nickel sponge were provided by Johnson Matthey 
plc, through a precious metals loan agreement.  
 
All manipulations involving air-sensitive reagents were performed using standard Schlenk 
techniques and oven dried glassware. Column chromatography was performed on silica gel 
(Kieselgel 60, 63-200μm). 
 
1
H, 
13
C and 
31
P NMR spectra were obtained on Bruker AVACE 400 instruments (
1
H at 400 
MHz, 
13
C at 100.6 MHz and 
31
P at 161.9 MHz). The chemical shifts (δ) are given in parts per 
million (ppm), referenced to TMS and the coupling constants (J) are reported in Hertz (Hz). 
Full assignment of resonance signals was aided by relevant 2D NMR experiments, namely, 
COSY and HMQC.  
 
Infrared spectra were recorded on a Perkin Elmer Spectrum 100 series FT-IR spectrometer 
fitted with an ATR accessory. Optical rotations were measured on a Perkin Elmer 343 
polarimeter using a 10 cm solution cell. [α]D values are given in 10
-1
 deg cm
2
 g
-1
 and 
concentrations in g per 100 mL. HPLC analyses were performed on a Gilson or a Hewlett 
Packard series 1050 HPLC system equipped with an autoinjector with a 20 μL loop, using 
Daicel Chiralpak AD and AD-H columns or a Hichrom-CHI-PGG-2759 column. Detection 
was effected by UV absorption at 254 nm.  
 
Mass spectra (MS) were recorded on either a Micromass Autospec Premier or a VG Platform 
II spectrometer using EI, ESI, CI or FAB techniques. Melting points were determined on an 
Electrothermal Gallenhamp apparatus and were uncorrected. Elemental analyses were 
conducted by the Science Technical Support Unit at the London Metropolitan University.  
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5.1 Compounds used in Chapter 2 
General synthesis of phosphonate carbamates.
24
 
A mixture of the requisite alkyl carbamate (0.40 mol) and chloroacetyl chloride (32.3 mL, 
0.40 mol) was heated to 100 °C under a N2 atmosphere, whereupon the mixture became 
homogenous and then solidified. Heating was continued for a further 30 min before cooling 
to room temperature. The solid was placed under vacuum for 30 min to remove volatile side 
products, and the residue was triturated with Et2O. The resultant suspension was filtered to 
obtain an off-white solid. The solid and P(OEt)3 (15.9 mL, 92.7 mmol) were then combined 
in a round bottomed flask fitted with an air condenser. The mixture was heated to 80 °C 
under N2 until complete consumption of starting material (followed by TLC). The solution 
was then cooled and hexane added. The clear hexane top layer was decanted and the process 
repeated 7 times, to remove the excess P(OEt)3. The remaining residue was purified by 
recrystallisation from toluene/n-hexane to afford the desired phosphonate imide. 
 
Benzyl 2-(diethoxyphosphoryl)acetylcarbamate (2.14b)  
 
The product was obtained as an off white solid (12.4 g, 79%); mp 103-105 °C (lit. 101-102 
°C)
24
; max/cm
-1 
3120, 2980, 1770, 1690, 1210; δH (400 MHz, CDCl3) 9.40 (1H, br. s, NH), 
7.43-7.28 (5H, m, Ar-H), 5.17 (2H, s, CO2CH2), 4.15-4.03 (4H, m, OCH2CH3), 3.29 (2H, br. 
d, J 22.1, PCH2), 1.27 (6H, t, J 7.1, CH3); δC (100 MHz, CDCl3) 164.6 (CONH), 151.1 (CO2), 
135.0 (C-1), 128.7 (C-3), 128.6 (C-2/C-4), 128.5 (C2/C4), 67.8 (CO2CH2), 63.0 (d, J 7, 
OCH2CH3), 36.0 (d, J 130, PCH2), 16.3 (d, J 6, CH3);  m/z (EI) 329.1031 (M
+
, C14H20NO6P 
requires 329.1028), 152 (50), 91 (100). 
 
Methyl 2-(diethoxyphosphoryl)acetylcarbamate (2.14a) 
 
The product was obtained as an off-white solid (84%); mp 46-48°C (lit. 45-47 °C)
24
; max/ 
cm
-1 
3170, 2995, 1780, 1210; δH (400 MHz, CDCl3) 8.38 (1H, br. s, NH), 4.33-4.14 (4H, m, 
OCH2), 3.82 (3H, s, OCH3), 3.37 (2H, d, J 21.7, PCH2), 1.37 (6H, t, J 7.1, CH3CH2); δC (100 
MHz, CDCl3) 164.6 (CONH), 151.8 (CO2), 63.0 (d, J 6, OCH2), 52.9 (OCH3), 35.9 (d, J 130, 
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PCH2), 16.3 (d, J 6, CH3CH2); m/z (EI) 253.0724 (M
+
, C8H16NO6P requires 253.0715), 226 
(30), 208 (25), 179 (55), 152 (100), 123 (90). 
 
General Synthesis of Phosphonium Salts 
PPh3 (38.4 g, 0.15 mol) was added to benzyl 2-chloroacetylcarbamate (27.8 g, 0.12 mol) in 
THF (300 mL). The reaction was heated to reflux until complete consumption of starting 
material (
1
H NMR spectroscopy). The reaction mixture was cooled to room temperature, 
whereupon the resultant precipitate was collected by filtration.   
 
(2-(Benzyloxycarbonylamino)-2-oxoethyl)triphenylphosphonium chloride (2.19b) 
 
The product was obtained as a white solid (45.5 g, 76%); mp 144-146 °C; max/cm
-1
 2870, 
1778, 1437, 1109; δH (400 MHz, CDCl3) 12.25 (1H, s, NH), 7.85–7.70 (10H, m, Ar-H), 7.61-
7.55 (5H, m, Ar-H), 7.40–7.19 (5H, m, Ar-H), 5.44 (2H, d, J 14.0, PCH2), 5.11 (2H, s, 
OCH2Ar); δC (100 MHz, CDCl3) 163.0 (CONH), 150.6 (CO2), 135.1 (C-4), 135.0 (C-5), 
134.0 (d, J 11, C-3), 130.3 (d, J 13, C-2), 128.6 (C-7), 128.4 (C-6), 128.1 (C-8), 117.9 (d, J 
89, C-1), 67.0 (OCH2Ar), 33.5 (d, J 58, PCH2); m/z (ESI) 454.1568 ([M-Cl]
+
, C28H25NO3P 
requires 454.1572), 326 (6), 224 (15).  
 
(2-(Methoxycarbonylamino)-2-oxoethyl)triphenylphosphonium chloride (2.19a) 
 
The product was obtained from methyl 2-chloroacetylcarbamate as a white solid (39.0 g, 
78%); mp 184-186 °C; max/cm
-1 
3090, 2060, 2890, 3830, 2770, 1780, 1620, 1530, 1440; δH 
(400 MHz, CDCl3) 12.25 (1H, br. s, NH), 7.83-7.70 (9H, m, Ar-H), 7.55-7.65 (6H, m, Ar-H), 
5.45 (2H, d, J 16.0, PCH2), 3.62 (3H, s, OCH3); δC (100 MHz, CDCl3) 163.1 (d, J 4, CONH), 
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151.2 (CO2), 135.1 (C-4), 134.0 (d, J 10, C-3), 130.2 (d, J 13, C-2), 118.0 (d, J 88, C-1), 52.7 
(3H, s, OCH3), 33.4 (d, J 58, PCH2); m/z (ESI) 378.1253 ([M-Cl]
+
, C22H21NO3P requires 
378.1259), 326 (4), 303 (6).  
  
KO
t
Bu (9.92 g, 88.2 mmol) was added slowly in several portions to a suspension of the 
phosphonium salt (44.1 mmol) in THF (150 mL) at -5 °C, whereupon the phosphonium salt 
gradually dissolved. The resultant homogeneous reaction mixture was stirred for 1 hour and 
CH2Cl2 (300 mL) and H2O (150 mL) then added. The aqueous layer was extracted with 
CH2Cl2 (200 mL) and the combined organic extracts were dried over MgSO4 and 
concentrated under vacuum. The phosphonium ylids were used directly in the Wittig 
olefination reactions without further purification.  
 
Synthesis of protected aldehydes 
2-(Benzyloxy)ethanol (2.9)
87
   
 
Ethylene glycol (30.0 mL, 0.54 mol) was added under N2 to a slurry of sodium hydride (4.40 
g, 0.19 mol) in dry THF (500 mL) slowly over 1.5 h. Upon complete addition, the mixture 
was heated to reflux and benzyl bromide (21.3 mL, 0.18 mol) was added over 3 h. After 
refluxing for 16 h, the reaction mixture was allowed to cool to room temperature and diluted 
with Et2O (250 mL). The organic layer was washed with H2O (200 mL), dried over MgSO4, 
and concentrated. The resulting oily residue was distilled at 110 °C, 0.2 torr (lit. 82-83°C, 0.1 
torr)
168
 to give the alcohol as a colourless oil (22.7 g, 83%). max/cm
-1 
3364, 2941, 2870; δH 
(400 MHz, CDCl3) 7.43-7.40 (5H, m, Ar-H), 4.58 (2H, s, ArCH2), 3.77 (2H, t, J 5.0, 
HOCH2), 3.61 (2H, t, J 5.0, OCH2), 2.29 (1H, br. s, CH2OH); δC (100 MHz, CDCl3) 138.0 
(C-1), 128.5 (C-3), 127.9 (C-2/C-4), 127.8 (C2/C4), 73.3 (CH2O), 71.5 (HOCH2), 61.8 
(CH2Ar); m/z (EI) 152 (M
+
, 30%), 107 (32), 91 (100). 
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2-(2,2-dimethyl-1,1-diphenylpropoxy)ethanol (2.10)
88
 
 
tert-Butylchlorodiphenylsilane (10.0 mL, 38.5 mmol) was added to a mixture of ethylene 
glycol (12.0 mL, 0.23 mol) and imidazole (2.88g, 42.4 mmol) in THF (200 mL). The reaction 
mixture was stirred for 29 h before quenching, by the addition of H2O (200 mL) and Et2O 
(200 mL). The aqueous layer was extracted with Et2O (3 x 200 mL) and the combined 
organic extracts were dried over MgSO4 and concentrated under vacuum. The resulting oil 
was purified by column chromatography, EtOAc/n-pentane 4:1, Rf = 0.35, to give the alcohol 
(9.08 g, 78%) as a yellow oil. max/cm
-1 
3330 br,  2960, 2860, 1100, 1060; δH (400 MHz, 
CDCl3) 7.77- 7.65 (4H, m, Ar-H), 7.53-7.37 (6H, m, Ar-H), 3.80 (2H, dd, J 4.0, 5.6, OCH2), 
3.75- 3.68 (2H, br. m, CH2OH), 2.21 (1H, br. s, OH), 1.11 (9H, s, C(CH3)3); δC (100 MHz, 
CDCl3) 135.6 (C-2), 133.3 (C-1), 129.8 (C-4), 127.8 (C-3), 65.0 (CH2), 63.7 (CH2OH), 26.9 
(C(CH3)3), 19.2 (C(CH3)3); m/z (EI) 300 (M
+
, <1%), 243 (70), 199 (100), 181 (23), 165 (98). 
 
2-(Benzyloxy)acetaldehyde (2.11)
87
  
 
Under a N2 atmosphere, DMSO (29.5 mL, 0.42 mol) was added to a solution of oxalyl 
chloride (18.1 mL, 0.21 mol) in CH2Cl2 (600 mL) over 20 min, at -78°C. The reaction was 
stirred for 10 min, followed by the addition of the alcohol 2.9 (21.0 g, 0.14 mol) in CH2Cl2 
(10 mL) over 10 min. After stirring for a further 30 min, NEt3 (91 mL, 0.65 mol) was added 
over 20 min. The reaction was allowed to warm to room temperature, diluted with Et2O (600 
mL) and filtered through a pad of MgSO4. The filtrate was concentrated under vacuum to 
yield the aldehyde 2.11 as a yellow oil. This was employed in the next step without 
purification. 
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2-(tert-butyldiphenylsilyloxy)acetaldehyde (2.12)
88
 
 
 
 
Under a N2 atmosphere, DMSO (2.3 mL, 31.9 mmol) was added to a solution of oxalyl 
chloride (1.4 mL, 15.9 mmol) in CH2Cl2 (54 mL) at -78°C. When the addition was complete, 
alcohol 2.10 (4.0 g, 13.3 mmol) was added as a solution in CH2Cl2 (6 mL). After stirring for 
20 min, NEt3 (10 mL, 66.5 mmol) was slowly added. The reaction was allowed to warm to 
room temperature and the solvent removed under vacuum. The resulting slurry was triturated 
with EtOAc/n-hexane 1:4, and then filtered. The filtrate was evaporated under reduced 
pressure to yield the aldehyde as a yellow oil. This was employed in the next step without 
purification.  
 
General methods for the synthesis of the Michael acceptors  
Method A: (HWE reaction) DBU (1.0 eq) was added to a solution of the phosphonate 
carbamate (1.1 eq) in THF (10 mL), followed by the aldehyde (1.1 eq). The reaction was 
stirred for 18 h, before the mixture was diluted with EtOAc (20 mL) and H2O (20 mL). The 
aqueous layer was separated, washed with EtOAc and the combined organic layers dried over 
MgSO4, filtered, and concentrated under vacuum.  
 
Method B: (Masamune-Roush HWE reaction) To a solution of aldehyde (1.1 eq) in MeCN 
(10 mL), was added the phosphonate carbamate (1.3 eq), LiCl (7.5 eq) and 
i
Pr2NEt (1.0 eq). 
The mixture was stirred for 16 h and then quenched with H2O. The aqueous layer was 
extracted with EtOAc and the combined organic extracts washed with brine, dried over 
MgSO4 and concentrated under vacuum. 
 
Method C: (Wittig reaction) A solution of the ylid (1.0 eq) in CH2Cl2 (10 mL) was added to 
aldehyde (1.0 eq). The solution was stirred for 16 h, before it was concentrated under vacuum 
to give the alkene as mixture of E and Z isomers, which were separable by column 
chromatography.        
 
Method D: (Tandem DMP-Wittig reaction) To a solution of the alcohol 2.9 (10.0 g, 66.0 
mmol) dissolved in CH2Cl2 (150 mL) was added pyridine (15.0 mL, 185 mmol) and DMP 
Chapter 5  Experimental 
132 
 
(28.0 g, 66.0 mmol). The reaction was stirred at 15 °C for 2 h, before a solution of the ylid 
2.20a (37.4 g, 99.0 mmol) in CH2Cl2 (150 mL) was added. On complete consumption of the 
starting material (
1
H NMR spectroscopy) the CH2Cl2 was removed by evaporation.  
 
(E)-Benzyl 4-(benzyloxy) but-2-enoylcarbamate (2.15)  
 
The residue was purified by column chromatography, EtOAc/n-hexane 3:2, Rf = 0.30, to give 
the alkene as a white solid. Major E isomer; mp 98-100 °C; max/cm
-1 
3260, 1747, 1650, 
1510; δH (400 MHz, CDCl3) 7.76 (1H, br. s, NH), 7.44-7.29 (10H, m, Ar-H), 7.15 (1H, dt, J 
3.9, 15.5, CH2CH), 7.06 (1H, br. d, J 15.5, CHCO), 5.22 (2H, s, CO2CH2), 4.60 (2H, s, 
OCH2Ar), 4.23 (2H, dd, J 1.6, 3.9, CH2CH); δC (100 MHz, CDCl3) 165.3 (CONH), 151.4 
(CO2), 146.1 (CH2CH), 137.7 (C-1), 135.0 (C-5), 128.7 (C-7/C-3), 128.6 (C-7/C-3), 128.5 
(C-4), 128.4 (C-8), 127.9 (C-2), 127.8 (C-6), 121.2 (CHCO), 72.8 (OCH2Ar), 68.8 (CH2CH), 
67.9 (COOCH2); m/z (ESI) 326.1387 (MH
+
, C19H20NO4 requires 326.1392), 243 (78), 91 
(100).  
 
Minor Z isomer; Rf = 0.35; mp 72-74 °C; δH (400 MHz, CDCl3) 8.26 (1H, br. s, NH), 7.50-
7.26 (10H, m, Ar-H), 6.73 (1H, br. d, J 11.7, CHCO), 6.60 (1H, dt, J 4.5, 11.7, CH2CH), 5.22 
(2H, s, CO2CH2), 4.67 (2H, dd, J 2.2, 4.5, CH2CH), 4.57 (2H, s, OCH2Ar); δC (100 MHz, 
CDCl3) 165.6 (CONH), 151.6 (CO2), 150.5 (CH2CH), 137.9 (C-1), 135.0 (C-5), 129.6(C-
7/C-3), 128.7 (C-7/C-3), 128.5 (C-4), 128.4 (C-8), 127.9 (C-2), 127.8 (C-6), 119.5 (CHCO), 
72.9 (OCH2Ar), 69.3 (CH2CH), 67.9 (CO2CH2). 
 
(E)-Methyl 4-(benzyloxy)but-2-enoylcarbamate (2.16) 
 
Synthesised using method D. The residue was purified by column chromatography, EtOAc/n-
hexane 3:2, Rf = 0.28, to give the alkene as a white solid (12.2 g, 74%); mp 83-85 °C; 
Chapter 5  Experimental 
133 
 
max/cm
-1
 3250, 1770, 1650, 1200; δH (400 MHz, CDCl3) 8.66 (1H, s, NH), 7.39-7.25 (5H, m, 
Ar-H), 7.14 (1H, dt, J 4.2, 15.4, CH2CH), 7.01 (1H, br. d, J 15.4, CHCO), 4.57 (2H, s, 
OCH2Ar), 4.21 (2H, dd, J 1.8, 4.2, CH2CH), 3.77 (3H, s, OCH3); δC (100 MHz, CDCl3) 165.8 
(CONH), 152.2 (CO2), 145.9 (CH2CH), 137.7 (C-1), 128.5 (C-3), 127.8 (C-4), 127.7 (C-2), 
121.5 (CHCO), 72.8 (OCH2Ar), 68.8 (OCH2CH), 53.1 (OCH3); m/z (ESI) 250.1078 (MH
+
, 
C13H16NO4 requires 250.1079), 158 (38), 143 (78), 91 (100).   
 
(E)-Benzyl 4-(tert-butyldiphenylsilyloxy)but-2-enoylcarbamate (2.17) 
 
The residue was purified by recrystallisation from EtOAc/n-hexane to give the alkene as a 
white solid: mp 93-95 °C; max/cm
-1 
3261, 1750, 1655, 1216; δH (400MHz, CDCl3) 7.79-7.65 
(5H, m, Ar-H and NH), 7.52-7.35 (11H, m, Ar-H), 7.23 (1H, d, J 15.2, CHCO), 7.17 (1H, br. 
d, J 15.2, CH2CH), 5.25 (2H, s, OCH2Ar), 4.45-4.40 (2H, m, OCH2CH), 1.13 (9H, s, 
C(CH3)3); δC (100 MHz, CDCl3) 165.6 (CONH), 151.4 (CO2), 148.8 (CH2CH), 135.5 (C-2), 
135.1 (C-5), 133.0 (C-1), 130.1 (C-4), 128.7 (C-7/C-8), 128.6 (C-7/C-8), 128.4 (C-6), 127.8 
(C-3), 119.8 (CHCO), 67.9 (OCH2Ar), 63.3 (OCH2CH), 26.7 (C(CH3)3), 19.3 (C(CH3)3); m/z 
(EI) 473.2026 (M
+
, C28H31NO4Si requires 473.2022), 256 (4), 199 (100). 
 
(E)-methyl 4-(tert-butyldiphenylsilyloxy)but-2-enoylcarbamate (2.18) 
 
The residue was purified by recrystallisation from EtOAc/n-hexane to give the alkene as a 
white solid; mp 134-136 °C; max/cm
-1
 3169, 1746, 1655, 1540, 1230; δH (400MHz; CDCl3) 
7.69 (4H, dd, J 1.3, 7.7, Ar-H), 7.62 (1H, br. s, NH), 7.51-7.36 (6H, m, Ar-H), 7.23 (1H, d, J 
15.2, CHCO), 7.16 (1H, dt, J 2.7, 15.2, CH2CH), 4.45-4.38 (2H, m, OCH2CH), 3.83 (3H, s, 
OCH3), 1.12 (9H, s, C(CH3)3); δC (100 MHz, CDCl3) 165.8 (CONH), 152.2 (CO2), 148.9 
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(CHCO), 135.5 (C-2), 132.9 (C-1), 129.9 (C-4), 127.8 (C-3), 119.7 (CH2CH), 63.2 (OCH2), 
53.1 (OCH3), 26.7 (C(CH3)3), 19.3 (C(CH3)3); m/z (ESI) 398.1790 (MH
+
, C22H28NO4Si 
requires 398.1788), 256 (10) 199 (100).  
 
(E)-Methyl but-2-enoylcarbamate (2.21)
81
 
 
To a solution of the phosphonate carbamate 2.14a (5.00 g, 20.0 mmol) in THF (20 mL), 
cooled in a water bath, was added acetaldehyde (5.60 mL, 100 mmol) and DBU (3.00 mL, 
20.0 mmol). The reaction mixture was stirred for 16 h, then diluted with EtOAc (50 mL) and 
H2O (50 mL). The aqueous layer was separated and washed with EtOAc (2 x 50 mL) and the 
combined organic extracts washed with brine, dried over MgSO4, filtered and evaporated to 
dryness. The residue was purified by column chromatography, EtOAc/n-hexane 1:1, Rf = 0.5, 
to give the alkene as a white solid (1.67 g, 59%); mp 147-149 °C (lit. 149-150 °C)
24
; max/ 
cm
-1
 3270, 3070, 3030, 2980, 1770, 1680, 1640, 1500; δH (400 MHz, CDCl3) 7.60 (1H, br. s, 
NH), 7.18 (1H, dq, J 6.9, 15.2, CH3CH), 6.87 (1H, dd, J 1.5, 15.2, CHCO), 3.81 (3H, s, 
OCH3), 1.97 (3H, dd, J 1.5, 6.9, CH3CH); δC (100 MHz, CDCl3) 165.8 (CONH), 152.3 
(CO2), 146.8 (CH3CH), 122.7 (CHCO), 53.1 (OCH3), 18.5 (CH3CH); m/z (EI) 143.0580 (M
+
, 
C6H9NO3 requires 143.0582), 69 (100), 41 (66).  
 
Catalyst synthesis 
Palladium triflate dihydrate
97
  
A Schlenk tube was charged with Pd(NO3)2∙2H2O (2.50 g, 10.8 mmol), which was dried 
under vacuum overnight. The Schlenk tube was attached to an aq. K2CO3 bubbler and purged 
with N2. Triflic acid (13.3 mL, 0.15 mol) was added drop wise and the resultant mixture was 
stirred for a further 2 h under a stream of N2. The slurry was transferred to boiling tubes and 
the excess triflic acid was decanted off after centrifuge. The residue was dried in the 
dessicator at 100 °C for 16 h to give Pd(OTf)2∙2H2O (4.00 g, 84%) as a light purple powder.      
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[(R-BINAP)Pd(NCMe)2]
2+
 [TfO
-
]2 (1.117)
67
  
 
To Pd(OTf)2∙2H2O (2.90 g, 6.70 mmol) in a N2-purged Schlenk tube was added dry MeCN 
(60 mL). (R)-BINAP (4.15 g, 6.70 mmol) was added and the resultant orange solution was 
stirred for 30 min and filtered through celite. EtOH (~ 400 mL) was added and the resultant 
precipitate was collected by filtration to give the complex as a yellow solid (6.32 g, 89%). 
max/cm
-1
 3350, 3070, 2290, 1440, 1250, 1230, 1170; δH (400MHz; CDCl3) 8.03-7.75 (7H, m, 
Ar-H), 7.73-7.47 (15H, m, Ar-H), 7.21 (2H, t, J 7.2, Ar-H), 7.02 (2H, t, J 7.3, Ar-H), 6.90 
(4H, br. s, Ar-H), 6.73 (2H, d, J 8.6, Ar-H), 1.97 (3H, s, CH3); δC (100 MHz, CDCl3) 139.7, 
135.0, 134.9, 134.8, 133.0, 132.9, 132.18, 132.13, 130.5, 130.4, 129.5, 129.3, 129.2, 128.5, 
127.8, 127.7, 127.0, 124.6, 124.0, 122.9, 122.2, 122.0, 121.2, 118.9, 118.9, 118.3, 2.33; δP 
(162 MHz, CDCl3) + 32.0 (s); m/z (FAB) 877 (C45H32F3O3P2PdS
+
), (56), 728 (37), 437 (100), 
154 (48).  
 
General methods for the Aza-Michael reaction 
Method A: A Radley‟s reaction tube was charged with a stir bar and [(R-
BINAP)Pd(NCMe)2]
2+
 [TfO]
-
2, placed under vacuum for 30 min and then flushed with N2. 
Toluene was added, the reaction tube placed in a carousel and heated to 50 °C. On reaching 
temperature, the Michael acceptor and aniline were added. Upon completion (
1
H NMR 
spectroscopy), the reaction mixture was evaporated to dryness and the residue was purified 
by column chromatography.    
 
Method B: (Ligand Screening) A Radley‟s reaction tube was purged with N2 and charged 
with Pd(OTf)2.2H2O (5 mol%), the appropriate ligand (5.5 mol%), and a stir bar. The 
Radley‟s tube was re-purged with N2 before the addition of dry toluene. The reaction tube 
was placed in the carousel, stirred for 45 min and then heated to 50 °C. The Michael acceptor 
and aniline were added. Upon completion (
1
H NMR spectroscopy), the reaction mixture was 
evaporated to dryness and the residue purified by column chromatography.    
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Method C: (Slow addition) A round bottom flask was charged with [(R-
BINAP)Pd(NCMe)2]
2+
 [TfO
-
]2 (0.35 g, 0.33 mmol) and the Michael acceptor (6.58 mmol). 
Dry toluene (20 mL) was added and the mixture was heated to 50 °C. Once a clear solution 
was obtained, a solution of aniline (0.6 mL, 6.58 mmol) in toluene (15 mL) was added slowly 
using a syringe pump, over 20 h. The reaction mixture was stirred at 50 °C for an additional 
18 h, cooled to room temperature and concentrated under vacuum. The residue was purified 
by column chromatography.  
 
Benzyl 4-(benzyloxy)-3-(phenylamino)butanoylcarbamate (2.23) 
 
Using method C, the product was obtained as a brown oil (96%); [α]D
25
 + 3.5° (c = 1.3, 
CH2Cl2, 85% ee); Daicel Chiralpak AD-H, 10 % IPA in n-hexane, 1.0 mL/min, tR(major) = 
28.7 min, tR(minor) = 33.9 min; Column chromatography, Et2O/n-pentane 1:1, Rf  = 0.38; 
max/cm
-1
 3380, 3280, 1750, 1660, 1210; δH (400MHz, CDCl3) 7.90 (1H, br. s, NHCO), 7.45-
7.29 (10H, m, Ar-H), 7.19 (2H, dd, J 7.3, 7.8, H-3), 6.76 (1H, t, J 7.3, H-4), 6.66 (2H, d, J 
7.8, H-2), 5.19 (2H, s, CO2CH2), 4.54 (2H, s, OCH2Ar), 4.16 (2H, br. s, ArNH and CH), 
3.71-3.57 (2H, m, OCH2CH), 3.18-3.00 (2H, m, CHCH2CO); δC (100 MHz, CDCl3) 172.3 
(CONH), 151.3 (CO2), 146.5 (C-1), 137.9 (Ar-C), 134.9 (Ar-C), 129.4 (C-3), 128.7 (Ar-C), 
128.5 (Ar-C), 128.48 (Ar-C), 128.45 (Ar-C), 127.8 (Ar-C), 127.7 (Ar-C), 118.3 (C-4), 114.1 
(C-2), 73.3 (OCH2Ar), 70.9 (OCH2CH), 67.9 (CO2CH2), 50.0 (CH), 37.9 (CHCH2CO); m/z 
(EI) 418.1898 (M
+
, C25H26N2O4 requires 418.1893), 310 (35), 297 (100), 189 (89), 146 (92), 
104 (82), 77 (75); Anal. Calcd. for C25H26N2O4: C, 71.75; H, 6.26; N, 6.69%. Found: C, 
71.71; H, 6.16; N, 6.79%.       
 
General procedure for optical enrichment by recrystallisation:  
A sample of optically active 2.24 (4.12 g, 84% ee) was suspended in EtOAc (6 mL) and 
heated to reflux. Hexane was then added drop wise until the solution just started to turn 
cloudy (~ 18 mL). The mixture was cooled to room temperature, whereupon white needle 
like crystals were formed, and collected by filtration (2.05 g, 70% ee). The filtrate was 
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evaporated to give optically enrich material (2.04 g, 99% ee). This process was repeated with 
the less optically pure product until the enantioselectivity of the recrystallised solid reached 
27%. The aza-Michael product can be recovered in 77% yield in 99% ee, as a yellow oil. 
 
Methyl 4-(benzyloxy)-3-(phenylamino)butanoylcarbamate (2.24) 
 
Using method C, the product was obtained as a yellow oil (67%); [α]D
25
 + 4.2° (c = 1.2, 
CHCl3, 97% ee); Daicel Chiralpak AD-H, 2% IPA in n-hexane, 1.0 mL/min, tR(major) = 22.3 
min, tR(minor) = 25.5 min; Column chromatography, Et2O/n-pentane 2:1, Rf = 0.33; max/cm
-1
 
3260, 3180, 1755, 1600; δH (400MHz, CDCl3) 7.92 (1H, br. s, NHCO), 7.41-7.30 (5H, m, Ar-
H), 7.19 (2H, dd, J 7.4, 7.8, H-3), 6.76 (1H, t, J 7.4, H-4), 6.67 (2H, d, J 7.8, H-2), 4.54 (2H, 
s, OCH2Ar), 4.09-4.23 (2H, br. m, ArNH and CH), 3.77 (3H, s, OCH3), 3.59-3.68 (2H, m, 
OCH2), 2.99-3.15 (2H, m, CH2CO); δC (100 MHz, CDCl3) 172.4 (NHCO), 152.0 (CO2), 
145.6 (C-1), 137.9 (C-5), 129.4 (C-3), 128.4 (C-7), 127.8 (C-8), 127.7 (C-6), 118.3 (C-4), 
114.1 (C-2), 73.3 (OCH2Ar), 70.9 (OCH2CH), 53.0 (OCH3), 50.1 (CH), 37.9 (CH2CO); m/z 
(EI) 342.1581 (M
+
, C19H22N2O4 requires 342.1580), 310 (15), 221 (69), 189 (48), 146 (100), 
104 (41), 91 (60).          
 
Benzyl 4-(tert-butyldiphenylsilyloxy)-3-(phenylamino)butanoylcarbamate (2.25) 
 
The product was obtained as a yellow oil; Column chromatography, Et2O/n-pentane 3:2, Rf  = 
0.30; Separation of enantiomers by Chiral HPLC was not possible;max/cm
-1 
2960, 2940, 
2870, 1780, 1700, 1610, 1500 ; δH (400MHz; CDCl3) 7.85 (1H, br. s, CONH), 7.69-7.57 (4H, 
m, Ar-H), 7.49-7.31 (11H, m, Ar-H), 7.14 (1H, dd, J 7.3, 7.8, H-3), 6.74 (1H, t, J 7.3, H-4), 
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6.54 (2H, d, J 7.8, H-2), 5.20 (2H, s, OCH2Ar), 4.17 (1H, br. s, ArNH), 4.06-3.98 (1H, br. m, 
CH), 3.82 (1H, dd, J 4.8, 10.2, SiOCH2), 3.77 (1H, dd, J 3.1, 10.2, SiOCH2), 3.17 (1H, dd, J 
6.4, 16.2, CH2CO2), 3.08 (1H, dd, J 5.6, 16.2, CH2CO2), 1.09 (9H, s, C(CH3)3); δC (100 MHz, 
CDCl3) 172.7 (CONH), 151.5 (CO2), 146.6 (C-1), 135.6 (C-6/C-10), 135.6 (C-6/C-10), 135.4 
(Ar-C), 135.0 (Ar-C), 133.1 (C-5/C-9), 133.0 (C-5/C-9), 129.9 (C-8/C-12), 129.8 (C-8/C-12), 
129.4 (C-3), 128.7 (Ar-C), 128.5 (Ar-C), 127.9 (C-7/C-11), 127.8 (C-7/C-11), 118.2 (C-4), 
114.1 (C-2), 67.8 (OCH2Ar), 64.5 (SiOCH2), 51.5 (CH), 37.8 (CH2CO), 26.9 (C(CH3)3), 19.3 
(C(CH3)3); m/z (ESI) 567.2668 (MH
+
, C34H38N2O4Si requires 567.2679), 537 (8), 496 (10).  
 
Methyl 4-(tert-butyldiphenylsilyloxy)-3-(phenylamino)butanoylcarbamate (2.26)  
 
The product was obtained as a yellow oil; Column chromatography, EtOAc/n-hexane 2:3, Rf 
= 0.34; Separation of enantiomers by Chiral HPLC was not possible; max/cm
-1
 2960, 2940, 
2870, 1770, 1700, 1610, 1500, 1210, 1110; δH (400 MHz, CDCl3) 8.11 (1H, br. s, NHCO), 
7.71-7.60 (4H, m, Ar-H), 7.52-7.33 (6H, m, Ar-H), 7.17 (2H, dd, J 7.3, 7.8, H-3), 6.76 (1H, t, 
J 7.3, H-4), 6.59 (2H, d, J 7.8, H-2), 4.17 (1H, br. s, ArNH), 3.85 (1H, dd, J 4.9, 10.2, CH), 
3.82-3.75 (5H, m, OCH3 and OCH2), 3.18 (1H, dd, J 6.6, 16.2, CH2CO), 3.11 (1H, dd, J 5.6, 
16.2, CH2CO), 1.12 (9H, s, C(CH3)3); δC (100 MHz, CDCl3) 172.7 (CONH), 152.1 (CO2), 
146.6 (C-1), 135.6 (C-6/C-10), 135.5 (C-6/C-10), 133.1 (C-5/C-9), 133.0 (C-5/C-9), 129.9 
(C-8/C-12), 129.8 (C-8/C-12), 129.4 (C-3), 127.8 (C-7/C-11), 127.7 (C-7/C-11), 118.3 (C-4), 
114.1 (C-2), 64.5 (OCH2), 53.0 (OCH3), 51.6 (CH), 37.8 (CH2CO), 26.9 (C(CH3)3), 19.3 
(C(CH3)3); m/z 490.2292 (M
+
, C28H34N2O4Si requires 490.2288), 433 (25), 340 (27), 316 
(92), 221 (90), 146 (100). 
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4-(Benzyloxy)-3-(phenylamino)butanoic acid (2.29) 
 
To the carbamate 2.24 (1.00 g, 2.90 mmol) in MeOH (30 mL) was added 1M aq. KOH (29.0 
mL, 29.0 mmol). The resultant solution was stirred at room temperature for 1 hour and then 
the MeOH was removed by evaporation. H2O (30 mL) was added to the residue and the 
aqueous layer washed with Et2O (2 x 30 mL). The aqueous layer was then acidified to pH 4 
by the addition of 1M aq. HCl, before it was extracted with EtOAc (3 x 50 mL). The 
combined organic extracts were washed with brine, dried over MgSO4 and the solvent 
evaporated to give the acid as a yellow oil (0.58 g, 70%); max/cm
-1 
3400, 3050, 2920, 2850, 
1710, 1600, 1500; δH (400MHz, CDCl3) 7.45-7.29 (5H, m, Ar-H), 7.22 (2H, dd, J 7.4, 8.0, H-
3), 6.81 (1H, t, J 7.4, H-4), 6.71 (2H, d, J 8.0, H-2) , 4.55 (2H, s, OCH2Ar), 4.05-3.96 (1H, m, 
NHCH), 3.63 (2H, d, J 4.0, OCH2), 2.74 (2H, dd, J 2.6, 6.5, CH2CO); δC (100 MHz, CDCl3) 
176.1 (CO2H), 146.0 (C-1), 137.8 (C-5), 129.5 (C-3), 128.5 (C-7), 127.9 (C-8), 127.7 (C-6), 
119.1 (C-4), 114.9 (C-2), 73.4 (OCH2Ar), 70.4 (OCH2), 50.9 (CHNH), 36.0 (CH2CO2), m/z 
(ESI) 286.1432 (MH
+
, C17H20NO3 requires 286.1443), 268 (10), 198 (8).  
 
4-(Benzyloxy)-3-(methyl(phenyl)amino)butanoic acid (2.30) 
 
To a solution of the carbamate 2.24 (1.30 g, 3.80 mmol) in MeCN (25 mL) was added 
formaldehyde (37% w/w solution in H2O, 2.80 mL, 38.0 mmol). Sodium cyanoborohydride 
(0.70 g, 11.0 mmol) and acetic acid (0.80 mL, 13.0 mmol) were then added sequentially to 
the reaction mixture at 0 °C. After 30 min, an additional portion of acetic acid (0.80 mL, 13.0 
mmol) was added and the reaction stirred for 1 h. Et2O (100 mL) was added and the organic 
layer was washed with 1M aq. KOH (3 x 20 mL), dried over MgSO4, filtered and evaporated 
to dryness. 1M aq. KOH (29.0 mL, 29.0 mmol) was added to the residue, and the resultant 
solution was stirred at room temperature for 1 h before evaporation. H2O (30 mL) was added 
to the residue and the aqueous layer was extracted with Et2O (2 x 30 mL). The aqueous layer 
was then acidified to pH 4 by the addition of 1M HCl and extracted with EtOAc (3 x 50 mL). 
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The combined organic extracts were washed with brine, dried over MgSO4 and the solvent 
evaporated to give the acid as a yellow oil (0.85 g, 77%); max/cm
-1 
3040, 2870, 1710, 1600, 
1510, 1110; δH (400MHz, CDCl3) 7.52-7.32 (7H, m, Ar-H), 7.06 (2H, d, J 8.2, C-2), 6.92 
(1H, t, J 7.2, C-4), 4.72-4.62 (1H, m, NCH), 4.58 (2H, s, OCH2Ar), 3.74 (1H, dd, J 6.2, 9.8, 
OCH2), 3.65 (1H, dd, J 6.3, 9.8, OCH2), 2.90 (3H, s, NCH3), 2.79 (2H, m, CH2CO2); δC (100 
MHz, CDCl3) 177.2 (CO2H), 150.0 (C-1), 138.1 (C-5), 129.3 (Ar-C), 128.5 (Ar-C), 127.8 
(Ar-C), 127.7 (C-3), 118.4 (C-4), 114.8 (C-2), 73.2 (OCH2Ar), 70.2 (OCH2), 56.3 (NHCH), 
34.9 (CH2CO2), 32.1 (NCH3); m/z (ESI) 300.1596 (MH
+
,
 
C18H22NO3 requires 300.1600), 240 
(4), 192 (3).  
 
Methyl 4-(benzyloxy)-3-(phenylamino)butanoate (2.35)  
 
CaCl2 (0.50 g, 4.40 mmol) was added to a solution of the carbamate 2.24 (1.00 g, 3.00 mmol) 
in MeOH (15 mL). A solution of NaOMe (0.40 g, 7.30 mmol) in MeOH (5 mL) was added 
drop wise. Upon completion of the reaction (TLC) the MeOH was removed by evaporation, 
and aq. NH4Cl (30 mL) was added to the residue. The aqueous layer was washed with Et2O 
(3 x 30 mL) and the combined organic layers washed with brine, dried over MgSO4, filtered 
and evaporated to dryness. The crude product was purified by column chromatography, 
EtOAc/n-hexane 1:1, Rf = 0.32, to give the ester as a yellow oil (0.52 g, 60%); max/cm
-1 
3050, 3030, 2920, 2850, 1730, 1600, 1510, 1440, 1270; δH (400MHz, CDCl3) 7.59-7.30 (5H, 
m, Ar-H), 7.21 (2H, t, J 7.2, H-3), 6.76 (1H, t, J 7.2, H-4), 6.68 (2H, d, J 7.2, H-2), 4.57 (2H, 
s, OCH2Ar), 4.30-4.00 (2H, m, CH and NH), 3.81-3.55 (5H, m, OCH3 and  OCH2), 2.73 (2H, 
d, J 6.2, CH2CO2); δC (100 MHz, CDCl3) 172.4 (CO2Me), 146.7 (C-1), 138.0 (Ar-C), 129.4 
(C-3), 128.5 (Ar-C), 127.8 (Ar-C), 127.7 (Ar-C), 118.0 (C-4), 113.8 (C-2), 73.4 (OCH2Ar), 
70.9 (OCH2CH), 51.7 (CO2CH3), 50.2 (NCH), 36.1 (CH2CO2); m/z (EI) 300.1585 (MH
+
, 
C18H22NO3 requires 300.1600), 250 (5). 
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4-(Methyl(phenyl)amino)dihydrofuran-2(3H)-one (2.34) 
 
To a suspension of the acid 2.30 (0.10 g, 0.33 mmol) and catalytic DMF in CH2Cl2 (2 mL) 
was added oxalyl chloride (43.0 μl, 0.50 mmol) at 0 °C. The mixture was stirred for 10 min at 
0 °C and 1 h at room temperature. The solvent was evaporated to dryness and then the 
residue re-dissolved in CH2Cl2 (2 mL). AlCl3 (0.13 g, 1.00 mmol) was added to the solution 
at 0 °C and the resulting mixture stirred at room temperature for 16 h. The reaction mixture 
was quenched by pouring into an ice-CHCl3 mixture. The aqueous layer was extracted with 
CHCl3 (2 x 10 mL) and the combined organic extracts dried with MgSO4 and concentrated 
under vacuum to give the lactone (0.02 g, 31%) as a yellow oil; max/cm
-1
 2933, 1773, 1597; 
δH (400 MHz, CDCl3) 7.39 (1H, m, H-4), 7.34–7.26 (2H, m, H-3), 6.91 (2H, m, H-2), 4.69 
(1H, m, CH), 4.54 (1H, dd, J 7.0, 10.0, OCH2), 4.38 (1H, dd, J 4.0, 10.0, OCH2), 2.84-2.76 
(4H, m, NCH3 and CH2CO), 2.63 (1H, dd, J 4.5, 18.0, CH2CO); δC (100 MHz, CDCl3) 175.7 
(CO), 149.6 (C-1), 129.3 (C-3), 119.9 (C-4), 116.3 (C-2), 71.1 (CO2CH2), 56.2 (NCH), 33.4 
(NCH3), 39.1 (CH2CO); m/z (EI) 191.0943 (M
+
, C11H13NO2 requires 191.0946), 132 (100). 
 
(2-Benzyloxymethyl-1,2,3,4-tetrahydro-quinolin-4-yl)-carbamic acid methyl ester (2.38) 
 
To a solution of the carbamate 2.24 (6.50 g, 19.0 mmol) dissolved in an ethanol/THF mixture 
(1:1, 65 mL) was added NaBH4 (0.50 g, 13.0 mmol) at -10 °C. A solution of MgCl2.6H2O 
(4.00 g, 20.0 mmol) in H2O (10 mL) was slowly added, maintaining the temperature below 0 
°C. When the addition was complete, the reaction was stirred at 0 °C for 30 min., then 
quenched by addition of CH2Cl2 (80 mL), 1M aq. HCl (80 mL) and citric acid (9.00 g, 47.0 
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mmol). The biphasic mixture was stirred at room temperature for 4 h. The organic layer was 
separated, before the addition of H2O (100 mL) and citric acid (5.50 g, 28.0 mmol). The 
mixture was stirred at room temperature for 45 min. The organic layer was then separated, 
dried over MgSO4 and concentrated under vacuum. The volatiles remaining in the residue 
were displaced by co-distillation with hexane under reduced pressure, to give the 2, 4- 
disubstituted tetrahydroquinoline as an off-white solid (5.40 g, 87%); [α]D
25
 -13.5° (c = 0.7, 
CHCl3); mp 90-92 °C; max/cm
-1 
3370, 3330, 2950, 2940, 2860, 1710, 1520, 1470, 1240, 
1090; δH (400 MHz, CDCl3) 7.47-7.29 (5H, m, Ar-H), 7.19 (1H, dd, J 1.6, 7.7, H-6), 7.05 
(1H, dt, J 1.6, 7.7, H-8), 6.70 (1H, dt, J 1.2, 7.7, H-7), 6.54 (1H, dd, J 1.2, 7.7, H-9), 5.12-
5.00 (2H, m, H-4 and H-17), 4.59 (2H, s, H-12), 4.41 (1H, br. s, H-1), 3.78-3.69 (4H, m, H-2 
and H-19), 3.57 (1H, dd, J 3.3, 9.1, H-11), 3.40 (1H, t, J 9.1, H-11), 2.29-2.09 (1H, m, H-3), 
1.55-1.35 (1H, m, H-3); δC (100 MHz, CDCl3) 157.2 (C-18), 144.5 (C-10), 137.9 (C-13), 
128.6 (C-15), 128.4 (C-8), 127.9 (C-16), 127.8 (C-14), 126.9 (C-6), 121.8 (C-5), 117.8 (C-7), 
114.7 (C-9), 74.0 (C-11), 73.3 (C-12), 52.2 (C-2), 50.4 (C-19), 47.6 (C-4), 32.7 (C-3); m/z 
(EI) 326.1620 (M
+
, C19H22N2O3 requires 326.1630), 205 (7), 143 (8), 130 (100), 91 (20); 
Anal. Calcd for C19H22N2O3: C, 69.92; H, 6.79; N, 8.58%. Found: C, 70.14; H, 6.91; N, 
8.68%.    
 
Methyl 2-(benzyloxymethyl)-1-methyl-1,2,3,4-tetrahydroquinolin-4-ylcarbamate (2.39) 
 
A mixture of tetrahydroquinoline 2.38 (6.20 g, 19.0 mmol) and formaldehyde (37% w/w 
solution in H2O, 14.2 mL, 0.19 mol) in MeCN (150 mL) was cooled to 5 °C. Sodium 
cyanoborohydride (3.60 g, 57.0 mmol) was added portion-wise to the solution, followed by 
glacial acetic acid (3.80 mL, 66.0 mmol), maintaining the temperature below 10 °C. After 30 
min an additional portion of glacial acetic acid (3.80 mL, 66.0 mmol) was added. Stirring was 
continued at 5 °C for another 30 min and Et2O (400 mL) was added. The organic layer was 
washed with 1M aq. KOH (3 x 100 mL), dried over MgSO4, filtered and then evaporated in 
vacuo. The residue was purified by column chromatography, EtOAc/n-hexane 1:1.5, Rf = 
0.35, to afford the product as an off white solid (5.70 g, 88%); [α]D
25 
+ 10.0° (c = 1.1, 
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CHCl3); mp 90-92°C; max/cm
-1 
3320, 3030, 2920, 1710, 1700, 1520, 1490, 1240, 1210; δH 
(400 MHz, CDCl3) 7.44-7.25 (6H, m, H-6 and Ar-H), 7.21 (1H, m, H-8), 6.72 (1H, t, J  7.3, 
H-7), 6.65 (1H, d, J 8.2, H-9), 5.63 (1H, br. d, J  7.7, H-17), 4.99-4.85 (1H, m, H-4), 4.53 
(2H, s, H-12), 3.85-3.54 (6H, m, H-11, H-2 and H-19), 2.99 (3H, s, H-20), 2.40-2.28 (1H, m, 
H-3), 2.28-2.16 (1H, m, H-3); δC (100 MHz, CDCl3) 156.7 (C-18), 145.9 (C-10), 137.8 (C-
13), 128.9 (Ar-C), 128.4 (Ar-C), 127.8 (Ar-C), 127.7 (Ar-C), 127.6 (Ar-C), 122.3 (C-5), 
116.4 (C-7), 111.5 (C-9), 73.4 (C-12), 71.3 (C-11), 56.8 (C-2), 51.9 (C-19), 45.9 (C-4), 37.8 
(C-20), 32.1 (C-3); m/z (EI) 340.1789 (M
+
, C20H24N2O3 requires 340.1787), 219 (19), 187 
(6), 144 (100), 91 (15); Anal. Calcd for C20H24N2O3: C, 70.56; H, 7.11; N, 8.23%. Found: C, 
70.74; H, 6.96; N, 8.16%.    
 
Methyl-1-benzoyl-2-(benzyloxymethyl)-1,2,3,4-tetrahydroquinolin-4-ylcarbamate (2.49) 
 
The tetrahydroquinoline 2.38 (0.50 g, 1.50 mmol) was dissolved in Et2O (10 mL) and cooled 
to 0 °C, whereupon triethylamine (3.20 mL, 23.0 mmol) and benzoyl chloride (0.20 mL, 1.90 
mmol) were added consecutively. The reaction was then allowed to warm to room 
temperature where it was stirred for 16 h. Additional benzoyl chloride (0.20 mL, 1.90 mmol) 
was added and after a further 16 h, the reaction was quenched by the addition of 10 % aq. 
NaOH (30 mL). The organic layer was washed with 10 % aq. HCl (3 x 10 mL), dried over 
MgSO4, filtered and evaporated to dryness. The product was purified by column 
chromatography, EtOAc/n-hexane 1:1, Rf = 0.33, to give 2.49 as a brown gum (0.55 g, 84%); 
max/cm
-1
 2960, 2870, 1720, 1640, 1400, 1360; δH (400 MHz, CDCl3) 7.34-7.12 (11H, m, Ar-
H), 7.07 (1H, t, J 7.5, H-8), 6.88 (1H, t, J 7.5, H-7), 6.51 (1H, d, J 7.5, H-6), 5.56 (1H, d, J 
9.2, H-17), 5.11-5.01 (1H, m, H-2), 5.01-4.90 (1H, m, H-4), 4.55-4.36 (2H, m, H-12), 3.80-
3.67 (4H, m, H-19 and H-11), 3.50 (1H, dd, J 6.7, 9.3, H-11), 2.76-2.58 (1H, m, H-3), 1.83-
1.72 (1H, m, H-3); δC (100 MHz, CDCl3) 169.9 (C-20), 156.8 (C-18), 138.1 (Ar-C), 137.6 
(Ar-C), 135.6 (Ar-C), 134.3 (Ar-C), 130.2 (Ar-C), 128.7 (Ar-C), 128.3 (Ar-C), 127.9 (Ar-C), 
127.5 (Ar-C), 127.3 (Ar-C), 126.9 (C-7), 126.6 (C-6), 125.3 (C-8), 123.4 (C-9), 73.0 (C-12), 
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71.6 (C-11), 52.4 (C-19), 50.9 (C-2), 46.8 (C-4), 35.9 (C-3); m/z (ESI) 431.1970 (MH
+
, 
C26H27N2O4 requires 431.1971), 356 (15), 296 (8), 250 (9). 
 
4-Amino-2-(benzyloxymethyl)-3,4-dihydroquinolin-1(2H)-yl)(phenyl)methanone (2.50)  
  
To a solution of the Moc-protected tetrahydroquinoline 2.49 (1.80 g, 4.20 mmol) in MeCN 
(30 mL) was added TMSI (2.30 mL, 17.0 mmol). The resultant solution was stirred at room 
temperature for 18 h. The reaction was quenched by the addition of MeOH (20 mL), before 
the solvents were removed by rotary evaporation. Et2O (30 mL) and 1M aq. HCl (30 mL) 
were added to the residue and the aqueous layer was separated. The pH was adjusted to 12 by 
the addition of 1M aq. KOH and the aqueous layer then extracted with CH2Cl2 (3 x 60 mL). 
The combined organic extracts were dried over MgSO4, filtered, and evaporated to dryness. 
The amine was purified by column chromatography using EtOAc/n-hexane 1:1.5, Rf = 0.2, to 
give the amine as a brown oil (0.95 g, 61%); max/cm
-1
 3060, 3040, 2920, 2860, 1640, 1490, 
1340, 1100; δH (400 MHz, CDCl3) 7.51 (1H, d, J 7.7, H-9), 7.40-7.13 (11H, m, Ar-H), 6.91 
(1H, t, J 7.7, H-7), 6.51 (1H, d, J 7.7, H-6), 5.08 (1H, m, H-2), 4.57-4.48 (2H, m, H-12), 4.08 
(1H, dd, J 4.7, 12.0, H-4), 3.76 (1H, dd, J 5.0, 9.2, H-11), 3.48 (1H, dd, J 6.8, 9.2, H-11), 
2.76-2.65 (1H, m, H-3), 1.98 (2H, br. s, H-17), 1.62 (1H, dt, J 8.0, 12.0, H-3); δC (100 MHz, 
CDCl3) 169.8 (C-18), 138.3 (Ar-C), 137.9 (Ar-C), 137.6 (Ar-C), 135.8 (Ar-C), 130.0 (Ar-C), 
128.6 (Ar-C), 128.3 (Ar-C), 127.9 (Ar-C), 127.5 (Ar-C), 127.4 (Ar-C), 126.5 (C-7 and C-6), 
125.5 (C-8), 122.5 (C-9), 73.0 (C-12), 71.9 (C-11), 54.1 (C-2), 47.2 (C-4), 39.6 (C-3); m/z 
(ESI) 373.1899 (MH
+
, C24H25N2O2 requires 373. 1916), 356 (84), 250 (77).   
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2-(benzyloxymethyl)-1-methyl-1,2,3,4-tetrahydroquinolin-4-amine (2.40) 
 
The above procedure was repeated for the deprotection of the tetrahydroquinoline 2.39 (1.00 
g, 3.00 mmol) to give the amine as a brown oil (0.65 g, 78%); max/cm
-1
 2920, 1600, 1500, 
1450, 1370, 1070; δH (400 MHz, CDCl3) 7.38-7.24 (6H, m, H-6 and Ar-H), 7.20 (1H, t, J 7.6, 
H-8), 6.74 (1H, t, J 7.6, H-7), 6.63 (1H, d, J 7.6, H-9), 4.58 (1H, d, J 11.9, H-12), 4.51 (1H, 
d, J 11.9, H-12),  4.14 (1H, apparent triplet, J 5.5, H-4), 3.77 (1H, dd, J 4.6, 9.7, H-11), 3.70 
(1H, dd, J 5.3, 9.7, H-11), 3.59 (1H, m, H-2), 3.38 (2H, br. s, H-17), 2.98 (3H, s, H-18), 2.33 
(1H, dt, J 5.5, 13.7, H-3), 2.08 (1H, dt, J 5.7, 13.7, H-3); δC (100 MHz, CDCl3) 145.3 (C-10), 
137.9 (C-13), 128.5 (C-6), 128.4 (C-15), 127.9 (C-8), 127.7 (C-16), 127.6 (C-14), 125.4 (C-
5), 116.4 (C-7), 111.6 (C-9), 73.3 (C-12), 72.2 (C-11), 57.2 (C-2), 46.6 (C-4), 37.7 (C-18), 
34.5 (C-3); m/z (EI) 282.1731 (M
+
,
 
C18H22N2O requires 282.1732), 265 (5), 161 (55), 144 
(100), 91 (32). 
  
2-(Benzyloxymethyl)-1-methyl-2,3-dihydroquinolin-4(1H)-one (2.44) 
 
To a solution of the amine 2.40 (2.50 g, 8.80 mmol) in a CH2Cl2/DMF mixture (1:1, 50 mL) 
was added 4-formyl-1-methylpyridinium benzenesulfonate (3.70 g, 13.0 mmol). After stirring 
for 1 h, DBU (3.90 mL, 26.0 mmol) was added and the resulting dark purple solution was 
stirred for a further hour at room temperature. The reaction was quenched by the addition of 
sat. aq. oxalic acid (50 mL) and stirred for 16 h. The biphasic mixture was evaporated to 
dryness and the residue purified by column chromatography, EtOAc/n-hexane 1:1.5, Rf = 
0.40, to afford the tetrahydroquinolone as a yellow oil (1.85 g, 75%); [α]D
25
 – 88.0° (c = 1.0, 
CHCl3); max/cm
-1 
2870, 1670, 1600, 1490, 1450, 1350, 1210; δH (400 MHz, CDCl3) 7.88 
(1H, dd, J 1.7, 7.8, H-6), 7.42 (1H, m, H-8), 7.34-7.24 (5H, m, Ar-H), 6.68 (1H, m, H-7), 
6.65 (1H, d, J 8.5, H-9), 4.46 (2H, s, H-12), 3.83 (1H, m, H-2), 3.71 (1H, dd, J 6.6, 9.5, H-
11), 3.53 (1H, dd, J 5.9, 9.5, H-11), 3.11 (3H, s, H-17), 3.00 (1H, dd, J 6.6, 16.6, H-3), 2.73 
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(1H, dd, J 2.4, 16.6, H-3); δC (100 MHz, CDCl3) 192.9 (C-4), 150.2 (C-10), 137.8 (Ar-C), 
135.8 (C-8), 128.4 (Ar-C), 127.7 (Ar-C), 127.6 (Ar-C), 127.4 (Ar-C), 119.0 (C-5), 116.2 (C-
7), 112.8 (C-9), 73.4 (C-12), 68.9 (C-11), 60.6 (C-2), 38.9 (C-3), 38.8 (C-17); m/z (EI) 
281.1416 (M
+
, C18H19NO2 requires 281.1416), 174 (12), 160 (100), 91 (20); Anal. Calcd for 
C18H19NO2: C, 76.84%: H, 6.81%: N, 4.98%. Found: C, 76.94%: H, 6.66%: N, 4.85%.    
 
2-(benzyloxymethyl)-1-methyl-1,2,3,4-tetrahydroquinoline (2.43) 
 
Aluminium trichloride (60.0 mg, 0.43 mmol) was suspended in Et2O (1 mL) and lithium 
aluminium hydride (30.0 mg, 0.75 mmol) in THF (0.75 mL) was slowly added under 
vigorous stirring at room temperature. After 20 min a solution of the tetrahydroquinolone 
2.44 (60.0 mg, 0.21 mmol) in THF (1 mL) was added at a rate such as to maintain a gentle 
reflux. The reaction was monitored by TLC. When the reaction was judged to be complete, 
the mixture was cooled to 0 °C and H2O (5 mL) and Et2O (3 mL) were added. The Et2O layer 
was decanted and the aqueous layer was washed several times with Et2O until the washings 
were colourless. The combined organic extracts were dried over MgSO4, filtered, 
concentrated and purified by column chromatography, EtOAc/n-hexane 1:1, Rf = 0.45, to 
give the tetrahydroquinoline as a colourless oil (50.0 mg, 87%); [α]D
25
 – 4.5° (c = 1.4, 
CH2Cl2); max/cm
-1 
2920, 2850, 1720, 1600, 1500, 1380, 1250; δH (400 MHz, CDCl3) 7.43-
7.30 (5H, m, Ar-H), 7.13 (1H, t, J 7.6, H-8), 7.00 (1H, d, J 7.6, H-6), 6.64 (1H, t, J 7.6, H-7), 
6.58 (1H, d, J 7.6, H-9), 4.60 (1H, d, J 12.0, H-12), 4.52 (1H, d, J 12.0, H-12), 3.65-3.56 (2H, 
m, H-11 and H-2), 3.53-3.45 (1H, m, H-11), 3.03 (3H, s, H-17), 2.82-2.65 (2H, m, H-4), 
2.20-2.11 (1H, m, H-3), 1.97-1.85 (1H, m, H-3); δC (100 MHz, CDCl3) 145.1 (C-10), 138.4 
(Ar-C), 128.6 (Ar-C), 128.4 (Ar-C), 127.7 (C-6), 127.6 (Ar-C), 127.2 (C-8), 121.7 (C-5), 
115.5 (C-7), 110.3 (C-9), 73.4 (C-12), 70.5 (C-11), 58.2 (C-2), 38.3 (C-17), 23.7 (C-4), 22.9 
(C-3); m/z (EI) 267.1620 (M
+
, C18H21NO requires 267.1623), 146 (100), 131 (8), 91 (8); 
Anal. Calcd for C18H21NO: C, 80.86; H, 7.92; N, 5.24%. Found: C, 80.66; H, 8.02; N, 5.26%.  
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2-(benzyloxymethyl)-1-methyl-1,2,3,4-tetrahydroquinolin-2-ol (2.48) 
 
The product was isolated in a 1:1 mixture of diastereoisomers, as a brown oil (25.0 mg, 
25%); max/cm
-1
 3410, 3040, 2870, 1600, 1490, 1230, 1030; δH (400 MHz, CDCl3) 7.45-7.12 
(14H, m, Ar-H), 6.78-6.68 (2H, m, Ar-H), 6.63 (1H, d, J 4.4, H-9), 6.61 (1H, d, J 4.4, H-9), 
4.81-4.68 (2H, br. m, H-4), 4.62-4.45 (4H, m, H-12), 3.80 (1H, dd, J 4.7, 10.0, H-2) (isomer 
one), 3.75 (1H, dd, J 4.2, 10.0, H-2) (isomer two), 3.69-3.41 (4H, m, H-11), 3.0 (3H, s, H-17) 
(isomer one), 2.98 (3H, s, H-17) (isomer two), 2.37-2.26 (3H, m, H-3), 2.02-1.94 (1H, m, H-
3); δC (100 MHz, CDCl3) 145.0 (C-10), 144.8 (C-10), 138.1 (Ar-C), 137.6 (Ar-C), 130.1 (Ar-
C), 129.2 (Ar-C), 129.0 (Ar-C), 128.5 (Ar-C), 128.47 (Ar-C), 128.43 (Ar-C), 127.7 (Ar-C), 
127.6 (Ar-C), 127.05 (Ar-C), 127.01 (Ar-C), 124.7 (C-5), 123.8 (C-5), 166.0 (C-7), 116.0 (C-
7), 111.2 (C-9), 110.7 (C-9), 73.4 (C-12), 71.7 (C-2), 71.3 (C-2), 64.6 (C-4), 64.6 (C-4), 56.9 
(C-11), 56.4 (C-11), 37.9 (C-17), 37.4 (C-17), 33.5 (C-3), 33.4 (C-3); m/z (EI) 283.1575 (M
+
, 
C18H21NO2 requires 283.1572), 279 (19), 252 (21), 162 (48), 146 (100), 108 (38), 91 (55).   
 
(1-methyl-1,2,3,4-tetrahydroquinolin-2-yl)methanol (2.1) 
 
The tetrahydroquinoline 2.43 (0.80 g, 3.00 mmol) was dissolved in a mixture of EtOH (7 mL) 
and THF (8 mL). Ni sponge (4.00 g) was added and the reaction was heated to reflux under a 
H2 atmosphere. On completion of the reaction (TLC), the mixture was filtered through celite 
to remove the catalyst, and the filtrate was evaporated to dryness. Purification by column 
chromatography, EtOAc/n-hexane 1:1, Rf =  0.4, gave the alcohol as a colourless oil (0.37 g, 
71%): [α]D
25
 –16.7° (c = 0.9, CHCl3); max/cm
-1 
3370, 2940, 2890, 1600, 1510, 1310, 1220, 
1040; δH (400 MHz, CDCl3) 7.14 (1H, t, J 7.6, H-8), 7.01 (1H, d, J 7.6, H-6), 6.71-6.62 (2H, 
m, H-9 and H-7), 3.77-3.67 (2H, m, H-11), 3.44-3.37 (1H, m, H-2), 3.04 (3H, s, H-13), 2.91-
2.64 (2H, m, H-4), 2.14-2.05 (1H, m, H-3), 1.97-1.85 (1H, m, H-3), 1.65 (1H, br. s, H-12); δC 
(100 MHz, CDCl3) 145.5 (C-10), 128.7 (C-6), 127.3 (C-8), 122.5 (C-5), 116.2 (C-9), 111.3 
(C-7), 63.3 (C-11), 60.1 (C-2), 38.6 (C-13), 24.3 (C-4), 23.0 (C-3); m/z (EI) 177.1154 (M
+
, 
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C11H15NO requires 177.1154); Anal. Calcd for C11H15NO: C, 74.54; H, 8.53; N, 7.90%. 
Found: C, 74.65; H, 8.46; N, 7.80%.    
 
2-(Iodomethyl)-1-methyl-1,2,3,4-tetrahydroquinoline (2.54)
169
 
 
To the alcohol 2.1 (0.25 g, 1.40 mmol) in toluene (2.5 mL) and MeCN (0.5 mL) was added 
triphenylphosphine (0.93 g, 3.50 mmol) and imidazole (0.24 g, 3.50 mmol). The suspension 
was cooled to 0 °C and a solution of I2 (0.72 g, 2.90 mmol) in toluene/MeCN (5:1, 1 mL) 
added. The reaction was stirred at 0 °C for 1 h and then for an additional 1.5 h at room 
temperature. The reaction was quenched with sat. aq. Na2S2O3 (10 mL), the organic layer 
separated and evaporated to dryness. The residue was subjected to column chromatography, 
EtOAc/n-hexane 1:9, Rf = 0.33, to give the iodide as an oil, which was used without further 
purification.    
 
2-(Bromomethyl)-1-methyl-1,2,3,4-tetrahydroquinoline (2.55)
128
 
 
To a mixture of the alcohol 2.1 (0.25 g, 1.40 mmol) and triethylamine (0.39 mL, 2.80 mmol) 
in THF (7 mL) was added MsCl (0.14 mL, 1.80 mmol) at -40 °C. The reaction was stirred for 
2 h at -40 °C, before the addition of LiBr (0.49 g, 5.60 mmol). After 30 min the reaction was 
warmed to room temperature, over 3 h. The reaction was quenched by the addition of sat. aq. 
NaHCO3 (10 mL) and the organic layer separated. The aqueous layer was washed with 
CH2Cl2 (3 x 10 mL) and the combined organic extracts dried over MgSO4, filtered and 
evaporated to dryness to give the bromide, which was used without further purification.  
 
(3-(Benzyloxy)-4-methoxyphenyl)methanol (2.67) 
 
To a mixture of the alcohol 2.66 (0.50 g, 3.20 mmol) and K2CO3 (0.67 g, 4.80 mmol) in 
acetone (30 mL) was added benzyl bromide (0.39 mL, 3.20 mmol). The resultant mixture was 
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heated to reflux under N2 for 4 h. The reaction was then cooled to room temperature and 
stirred overnight. EtOAc (50 mL) and H2O (50 mL) were added and the aqueous layer 
extracted with EtOAc. The combined organic extracts were dried over MgSO4, filtered and 
evaporated to dryness to give the product as a white solid (0.56 g, 71%); mp 68-70 °C (lit. 
65-66°C)
170
; max/cm
-1
 3360, 2940, 2880, 2840, 1590, 1520, 1420, 1260, 1140; δH (400 MHz, 
CDCl3) 7.47 (2H, d, J 7.3, Ar-H), 7.39 (2H, t, J 7.3, Ar-H), 7.36-7.28 (1H, m, Ar-H), 6.95 
(1H, s, H-1), 6.92-6.84 (2H, m, H-2 and H-3), 5.14 (2H, s, OCH2Ar), 4.54 (2H, s, HOCH2), 
3.88 (3H, s, OCH3); δC (100 MHz, CDCl3) 149.2 (Ar-C), 148.3 (Ar-C), 137.1 (Ar-C), 133.7 
(Ar-C), 128.6 (Ar-C), 127.9 (Ar-C), 127.4 (Ar-C), 120.0 (C-3), 113.1 (C-1), 111.7 (C-2), 
70.9 (OCH2Ar), 65.0 (HOCH2), 56.1 (OCH3); m/z (EI) 244.1094 (M
+
, C15H16O3 requires 
244.1099), 136 (5), 91 (100), 65 (10). 
 
General procedure for the formation of Ylids from benzyl alcohols 
To the alcohol (2.00 g, 1.0 eq) in CH2Cl2 (30 mL) at -5 °C was added PBr3 (2.0 eq) drop 
wise, maintaining the temperature below 0 °C. After 20 min the reaction was allowed to 
warm to room temperature and then stirred for an additional 2 h. The reaction was quenched 
by the drop wise addition of sat. aq. NaHCO3 (30 mL) and the aqueous layer extracted with 
CH2Cl2 (2 x 30 mL). The combined organic extracts were dried over MgSO4, filtered and 
evaporated to dryness. The resultant bromide was then dissolved in toluene (30 mL) and 
triphenylphosphine (1.0 eq) was added. The resultant slurry was heated to reflux for 18 h. 
The reaction mixture was cooled to room temperature and the solid collected by filtration. 
The yilds were recrystallised from EtOH.    
 
(3-(benzyloxy)-4-methoxybenzyl)triphenylphosphonium bromide (2.70)  
 
The product was obtained as a white solid (4.30 g, 92%); mp 223-225 °C; max/cm
-1
 3030, 
2980, 1750, 1520, 1420, 1380, 1240; δH (400 MHz, CDCl3) 7.84-7.57 (15H, m, Ar-H), 7.28-
7.23 (5H, m, Ar-H), 6.85 (1H, s, H-1), 6.69 (1H, d, J 8.3, H-2), 6.63 (1H, d, J 8.3, H-3), 5.31 
(2H, d, J 13.7, CH2P), 4.77 (2H, s, OCH2Ar), 3.81 (3H, s, OCH3); δC (100 MHz, CDCl3) 
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149.6 (Ar-C), 148.1 (Ar-C), 136.7 (Ar-C), 134.9 (Ar-C), 134.5 (d, J  10, Ar-C), 130.1 (d, J 
12, Ar-C), 128.4 (Ar-C), 127.8 (Ar-C), 127.6 (Ar-C), 124.5 (d, J 6, C-2), 118.9 (d, J 9, Ar-C), 
118.4 (Ar-C), 116.7 (d, J 5, C-1), 111.7 (C-3), 70.7 (OCH2Ar), 55.9 (OCH3), 30.3 (CH2P); 
m/z (ESI) 489.1968 ([M-Br]
+
, C33H30O2P requires 489.1983).   
 
(Benzo 1,3 dioxol-5-ylmethyl) triphenylphosphonium bromide (2.68)
171
 
 
The product was obtained as a white solid (5.90 g, 95%); mp 221-223 °C (lit. 227-229 °C)
134
; 
max/cm
-1 
2890, 2850, 2780, 1510, 1490, 1440, 1250, 1110; δH (400 MHz, CDCl3) 7.83-7.60 
(15H, m, Ar-H), 6.65-6.60 (1H, m, H-2), 6.58-6.51 (2H, m, H-1 and H-3), 5.88 (2H, s, 
OCH2), 5.31 (2H, d, J 13.9, CH2P); δC (100 MHz, CDCl3) 147.7 (Ar-C), 135.0 (Ar-C), 134.4 
(d, J 10, Ar-C), 130.1 (d, J  12, Ar-C), 125.5 (d, J 7, C-2), 120.1 (d, J 9, Ar-C), 117. 8 (Ar-C), 
111.4 (C-3), 108.6 (C-1), 101.3 (OCH2), 30.5 (d, J  47,CH2P); m/z (ESI) 397.1353 ([M-Br]
+
, 
C26H22O2P requires 397.1357). 
 
General procedure for the synthesis of the Galipea alkaloids 
To a solution of oxalyl chloride (28.0 μL, 0.31 mmol) in CH2Cl2 (1 mL) at -78 °C was added 
DMSO (40.0 μL, 0.56 mmol) in CH2Cl2 (0.5 mL), maintaining the temperature below -60 °C. 
The reaction was stirred at -78 °C for 1 h and the alcohol 2.1 (50.0 mg, 0.28 mmol) in CH2Cl2 
(0.5 mL) was added drop wise, again maintaining the temperature below -60 °C. The reaction 
was stirred for a further 1 h, before the addition of triethylamine (0.19 mL, 1.40 mmol). The 
reaction mixture was allowed to warm to room temperature, whereupon it was quenched by 
the addition of sat. aq. NH4Cl (2 mL) and the organic layer washed with addition sat. aq. 
NH4Cl (3 x 2 mL). The organic layer was dried over MgSO4, filtered and evaporated to 
dryness. The aldehyde was used immediately in the next step without further purification.  
 
To the ylid (0.62 mmol, 2.2 eq) in THF (2 mL) was added KO
t
Bu (63.0 mg, 0.56 mmol) in 
THF (0.5 mL) at 0 °C. After 30 min a solution of the aldehyde in THF (0.5 mL) was added 
and the reaction was stirred for 16 h at room temperature. The solvent was removed and the 
Chapter 5  Experimental 
151 
 
residue purified by column chromatography, eluting with 10% EtOAc in hexane, to give the 
olefinated product as a mixture of the E- and Z- isomers. The alkene was dissolved in EtOH 
(0.5 mL) and THF (0.5 mL) and 10 % Pd/C (0.20 g) was added. The reaction was stirred 
under an atmosphere of H2 for 16 h. The Pd/C was removed by filtration through celite and 
the solution evaporated to dryness.    
 
Angustureine (1.10) 
 
The product was purified by column chromatography, EtOAc/n-Hexane 1:100, Rf = 0.40, to 
give angustureine as a colourless oil (27 mg, 44%); [α]D
25
 + 7.5° (c = 0.4, CHCl3) Lit [α]D
25
 –
7.16 (c = 1.0, CHCl3, natural product)
18, 172
; max/cm
-1 
2930, 2860, 950, 750; δH (400 MHz, 
CDCl3) 7.11 (1H, t, J 7.6, H-7), 6.99 (1H, d, J 7.6, H-9), 6.60 (1H, t, J 7.6, H-8), 6.55 (1H, d, 
J 7.6, H-6), 3.31-3.19 (1H, m, H-2), 2.95 (3H, s, H-16), 2.91-2.74 (1H, m, H-4), 2.75-2.63 
(1H, m, H-4), 1.97-1.86 (2H, m, H-3), 1.62 (1H, m, H-11), 1.46-1.26 (10H, m, H-11, H-12, 
H-13, H-14 and H-15); δC (100 MHz, CDCl3) 145.4 (C-10), 128.6 (C-9), 127.1 (C-7), 121.9 
(C-5), 115.2 (C-8), 110.4 (C-6), 59.0 (C-2), 38.0 (C-16), 31.2 (CH2), 32.1 (CH2), 29.7 (CH2), 
25.8 (CH2), 24.4 (C-3), 23.6 (C-4), 22.7 (C-15); m/z (ESI) 217.1828 (M
+
, C15H23N requires 
217.1830), 146 (100), 83 (60).  
 
  
Galipeine (1.11) 
 
The product was purified by column chromatography Et2O/n-pentane, 3:7, Rf = 0.28, to give 
galipeine as a colourless gum (27.0 mg, 32%); [α]D
25
 – 27° (c = 0.7, CHCl3) Lit [α]D
25
 – 26.1 
(c = 0.44, CHCl3, 96%)
19
; max/cm
-1 
3500, 2940, 2850, 1600, 1500, 1280; δH (400 MHz, 
CDCl3) 7.12 (1H, t, J 8.0, H-8), 7.02 (1H, d, J 7.2, H-6), 6.88-6.76 (2H, m, H-17 and H-14), 
6.70 (1H, dd, J 2.0, 8.2, H-18), 6.63 (1H, t, J 7.2, H-7), 6.57 (1H, d, J 8.0, H-9), 5.61 (1H, br. 
s, H-20), 3.91 (3H, s, H-19), 3.39-3.23 (1H, m, H-2), 2.94 (3H, s, H-21), 2.92-2.82 (1H, m, 
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H-4), 2.79-2.60 (2H, m, H-4 and H-12), 2.60-2.46 (1H, m, H-12), 2.04-1.86 (3H, m, H-11 
and H-3), 1.84-1.67 (1H, m, H-11); δC (100 MHz, CDCl3) 145.5 (Ar-C), 145.4 (Ar-C), 144.8 
(Ar-C), 135.4 (C-13), 128.8 (C-6), 127.1 (C-8), 121.8 (C-5), 119.6 (C-18), 115.4 (C-7), 114.5 
(C-17/C-14), 110.7 (C-17/C-14), 110.6 (C-9), 58.2 (C-2), 56.0 (C-19), 38.0 (C-21), 32.9 (C-
11), 31.6 (C-12), 24.4 (C-3), 23.6 (C-4); m/z (ESI) 298.1796 (MH
+
, C19H24NO2 requires 
298.1807), 194 (2).  
 
Galipinine (1.13) 
 
The product was purified by column chromatography, Et2O/n-hexane 1:20, Rf  = 0.31, as a 
colourless gum (26.0 mg, 31%); max/cm
-1 
2940, 2880, 1610, 1500, 1490, 1450, 1240; δH (400 
MHz, CDCl3) 7.12 (1H, t, J 7.9, H-8), 7.01 (1H, d, J 7.2, H-6), 6.78-6.62 (4H, m, Ar-H), 6.56 
(1H, d, J 7.9, H-9), 5.95 (2H, s, H-19), 3.36-3.26 (1H, m, H-2), 2.95 (3H, s, H-20), 2.93-2.85 
(1H, m, H-12), 2.78-2.60 (2H, m, H-4 and H-12), 2.61-2.46 (1H, m, H-4), 2.03-1.84 (3H, m, 
H-3 and H-11), 1.80-1.67 (1H, m, H-3); δC (100 MHz, CDCl3) 147.6 (Ar-C), 145.6 (Ar-C), 
145.4 (Ar-C), 135.9 (C-13), 128.7 (C-6), 127.1 (C-8), 121.7 (C-5), 120.9 (Ar-C), 115.4 (Ar-
C), 110.6 (C-9), 108.7 (Ar-C), 108.2 (Ar-C), 100.8 (H-19), 58.2 (H-2), 38.1 (H-20), 33.2 (C-
3), 32.0 (C-4), 24.4 (C-11), 23.6 (C-12). m/z (ESI) 296.1647 (MH
+
, C19H22NO2 requires 
296.1651).   
5.2 Compounds used in Chapter 3  
4-(benzyloxy)butan-1-ol (3.11) 
 
To NaH (2.50 g, 55.5 mmol) in THF (35 mL) was added 1,4-butanediol (5.00 mL, 56.4 
mmol), followed by BnBr (6.60 mL, 55.5 mmol) in dry THF (15 mL) at 0 °C. The suspension 
was stirred at room temperatureunder N2 for 18 hours, then quenched by the addition of 
NH4Cl (50 mL) and the aqueous layer extracted with Et2O (50 mL). The combined organic 
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extracts were dried over MgSO4, filtered and concentrated to give the crude product as a 
yellow oil, purified by column chromatography, n-Hexane /EtOAc 1:1, Rf = 0.4, to give a 
yellow oil (7.77 g, 76%); νmax/cm
-1
 3380, 2940, 2860, 1450, 1060, 690; δH (400 MHz, CDCl3) 
7.36 (5H, m, Ar-H), 4.53 (2H, s, OCH2Ar), 3.64 (2H, t, J 6.0, H-1), 3.54 (2H, t, J 5.9, H-4), 
2.68 (1H, s, OH), 1.71 (4H, m, H-2 and H-3);
 δC (100 MHz, CDCl3) 138.2 (Ar-C), 128.4 (Ar-
C), 127.76 (Ar-C), 127.72 (Ar-C), 73.0 (OCH2Ar), 70.3 (C-4), 62.4 (C-1), 29.8 (C2/C3), 26.5 
(C2/C3); m/z (EI) 180 (M
+
, 12), 107 (75), 91 (100), 71 (27), 43 (27).  
 
4-(tert-Butyldiphenylsilyloxy)butan-1-ol (3.12)
143
 
 
To a solution of 1, 4-butandiol (9.80 mL, 111 mmol) in CH2Cl2 (20 mL) was added DIPEA 
(20.0 mL, 115 mmol). TBDPSCl (10.0 mL, 38.0 mmol) was added drop wise to the solution 
and the mixture was stirred at room temperature for 2 h. The solvent was removed by 
evaporation and the residue purified by column chromatography with n-hexane/EtOAc 2:1, Rf 
= 0.33, to give the alcohol as a colourless oil (6.90 g, 55%); max/cm
-1
 3380, 2940, 2860, 
1430, 1110; δH (400 MHz, CDCl3) 7.89-7.61 (4H, m, Ar-H), 7.61-7.37 (6H, m, Ar-H), 3.77 
(2H, t, J 3.7, H-4), 3.71 (2H, t, J 5.9, H-1), 2.47 (1H, br. s, OH), 1.73 (4H, m, H-2 and H-3), 
1.13 (9H, s, C(CH3)3);
 δC (100 MHz, CDCl3) 135.6 (C-6), 133.7 (C-5), 129.7 (C-8), 127.7 (C-
7), 64.1 (C-4), 62.8 (C-1), 29.8 (C-2/C-3), 29.3 (C-2/C-3), 26.9 (C(CH3)3), 19.2 (C(CH3)3); 
m/z (EI) 329.1930 (MH
+
, C20H29O2Si requires 329.1937), 216 (12), 210 (10).  
 
4-(tert-butyldimethylsilyloxy)butan-1-ol (3.13)
144
 
 
To a mixture of 1, 4-butandiol (9.80 mL, 111 mmol) and imidazole (5.30 g, 78 mmol) in 
DMF (30 mL) was added tert-butyldimethyl silyl chloride (4.20 g, 28.0 mmol). The reaction 
was stirred at room temperature for 2 h, and quenched by the addition of H2O (150 mL). The 
aqueous layer was extracted with EtOAc (3 x 100 mL). The combined organic layers were 
dried over MgSO4, filtered and evaporated to dryness. The residue was purified by column 
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chromatography, n-hexane/EtOAc 1.5:1, Rf = 0.41, to give the alcohol as a colourless oil 
(4.00 g, 71%); max/cm
-1
 3350, 2960, 2940, 2670, 1470, 1260, 1100; δH (400 MHz, CDCl3) 
3.71-3.58 (4H, m, H-1 and H-4), 2.97 (1H, br. s, OH), 1.72-1.57 (4H, m, H-2 and H-3), 0.9 
(9H, s, C(CH3)3), 0.07 (6H, br. s, Si(CH3)2); δC (100 MHz, CDCl3) 63.3 (C-1/C-4), 62.6 (C-
1/C-4), 30.1 (C-2/C-3), 29.8 (C-2/C-3), 25.9 (C(CH3)3), 18.2 (C(CH3)3), -5.4 (Si(CH3)2); m/z 
(EI) 205 (MH
+
, 5%), 189 (28), 147 (62), 105 (82), 75 (100). 
 
4-Hydroxybutyl acetate (3.14)
145
 
 
Acetyl chloride (4.60 mL, 65.0 mmol) was added drop wise to a solution of 1, 4-butandiol 
(10.0 g, 111 mmol) and pyridine (5.30 mL, 65.0 mmol) in CH2Cl2 (10 mL) at 0 °C. The 
reaction was stirred at room temperature over night, evaporated to dryness and purified by 
column chromatography with EtOAc/n-hexane 1:1, Rf = 0.33. The product was obtained as a 
colourless oil (3.90 g, 45%); max/cm
-1
 3420, 2950, 2880, 1730, 1240, 1050;
 δH (400 MHz, 
CDCl3) 4.12 (2H, t, J 6.5, H-4), 3.70 (2H, t, J 6.1, H-1), 2.07 (3H, s, COCH3), 1.81-1.60 (4H, 
m, H-2 and H-3), 1.48 (1H, br. s, OH); δC (100 MHz, CDCl3) 171.2 (COOCH3), 64.2 (C-4), 
62.3 (C-1), 29.1 (C-2/C-3), 25.0 (C-2/C-3), 20.9 (COCH3); m/z (CI) 133.0868 (MH
+
, 
C6H13O3 requires 133.0865), 71 (3), 52 (5). 
 
General methods for the synthesis of the Michael acceptors   
DMSO (2.40 mL, 33.0 mmol) in CH2Cl2 (6 mL) was added to a solution of oxalyl chloride 
(1.40 mL, 16.7 mmol) in CH2Cl2 (35 mL) at -78 °C, maintaining the temperature below -60 
°C. After 30 min the alcohol (15.0 mmol) in CH2Cl2 (12 mL) was added, maintaining the 
temperature below -60 °C. The reaction was stirred for another 30 min, before triethylamine 
(10.5 mL, 76.0 mmol) was added. The reaction was warmed to room temperature and diluted 
with sat. aq. NH4Cl (50 mL). The organic layer was separated and evaporated to dryness to 
give the aldehyde, which was used without further purification.  
 
 Synthesis of the Michael acceptor was achieved using general method A or C (See Section 
5.1). 
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Methyl 6-(benzyloxy)hex-2-enoylcarbamate (3.19) 
 
The product was obtained using general method A and purified by recrystallisation from 
toluene/n-hexane to give a white solid (1.50 g, 40%); mp 63-65 °C; max/cm
-1 
3280, 3085, 
2960, 2860, 1780, 1700, 1650, 1530; δH (400 MHz, CDCl3) 7.78 (1H, br. s, NH), 7.43-7.27 
(5H, m, Ar-H), 7.17 (1H, dt, J 7.0, 15.4, CH2CH), 6.85 (1H, d, J 15.4, CHCO), 4.53 (2H, s, 
OCH2Ar), 3.81 (3H, s, OCH3), 3.53 (2H, t, J 6.2, H-1), 2.41 (2H, m, H-3), 1.83 (2H, m, H-2); 
δC (100 MHz, CDCl3) 165.8 (CONH), 152.2 (CO2), 150.8 (CH2CH), 138.4 (C-4), 128.4 (C-
6), 127.7 (C-5), 127.6 (C-7), 121.5 (CHCO), 73.0 (OCH2Ar), 69.2 (C-1), 53.1 (OCH3), 29.3 
(C-3), 28.1 (C-2); m/z (EI) 277.1313 (M
+
, C15H19NO4 requires 277.1314), 202 (12), 143 (30), 
91 (100).  
 
(E)-methyl 6-(tert-butyldiphenylsilyloxy)hex-2-enoylcarbamate (3.20) 
 
The product was obtained using general method C and purified by column chromatography, 
EtOAc/n-hexane 1.5:1, Rf = 0.31, to give a white solid (4.40 g, 70%); mp 93-95°C; max/cm
-1 
3250, 2970, 2930, 2880, 1780, 1690, 1640, 1500, 1440, 1170; δH (400 MHz, CDCl3) 7.75-
7.63 (4H, m, Ar-H), 7.57 (1H, br. s, NH), 7.51-7.34 (6H, m, Ar-H), 7.17 (1H, dt, J 6.9, 15.4, 
CH2CH), 6.81 (1H, d, J 15.4, CHCO), 3.82 (3H, s, OCH3), 3.71 (2H, t, J 6.1, H-1), 2.50-2.34 
(2H, m, H-3), 1.81-1.71 (2H, m, H-2), 1.08 (9H, s, C(CH3)3); δC (100 MHz, CDCl3) 165.8 
(CONH), 152.3 (CO2), 151.9 (CH2CH), 135.5 (C-5), 133.8 (C-4), 129.6 (C-7), 127.7 (C-6), 
121.3 (CHCO), 62.9 (C-1), 53.1 (OCH3), 30.9 (C-2), 29.1 (C-3), 26.9 (C(CH3)3), 19.2 
(C(CH3)3). m/z (EI) 426 (MH
+
, < 5%), 368 (100), 293 (65), 213 (35). 
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Methyl 6-(tert-butyldimethylsilyloxy)hex-2-enoylcarbamate (3.21) 
 
The product was obtained using general method C and purified by column chromatography, 
EtOAc/n-hexane 1.5:1, Rf = 0.4, to give a white solid (2.40 g, 55%); mp 83-85 °C; max/cm
-1
 
3230, 2940, 2850, 1770, 1690, 1660, 1530, 1240; δH (400 MHz, CDCl3) 8.04 (1H, br. s, NH), 
7.28 (1H, dt, J 6.9, 15.4, CH2CH), 6.85 (1H, J 15.4, CHCO), 3.80 (3H, s, OCH3), 3.65 (2H, t, 
J 6.2, H-1), 2.43-2.26 (2H, m, H-3), 1.80-1.62 (2H, m, H-2), 0.9 (9H, s, (C(CH3)3), 0.06 (6H, 
s, Si(CH3)2); δC (100 MHz, CDCl3) 166.2 (CONH), 152.5 (CO2), 151.2 (CH2CH), 121.4 
(CHCO), 62.2 (C-1), 53.0 (OCH3), 31.1 (C-2), 29.1 (C-3), 25.9 (C(CH3)3), 18.3 (C(CH3)3), 
5.34 (Si(CH3)2); m/z (ESI) 302.1779 (MH
+
, C14H28NO4Si requires 302.1788), 224 (14), 196 
(5).  
 
6-(Methoxycabonylamino)-6-oxohex-4-enyl acetate (3.22)  
 
The product was obtained using general method C and purified by column chromatography 
EtOAc/n-hexane 2.5:1, Rf = 0.32, to give a white solid in a 10:1 mixture of E and Z isomers 
(1.50 g, 45%); mp 55-57 °C; max/cm
-1
 3560, 3270, 2960, 1770, 1720, 1650, 1510; δH (400 
MHz, CDCl3) 8.19 (1H, br. s, NH) (major isomer), 8.08 (1H, br. s, NH) (minor isomer), 7.13 
(1H, dt, J 6.8, 15.5, CH2CH) (major isomer), 6.87 (1H, d, J 15.5, CHCO) (major isomer), 
6.60 (1H, d, J 11.5, CHCO) (minor isomer), 6.32 (1H, dt, J 7.5, 11.5, CH2CH) (minor 
isomer), 4.09 (2H, t, J 6.5, H-1), 3.79 (3H, s, OCH3) (major isomer), 3.78 (3H, s, OCH3) 
(minor isomer), 2.78-2.67 (2H, m, H-3) (minor isomer), 2.42-2.30 (2H, m, H-3) (major 
isomer), 2.06 (3H, s, COCH3) (major isomer), 2.04 (3H, s, COCH3) (minor isomer), 1.91-
1.75 (2H, m, H-2); δC (100 MHz, CDCl3) 171.1 (COCH3), 165.8 (CONH), 152.3 (CO2CH3), 
149.8 (CH2CH), 121.8 (CHCO), 63.5 (C-1), 53.1 (CO2CH3), 29.1 (C-3), 27.0 (C-2), 21.0 
(C=OCH3); m/z (ESI) 230.1030 (MH
+
, C10H16NO5 requires 230.1028), 169 (100), 113 (55), 
94 (98), 43 (95). Anal. Calcd for C10H16NO5: C, 52.40; H, 6.60; N, 6.11%. Found: C, 52.51; 
H, 6.46; N, 5.97%.    
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Methyl hexa-2,5-dienoylcarbamate (3.26) 
 
To the alcohol (1g, 13 mmol) in a Pentane/CH2Cl2 (9:1, 50 mL) mixture was added 
PhI(OAc)2 (4.9 g, 15 mmol), immediately followed by TEMPO (0.2 g, 1.4 mmol). The 
reaction was stirred at room temperature for 2.5 hours. The reaction was quenched by the 
addition of sat.NaHCO3 at 0 °C. The organic layer was separated and the aldehyde in the 
Pentane/CH2Cl2 mixture (25 mL) was added to a solution of the ylid in CH2Cl2 (30 mL). The 
reaction was stirred over night and the solvent removed by evaporation. The crude product 
was purified by column chromatrography, EtOAc/Hexane 1:1 to give a white solid (0.18 g, 
15%); mp 123-128 °C; max/cm
-1
 3200, 2980, 1760, 1630; δH (400 MHz, CDCl3) 7.34 (1H, s, 
NH), 7.18 (1H, dt, J 6.5, 15.5), 6.89 (1H, d, J 15.5, Hd), 5.95-5.80 (1H, m, Hb), 5.19-5.16 
(1H, m, Ha), 5.14 (1H, dd, J 1.4, 6.4, Ha), 3.82 (3H, s, CO2CH3), 3.11-3.00 (2H, m, CH2); δC 
(100 MHz, CDCl3) 165.6 (CONH), 152.4 (CO2), 144.4 (Hc), 137.3 (Hb), 129.3 (Hd), 118.5 
(Ha), 53.1 (CO2CH3), 35.9 (CH2); m/z (EI) 169.0739 (M
+
, C8H11NO3 requires 169.0739), 154 
(100), 95 (75), 67 (10), 41 (32).  
 
Methyl hexa-2,4-dienoylcarbamate (3.27)  
 
To a solution of 3-Buten-1-ol (1.00 g, 13.0 mmol) in a pentane/CH2Cl2 (9:1, 50 mL) mixture 
was added PhI(OAc)2 (4.90 g, 15.0 mmol), immediately followed by TEMPO (0.20 g, 1.40 
mmol). The reaction was stirred at room temperature for 2.5 h and then quenched by the 
addition of sat. aq. NaHCO3 at 0 °C. The organic layer was separated and this solution (25 
mL) containing the aldehyde was added to a mixture of the phosphonate carbamate (1.75 g, 
7.00 mmol) and DBU (1.00 mL, 6.60 mmol) in CH2Cl2 (30 mL). The reaction was stirred 
overnight at room temperature, and then the solvent was removed by evaporation. The crude 
product was purified by column chromatography, EtOAc/n-hexane 1.5:1, Rf = 0.35, to give a 
white solid (0.11 g, 10%); mp 169-171 °C; max/cm
-1
 3260, 2960, 1770, 1650, 1610, 1500; δH 
(400 MHz, CDCl3) 7.86 (1H, dd, J 11.4, 15.0, Hc) (minor isomer), 7.47 (2H, br. dd, J 10.1, 
15.1, Hc and NH), 6.96 (1H, d, J 15.0, Hd) (minor isomer), 6.86 (1H, d, J 15.1, Hd) (major 
isomer), 6.28 (2H, m, Ha and Hb), 6.05 (1H, dd, J 7.5, 11.4, Hb) (minor isomer), 3.81 (3H, s, 
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CO2CH3), 1.91 (3H, d, J 5.9, CHCH3); δC (100 MHz, CDCl3) 166.4 (CONH), 152.3 (CO2), 
146.9 (C-Hc), 141.2 (C-H), 130.2 (C-H), 118.6 (C-Hd), 53.0 (OCH3), 18.8 (CHCH3); m/z (EI) 
169.0739 (M
+
, C8H11NO3 requires 169.0739), 154 (100), 95 (55), 67 (60), 41 (47).  
 
Methyl 6-(benzyloxy)-3-(phenylamino)hexanoylcarbamate (3.28) 
 
Using method A, the product was obtained as a yellow oil (20%); Column chromatography, 
EtOAc/n-hexane 1:1.5, Rf = 0.33; max/cm
-1
3320, 3080, 2880, 1750, 1660, 1630, 1540, 1420, 
1220; δH (400MHz, CDCl3) 7.81 (1H, br.s, NHCO), 7.41-7.29 (5H, m, Ar-C), 7.19-7.14 (2H, 
m, H-6), 6.71 (1H, t, J 7.2, H-7), 6.61 (2H, d, J 8.0, H-5), 4.50 (2H, s, OCH2Ar), 4.00-3.85 
(1H, m, CHNH), 3.76 (3H, s, OCH3), 3.56-3.44 (3H, m, H-1 and ArNH), 3.01 (1H, dd, J 5.8, 
15.9), 2.94 (1H, dd, J 5.4, 15.9, CH2CO), 1.89-1.64 (4H, m, H-2 and H-3); δC (100 MHz, 
CDCl3) 172.4 (CONH), 152.1 (CO2CH3), 147.0 (C-4), 138.4 (Ar-C), 129.4 (C-6), 128.4 (Ar-
C), 127.7 (Ar-C), 127.6 (Ar-C), 117.7 (C-7), 113.5 (C-5), 73.1 (OCH2Ar), 70.1 (C-1), 53.1 
(CO2CH3), 50.3 (CHNH), 40.4 (CH2CO), 31.9 (C-2/C-3), 26.4 (C-2/C-3); m/z (ESI) 
371.1953 (MH
+
, C21H27N2O4 requires 371.1971) 300 (70), 224 (100). 
 
Methyl 6-(tert-butyldimethylsilyloxy)-3-(phenylamino)hexanoylcarbamate (3.30) 
 
Using method A, the product was obtained as a yellow oil (40%); Column chromatography, 
EtOAc/n-hexane 1:1.5, Rf = 0.26; [α]D
25
 + 3.3° (c = 0.4, CHCl3, 46% ee); max/cm
-1 
3260, 
3000, 1750, 1710, 1590, 1200; δH (400MHz, CDCl3) 7.22-7.12 (2H, m, Ar-C), 6.79-6.63 (3H, 
m, Ar-C), 3.99-3.89 (1H, m, NHCH), 3.76 (3H, s, OCH3), 3.71-3.59 (2H, m, H-1), 3.03 (1H, 
dd, J 6.0, 16.1, CH2CO), 2.94 (1H, dd, J 6.2, 16.1, CH2CO), 1.83-1.55 (4H, m, H-2 and H-3), 
0.92 (9H, s, (C(CH3)3), 0.11 (6H, s, Si(CH3)2); δC (100 MHz, CDCl3) 172.8 (CONH), 152.2 
(CO2), 145.8 (C-4), 129.4 (C-6), 118.6 (C-7), 114.4 (C-5), 62.5 (C-1), 53.1 (OCH3), 50.7 
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(CHNH), 40.3 (CH2CO), 31.6 (C2/C3), 29.3 (C2/C3), 25.7 (C(CH3)3), 18.3 (C(CH3)3), -3.6 
(Si(CH3)2); m/z (ESI) 395 (MH
+
, 45), 224 (100).  
 
6-(methoxycarbonylamino)-6-oxo-4(phenylamino)hexyl acetate (3.31) 
 
Using method A, the product was obtained as a colourless oil (43%); Column 
chromatography, EtOAc/n-hexane 1:1.5, Rf = 0.35; [α]D
25
 - 0.9° (c = 1.1, CHCl3, 44% 
ee)max/cm
-1
 3330, 3070, 2860, 1770, 1740, 1650, 1550, 1450, 1200; δH (400MHz, CDCl3) 
8.62 (1H, br.s, NHCO), 7.30 (2H, m, H-6), 6.72 (1H, t, J 7.2, H-7), 6.66 (2H, d, J 8.0, H-5), 
4.14-4.07 (3H, m, ArNH and H-1), 4.05-3.93 (1H, m, NHCH), 3.77 (3H, s, OCH3), 3.03 (1H, 
dd, J 5.6, 16.0, CH2CO), 2.95 (1H, dd, J 5.2, 16.0, CH2CO), 2.40 (3H, s, COCH3), 1.88-1.63 
(4H, m, H2 and H-3); δC (100 MHz, CDCl3) 173.1 (CONH), 161.1 (COCH3), 152.5 (CO2), 
147.8 (C-4), 129.4 (C-6), 117.8 (C-7), 113.5 (C-5), 64.4 (C-1), 53.1 (CO2CH3), 49.8 
(CHNH), 40.6 (CH2CO), 31.5 (C2/C3), 25.4 (C2/C3), 21.4 (COCH3); m/z (ESI) 323.1599 
(MH
+
, C16H23N2O5 requires 323.1607) 293 (12), 252 (22). 
 
Methyl 6-(tert-butyldiphenylsilyloxy)-3-(phenylamino)hexanoylcarbamate (3.29) 
 
To the alkene (50.0 mg, 0.13 mmol) and [Pd(R-BINAP)(OH2)2]
2+
[OTf]
-
2 (7.00 mg, 6.5 μmol) 
in toluene (0.5 mL) was added the aniline (12.0 μL, 0.13 mmol). The reaction was stirred for 
48 h and then the solvent removed by evaporation. The crude reaction mixture was purified 
by column chromatography, EtOAc/n-hexane 1:1.5, Rf = 0.29, to give a colourless oil (44.0 
mg, 65%); Chiral HPLC Hichrom-CHI-PGG-2759, 10% IPA in n-hexane, 1 mL/min, 
tR(major) = 51.1 min, tR(minor) = 63.1 min; [α]D
25
 – 1.5° (c = 1.3, CHCl3, 71% ee); max/cm
-1 
3300, 2950, 2860, 1770, 1710, 1600, 1490, 1210, 1110; δH (400 MHz, CDCl3) 7.99 (1H, br. 
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s, CONH), 7.71-7.64 (4H, m, Ar-H), 7.50-7.36 (6H, m, Ar-H), 7.19 (2H, dd, J 7.4, 8.0, H-
10), 6.74 (1H, t, J 7.4, H-11), 6.64 (2H, d, J 8.0, H-9), 3.99-3.90 (1H, m, NHCH), 3.85 (1H, 
br. s, ArNH), 3.79 (3H, s, OCH3), 3.72-3.67 (2H, m, H-1), 3.03 (1H, dd, J 5.8, 15.8, CH2CO), 
2.95 (1H, dd, J 5.2, 15.8, CH2CO), 1.79-1.61 (4H, m, H-2 and H-3), 1.08 (9H, s, C(CH3)3); δC 
(100 MHz, CDCl3) 172.7 (CONH), 152.2 (CO2), 147.1 (C-8), 135.6 (Ar-C), 133.9 (Ar-C), 
129.6 (Ar-C), 129.4 (C-10), 127.7 (Ar-C), 117.8 (C-11), 113.7 (C-9), 63.5 (C-1), 53.1 
(OCH3), 50.3 (NHCH), 40.5 (CH2CO), 31.3 (C-2/C-3), 29.1 (C-2/C-3), 26.9 (C(CH3)3), 19.2 
(C(CH3)3); m/z (ESI) 519.2664 (MH
+
, C30H39N2O4Si requires 519.2679), 448 (28).   
 
Methyl 3-(4-bromophenylamino)-6-(tert-butyldiphenylsiloxy)hexanoylcarbamate (3.33) 
 
To a solution of the alkene 3.20 (1.50 g, 3.50 mmol) in toluene (25 mL) was added 
[Pd(BINAP)(OH2)2]
2+
[OTf]
-
2 (0.19 g, 0.18 mmol). The mixture was heated to 30 °C, 
whereupon a solution of 4-bromoaniline (0.60 g, 3.50 mmol) in toluene (5 mL) was added 
slowly over 5 h. The reaction was stirred for 48 h and then cooled to room temperature. The 
solvent was removed by evaporation and the residue purified by column chromatography, 
EtOAc/n-hexane 1:1.5, Rf = 0.40, to give a yellow oil (1.70 g, 85%); Chiral HPLC Daicel 
Chiralpak AD-H, 5% IPA in n-hexane, 0.5 mL/min, tR(minor) = 42.8 min, tR(major) = 48.6 
min; [α]D
25
 + 3.0° (c = 1.0, CHCl3, 71% ee); max/cm
-1 
2950, 2930, 2860, 1766, 1710, 1600, 
1490, 1210; δH (400 MHz, CDCl3) 7.84 (1H, br. s, NHCO), 7.74-7.61 (4H, m, Ar-H), 7.51-
7.32 (6H, m, Ar-H), 7.23 (2H, d, J 8.6, H-10), 6.48 (2H, d, J 8.6, H-9), 3.96-3.84 (2H, br. m, 
ArNH and CHNH), 3.78 (3H, s, CO2CH3), 3.72-3.66 (2H, m, H-1), 3.04 (1H, dd, J 5.5, 15.9, 
COCH2), 2.93 (1H, dd, J 4.9, 15.9, COCH2), 1.79-1.56 (4H, m, H-2 and H-3), 1.07 (9H, s, 
C(CH3)3); δC (100 MHz, CDCl3) 172.7 (CONH), 152.3 (CO2), 146.2 (C-8), 135.6 (C-5), 
133.8 (C-4), 132.0 (C-10), 129.6 (C-7), 127.7 (C-6), 115.1 (C-9), 109.1 (C-11), 63.4 (C-1), 
53.2 (OCH3), 50.4 (NHCH), 40.3 (COCH2), 31.3 (C-2/C-3), 29.0 (C-2/C-3), 26.8 (C(CH3)), 
19.2 (C(CH3)3); m/z (EI) 596.1704 (M
+
, C30H37N2O4SiBr requires 596.1706), 509 (40), 507 
(40), 424 (95), 422 (100), 226 (50), 224 (55), 199 (60).  
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Methyl 6-(tert-butyldiphenylsilyloxy)-3-(ethyl-4-aminobenzoate)hexanoylcarbamate 
(3.34) 
 
Using method A, the product was obtained as an off-white solid (72%); [α]D
25
 - 2.7° (c = 1.1, 
CHCl3, 57% ee); Daicel Chiralpak AD-H, 10% IPA in n-hexane, 1 mL/min, tR(minor) = 21.8 
min, tR(major) = 25.8 min; Column chromatography, EtOAc/n-hexane 1:1.5, Rf = 0.42; 
max/cm
-1
 3300, 3100, 3000, 1770, 1720, 1660, 1550, 1280; δH (400MHz, CDCl3) 7.85 (2H, d, 
J 8.7, H-10), 7.76-7.61 (4H, m, Ar-H), 7.50-7.34 (6H, m, Ar-H), 6.54 (2H, d, J 8.7, H-9), 
4.34 (2H, q, J 7.1, CO2CH2), 4.07-3.93 (1H, m, CHNH), 3.78 (3H, s, OCH3), 3.75-3.63 (2H, 
m, H-1), 3.10 (1H, dd, J 6.0, 16.0, CH2CO), 2.98 (1H, dd, J 5.6, 16.0, CH2CO), 1.83-1.57 
(4H, m, H-2 and H-3), 1.39 (3H, t, J 7.1, CH3CH2), 1.07 (9H, s, C(CH3)3); δC (100 MHz, 
CDCl3) 172.5 (CONH), 166.8 (CO2CH2), 152.3 (CO2CH3), 150.1 (C-8), 135.6 (Ar-C), 133.8 
(Ar-C), 131.6 (C-10), 129.6 (Ar-C), 127.7 (Ar-C), 118.8 (C-11), 111.9 (C-9), 63.4 (C-1), 60.2 
(CO2CH2), 53.2 (OCH3), 49.6 (CHNH), 40.3 (CH2CO), 31.3 (C-2/C-3), 29.0 (C-2/C-3), 26.9 
(C(CH3)3), 19.2 (C(CH3)3), 14.5 (CH3CH2); m/z (ESI) 591.2901 (MH
+
, C33H43N2O6Si 
requires 591.2890), 448 (68), 207 (11). 
 
6-(tert-Butyldiphenylsilyloxy)-3-(phenylamino)hexanoic acid (3.35) 
 
To a solution of the carbamate 3.33 (0.22 g, 0.36 mmol) in MeOH (5 mL) was added 1M aq. 
KOH (5.30 mL, 5.30 mmol). The resultant solution was stirred at room temperature for 1 h 
and the MeOH was removed by evaporation. CH2Cl2 (10 mL) was added and the organic 
layer separated, dried over MgSO4 and the solvent removed under vacuum to give a yellow 
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oil (0.16 g, 82%); [α]D
25
 + 1.8° (c = 1.1, CHCl3); max/cm
-1 
3070, 2950, 2860, 1680, 1600, 
1500, 1110; δH (400 MHz, CDCl3) 7.79-7.65 (4H, m, Ar-H), 7.54-7.37 (6H, m, Ar-H), 7.27 
(2H, d, J 8.6, H-10), 6.53 (2H, d, J 8.6, H-9), 6.40 (1H, br. s, NH/OH), 5.92 (1H, br. s, 
NH/OH), 3.88-3.64 (3H, m, H-1 and NHCH), 2.51-2.32 (2H, m, CH2CO), 1.88-1.57 (4H, m, 
H-2 and H-3), 1.11 (9H, s, C(CH3)3); δC (100 MHz, CDCl3) 174.6 (CO2H), 146.2 (C-8), 
135.6 (Ar-C), 133.9 (Ar-C), 132.1 (C-10), 129.7 (Ar-C), 127.7 (Ar-C), 115.4 (C-9), 109.4 (C-
11), 63.5 (C-1), 50.9 (CH), 40.2 (CH2CO), 31.0 (C-2/C-3), 29.1 (C-2/C-3), 26.9 (C(CH3)3), 
19.3 (C(CH3)3); m/z ESI 539 (88), 541(100), 539 (83), 519 (25), 245 (18). 
 
Methyl 6-bromo-2-(3-(tert-butyldiphenylsilyloxy)propyl)-1,2,3,4-tetrahydroquinolin-4-
ylcarbamate (3.39) 
 
To a solution of the carbamate 3.33 (1.60 g, 2.60 mmol) dissolved in an ethanol/THF mixture 
(1:1, 15 mL) was added NaBH4 (70.0 mg, 1.80 mmol) at -10 °C. MgCl2.6H2O (0.56 g, 2.80 
mmol) in H2O (2 mL) was slowly added, maintaining the temperature below 0 °C. Upon 
complete addition, the reaction was stirred at 0 °C for 30 min before quenching, by the 
addition of CH2Cl2 (20 mL), 1M aq. HCl (20 mL) and citric acid (1.30 g, 6.50 mmol). The 
biphasic layer was stirred at room temperature for 4 h. The organic layer was separated and 
then H2O (10 mL) was added, followed by citric acid (0.76 g, 4.00 mmol). The mixture was 
stirred at room temperature for 45 min and then the organic layer was separated, dried over 
MgSO4 and concentrated under vacuum. The volatiles remaining in the residue were 
displaced by co-distillation with hexane under reduced pressure to give the 2, 4-disubstituted 
tetrahydroquinoline as a colourless gum (1.50 g, 98%); [α]D
25
 + 6.0° (c = 1.0, CHCl3); 
max/cm
-1 
2940, 2860, 1720, 1600, 1500, 1111; δH (400 MHz, CD3CN) 7.81-7.61 (4H, m, Ar-
H), 7.59-7.35 (6H, m, Ar-H), 7.15 (1H, br. d, J 2.2, H-6), 7.08 (1H, dd, J 2.2, 8.6, H-8), 6.46 
(1H, d, J 8.6, H-9), 5.76 (1H, d, J 9.2, H-20), 4.84 (1H, m, H-4), 4.62 (1H, br. s, H-1), 3.75 
(2H, t, J 5.9, H-13), 3.69 (3H, s, H-22), 3.39 (1H, m, H-2), 2.10 (1H, ddd, J 2.5, 5.5, 11.9, H-
3), 1.76-1.54 (4H, m, H-11 and H-12), 1.48 (1H, q, J 11.9, H-3), 1.06 (9H, s, H-19); δC (100 
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MHz, CDCl3) 157.0 (H-21), 143.9 (C-10), 135.6 (C-15), 133.8 (C-14), 131.0 (C-8), 129.7 (C-
17), 129.4 (C-6), 127.7 (C-16), 123.7 (C-5), 115.9 (C-9), 109.0 (C-7), 63.6 (C-13), 52.3 (C-
22), 50.8 (C-2), 47.9 (C-4), 36.1 (C-3), 32.6 (C-11), 28.3 (C-12), 26.9 (C-19), 19.2 (C-18); 
m/z (EI) 580.1757 (M
+
, C30H37N2O3BrSi requires 580.1757), 550 (17), 448 (100), 250 (96), 
208 (89). Anal. Calcd. for C30H37N2O3BrSi: C, 61.95; H, 6.41; N, 4.82%. Found: C, 61.84; H, 
6.28; N, 4.72%.     
 
4-Amino-6-bromo-1,2,3,4-tetrahydroquinolin-2-yl)propan-1-ol (3.41) 
 
To a solution of the tetrahydroquinoline 3.39 (3.15 g, 5.40 mmol) in MeCN (30 mL) was 
added TMSI (3.00 mL, 22.0 mmol). The reaction was stirred at room temperature for 16 h 
and then quenched by the additional of MeOH (20 mL). The solvent was removed by 
evaporation and 1M aq. HCl (30 mL) was added to the residue. The aqueous layer was 
washed with Et2O (30 mL) and the pH adjusted to 8 by the addition of 1M aq. KOH. Finally, 
the aqueous phase was washed with CH2Cl2 (3 x 50 mL) and the combined organic extracts 
dried over MgSO4, filtered and evaporated to dryness to give the amine as a brown gum (1.20 
g, 78%); [α]D
25
 - 30.0° (c = 0.67, CHCl3); max/cm
-1 
3310, 2940, 2860, 1600, 1490, 1360, 
1310, 1060; δH (400 MHz, CDCl3) 7.46 (1H, s, H-6), 7.09 (1H, d, J 8.5, H-8), 6.36 (1H, d, J 
8.5, H-9), 4.01 (2H, m, H-2 and H-14), 3.70 (2H, t, J 5.8, H-13), 3.43 (1H, br. s, H-4), 2.25-
2.08 (1H, br. m, H-3), 2.09-1.81 (2H, br. s, H-15), 1.64-1.54 (4H, m, H-11 and H-12), 1.55-
1.36 (1H, m, H-3); δC (100 MHz, CDCl3) 143.4 (C-10), 130.4 (C-8), 129.2 (C-6), 122.6 (C-
5), 115.6 (C-9), 109.1 (C-7), 62.5 (C-13), 51.1 (C-4), 48.1 (C-2), 39.8 (C-3), 33.0 (C-11/C-
12), 28.5 (C-11/C-12); m/z (ESI) 281.0278 ([M-3H]
+
, C12H14BrN2O requires 281.0289), 270 
(90), 268 (100), 250 (10).   
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6-Bromo-2-(3-(tert-butyldiphenylsilyloxy)propyl)-1,2,3,4-tetrahydroquinolin-4-amine 
(3.40) 
 
To a solution of the amine (0.60 g, 2.10 mmol) in CH2Cl2 (45 mL) was added imidazole (0.21 
g, 0.32 mmol), followed by TBDPSCl (0.57 mL, 2.20 mmol). The reaction was stirred 
overnight at room temperature and quench by the addition of H2O (40 mL). The organic layer 
was separated, dried over MgSO4, filtered and evaporated to dryness to give the product as a 
brown oil (1.05 g, quant.); [α]D
25
 - 14.7° (c = 0.75, CHCl3); max/cm
-1
 2940, 2860, 1590, 
1480, 1120; δH (400 MHz, CDCl3) 7.77-7.66 (4H, m, Ar-H), 7.56-7.37 (7H, m, Ar-H), 7.10 
(1H, d, J 8.4, H-8), 6.34 (1H, d, J 8.4, H-9), 3.91-3.67 (3H, m, H-13 and H-4), 3.41 (1H, br. s, 
H-2), 2.15 (1H, br. s, H-3), 1.78-1.52 (4H, m, H-11 and H-12), 1.46 (1H, br. s, H-3), 1.10 
(9H, s, H-19); δC (100 MHz, CDCl3) 143.4 (Ar-C),135.6 (Ar-C), 133.9 (Ar-C), 130.4 (C-8), 
129.7 (Ar-C), 129.2 (Ar-C), 127.7 (Ar-C), 115.5 (C-9), 108.9 (C-7), 63.7 (C-4 and C-13), 
51.1 (C-2), 40.3 (C-3), 32.9 (C-11/C-12), 28.4 (C-11/C-12), 27.0 (C-19), 19.3 (C-18); m/z 
(ESI) 523.1780 (MH
+
, C28H36N2OSiBr requires 523.1780), 508 (100), 250 (10).  
 
General method for transamination of amine  
To a solution of the amine (2.1 mmol) in CH2Cl2/ DMF (10 mL, 1/1) was added 4-formyl-1-
methylpyridinium benzenesulfonate (0.88 g, 3.20 mmol). After stirring for 1 h, DBU (0.95 
mL, 6.30 mmol) was added, and the resulting dark purple solution was stirred for a further 1 
h at room temperature. The reaction was quenched with sat. aq. oxalic acid (10 mL) and 
stirred for 16 h. Et2O (20 mL) was added to the reaction, the organic layer was separated and 
washed with H2O (2 x 10 mL), brine (10 mL) then dried over MgSO4, filtered and evaporated 
to dryness. The residue was purified by column chromatography. 
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6-Bromo-2-(3-hydroxypropyl)-2,3-dihydroquinolin-4(1H)-one (3.44) 
 
The product was purified by column chromatography, MeOH/CH2Cl2 1:10, Rf = 0.45, to give 
a yellow solid (0.30 g, 50%); [α]D
25
 – 63.4° (c = 0.71, CHCl3); mp 108-110 °C; max/cm
-1
 
3340, 2940, 2880, 1660, 1610, 1500, 1410, 1290; δH (400 MHz, CDCl3) 7.93 (1H, d, J 2.4, 
H-6), 7.37 (1H, dd, J 2.4, 8.7, H-8), 6.60 (1H, d, J 8.7, H-9), 4.82 (1H, br. s, H-1), 3.81-3.72 
(2H, m, H-13), 3.72-3.63 (1H, m, H-2), 2.70 (1H, dd, J 3.8, 16.2, H-3), 2.50 (1H, dd, J 12.3, 
16.2, H-3), 1.83-1.61 (5H, m, H-11, H-12 and H-14); δC (100 MHz, CDCl3) 192.9 (C-4), 
150.2 (C-10), 137.8 (C-8), 129.7 (C-6), 120.1 (C-5), 117.7 (C-9), 110.0 (C-7), 62.4 (C-13), 
53.0 (C-2), 43.6 (C-3), 31.6 (C-12/C-11), 28.4 (C-12/C-11); m/z (ESI) 284.0282 (MH
+
, 
C12H15NO2Br requires 284.0286), 215 (10), 213 (19). 
 
6-Bromo-2-(3-(tert-butyldimethylsilyloxy)propyl-2,3-dihydroquinolin-4(1H)-one (3.45) 
 
To a solution of the ketone (1.00 g, 3.50 mmol) in dry CH2Cl2 (30 mL) was added imidazole 
(0.60 g, 8.70 mmol), 4-DMAP (42.0 mg, 0.35 mmol) and TBDMSCl (1.10 g, 7.00 mmol). 
The reaction was stirred at room temperature for 36 h and quenched by the addition of sat. aq. 
NH4Cl (30 mL). The aqueous layer was extracted with CH2Cl2 (2 x 30 mL) and the combined 
organic extracts dried over MgSO4, filtered and evaporated to dryness. The product was 
purified by column chromatography, MeOH/CH2Cl2 1:10, Rf = 0.35, to give a yellow solid 
(1.00 g , 72%); [α]D
25
 - 46.0° (c = 1.0, CHCl3); mp 126-128 °C; max/cm
-1 
3350, 2938, 2936, 
2860, 1670, 1620; δH (400 MHz, CDCl3) 7.94 (1H, d, J 2.4, H-6), 7.37 (1H, dd, J 2.4 and 8.7, 
H-8), 6.58 (1H, d, J 8.7, H-9), 4.76 (1H, s, H-1), 3.77-3.60 (3H, m, H-2 and H-13), 2.70 (1H, 
dd, J 3.1, 16.1, H-3), 2.50 (1H, dd, J 12.2, 16.1, H-3), 1.89-1.61 (4H, m, H-11 and H-12), 
0.93 (9H, s, H-15), 0.10 (3H, s, C-16), 0.09 (3H, s, C-16); δC (100 MHz, CDCl3) 192.8 (C-4), 
150.1 (C-10), 137.7 (C-6), 129.8 (C-8), 120.1 (C-5), 117.7 (C-9), 109.9 (C-7), 62.7 (C-13), 
52.9 (C-2), 43.6 (C-3), 31.7 (C-11), 28.6 (C-12), 25.9 (C-15), 18.3 (C-14), -5.3 (C-16); m/z 
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(EI) 397.1068 (M
+
, C18H28NO2SiBr  requires 397.1073), 342 (100), 343 (90), 266 (50), 226 
(70), 75 (50). 
 
6-bromo-2-(3-tert-butyldiphenylsiloxy)propyl)-2,3-dihydroquinolin-4(1H)-one (3.36) 
 
The product was purified by column chromatography, EtOAc/n-hexane, 1:1, Rf = 0.35, to 
give a yellow oil (75 %); [α]D
25
 – 19.2o (c = 1.2, CHCl3);  max/cm
-1
 3070, 2950, 2940, 2860, 
1670, 1600, 1490, 1430, 1110; δH (400MHz, CDCl3) 7.96 (1H, d, J 2.4, H-6), 7.76-7.66 (4H, 
m, Ar-H), 7.52-7.39 (6H, m, Ar-H), 7.36 (1H, dd, J 2.4, 8.7, H-8), 6.50 (1H, d, J 8.7, H-9), 
4.58 (1H, s, NH), 3.77 (2H, t, J 5.7, H-13), 3.68-3.49 (1H, m, H-2), 2.66 (1H, dd, J 3.8, 16.2, 
H-3), 2.46 (1H, dd, J 12.4, 16.2, H-3), 1.85-1.58 (4H, m, H-11 and  H-12), 1.13 (9H, s, 
C(CH3)3); δC (100 MHz, CDCl3) 193.0 (C-4), 150.1 (C-10), 137.8 (C-8), 135.4 (Ar-C), 133.6 
(Ar-C), 129.8 (C-6), 129.7 (Ar-C), 127.7 (Ar-C), 120.1 (C-5), 117.8 (C-9), 110.0 (C-7), 63.5 
(C-13), 52.8 (C-2), 43.4 (C-3), 31.4 (C-11/C-12), 28.3 (C-11/C-12), 26.6 (C(CH3)3), 19.1 
(C(CH3)3); m/z (ESI) 522.1447 (MH
+
, C28H33NO2SiBr requires 522.1464), 524 (100), 446 
(40), 323 (12). 
 
2-(4-Methylphenylsulfonamido)ethyl 4-methylbenzenesulfonate
173
  
 
To a solution of 2-aminoethanol (1.00 g, 16.3 mmol) in pyridine (7 mL) at 0 °C was added p 
-toluenesulfonyl chloride (6.50 g, 34.4 mmol) portion wise, maintaining the temperature 
below 10 °C. The reaction mixture was warmed to room temperature over 3 h and then 
partitioned between EtOAc (40 mL) and 1M aq. HCl (40 mL). The organic layer was washed 
consecutively with 1M aq. HCl, sat. aq. NaHCO3 and brine, then dried, filtered and 
evaporated to dryness. The orange residue was filtered through a pad of silica using CH2Cl2 
as eluant. Evaporation of the CH2Cl2, followed by trituration with Et2O gave the product as 
an off-white solid (4.38 g, 73%) which was used in the next step without further purification. 
δH (400 MHz, CDCl3) 7.77 (2H, d, J 8.1, Ar-H), 7.72 (2H, d, J 8.1, Ar-H), 7.38 (2H, d, J 8.1, 
Ar-H), 7.33 (2H, d, J 8.1, Ar-H), 4.87 (1H, br. t, J 6.3, NH), 4.07 (2H, t, J 5.3, OCH2), 3.25 
(2H, m, NCH2), 2.49 (3H, s, CH3), 2.46 (3H, s, CH3) .  
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1-Tosylaziridine
174
  
 
A solution of 20% aq. KOH (3.5 mL) was added to a solution of the tosylate (0.88 g, 2.38 
mmol) in toluene (20 mL). The biphasic solution was stirred at room temperature until the 
reaction was complete (monitored by TLC). The mixture was diluted with H2O (20 mL) and 
the organic phase separated, dried over Na2SO4, filtered and evaporated to dryness to give an 
off-white solid.  This was stored in the freezer and used without further purification. δH (400 
MHz, CDCl3) 7.86 (2H, d, J 8.2, Ar-H), 7.38 (2H, d, J 8.2, Ar-H), 2.48 (3H, s, CH3), 2.40 
(4H, br. s, NCH2). 
 
5.3 Compounds used in Chapter 4 
2,6-Dibromo-4-nitroaniline (4.12)
175
  
 
To a vigorously stirred solution of nitroaniline (10.0 g, 72.0 mmol) in glacial acetic acid (90 
mL) was added a solution of bromine (7.40 mL, 145 mmol) in glacial acetic acid (50 mL) 
over 4 h. Half way through the addition, H2O (20 mL) was added to dissolve the precipitate 
formed. Upon complete addition, the reaction mixture was poured into an ice/H2O mixture, 
stirred and filtered. The solid collected was thoroughly washed with H2O to give the aniline 
as a yellow/green solid (20.3 g, 95%); mp 199-201°C (lit 202-203 °C)
176
; max/cm
-1 
3550, 
3270, 2960, 1720, 1650, 1520; δH (400 MHz, DMSO-d6) 8.26 (2H, s, CH), 6.77 (2H, br .s, 
NH2); δC (100 MHz, CDCl3) 149.6 (C-NH2), 136.9 (C-NO2), 128.4 (CH), 103.7 (C-Br); m/z 
(EI) 293.8638 (M
+
, C6H4N2O2Br2 requires 293.8639), 268 (45), 266 (72), 264 (40), 252 (20), 
250 (40), 248 (20), 170 (50), 168 (48), 90 (50).   
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1,3-Dibromo-5-nitrobenzene (4.13)
175
 
 
To the aniline (1.00 g, 3.30 mmol) in EtOH (12 mL) and conc. sulfuric acid (1.2 mL) at 90 
°C, was added NaNO2 (0.50 g, 11.0 mmol) portion wise. When the addition was complete, 
the reaction mixture was stirred for 40 h at 90 °C. The cooled reaction mixture was poured 
into an ice/H2O mixture and the resultant slurry was filtered. The collected solid was 
dissolved in hot EtOH (15 mL), filtered and the filtrate was evaporated to give the required 
compound as a light brown solid (0.71 g, 75%); mp 99-101 °C, (lit. 95 °C)
177
; max/cm
-1 
3080, 
1530, 1340, 890; δH (400 MHz, CDCl3) 8.36 (2H, d, J 1.7, H-2), 8.03 (1H, t, J 1.7, H-1); δC 
(100 MHz, CDCl3) 149.0 (C-NO2), 140.1 (C-1), 125.6 (C-2), 123.5 (C-Br); m/z (EI) 278.8529 
(M
+
, C6H3NO2Br2 requires 278.8531), 235 (75), 154 (30), 75 (80).  
 
3,5-Dibromoaniline (4.8)
175
 
 
To a solution of 3, 5-dibromonitrobenzene (7.32 g, 26.1 mmol) in EtOH (60 mL) and THF 
(60 mL) was added tin(II) chloride dihydrate (28.6 g, 127 mmol). After stirring for 20 h at 
room temperature, the solvent was removed by evaporation and 1M aq. KOH (50 mL) added. 
After stirring for two hours, the aqueous layer was separated and extracted with Et2O (3 x 25 
mL). The combined organic extracts were dried over MgSO4, filtered and concentrated under 
vacuum to give the product as a light brown solid (5.51 g, 86%); mp 51-53 °C (lit 55-56 
°C)
178
; max/cm
-1 
3420, 3300, 3200, 1620, 1590, 1560, 1450; δH (400 MHz, CDCl3) 7.04 (1H, 
t, J 1.6, C-1), 6.77 (2H, d, J 1.6, C-2), 3.79 (2H, br. s, NH2); δC (100 MHz, CDCl3) 148.6 (C-
NH2), 123.7 (C-Br), 123.4 (C-1), 116.5 (C-2); m/z (EI) 251 (MH
+
, 100), 249 (66),172 (30), 
170 (30), 91 (50), 90 (45), 63 (40).  
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Methyl 3-(3,5-dibromophenylamino)butanoylcarbamate (4.9) 
 
The alkene (1.25 g, 8.70 mmol) and [Pd(R-BINAP)(H2O)2]
2+
[TfO]
-
2 (0.46 g, 0.43 mmol) 
were dissolved in toluene (22 mL) and heated to 50 °C. A solution of 3, 5-dibromoaniline 
(2.15 g, 8.60 mmol) in toluene (22 mL) was added over 24 h (via a syringe pump). The 
reaction was stirred for an additional 48 h at 50 °C and then the solvent was removed by 
evaporation. The residue was purified by column chromatography, CH2Cl2/EtOAc 9:1, Rf = 
0.35. The product was recrystallised from toluene, with the mother liquors evaporated to 
dryness, to give the product as an off-white solid (1.73 g,  50%); [α]D
25
 - 9.85° (c = 1, CHCl3, 
97% ee); Chiral HPLC Hichrom-CHI-PGG-2759, 10% IPA in n-hexane, 1.0 mL/min, tR 
(major) = 24.7 min, tR (minor) = 33.4 min; mp 117-118 
o
C; max/cm
-1 
3410, 3220, 2730, 1770, 
1670, 1590, 1650, 1380, 1230; δH (400 MHz, CDCl3) 7.47 (1H, br. s, NHCO), 6.97 (1H, t, J 
1.6, H-1), 6.69 (2H, d, J 1.6, H-2), 4.12 (1H, br. d, J 9.2, NH), 4.04-3.93 (1H, m, CH), 3.82 
(3H, s, OCH3), 3.14 (1H, dd, J 5.9, 16.0, CH2CO), 2.95 (1H, dd, J 6.0, 16.0, CH2CO), 1.32 
(3H, d, J 6.4, CHCH3); δC (100 MHz, CDCl3) 172.6 (CONH), 152.4 (CO2), 149.0 (C-3), 
123.6 (C-Br), 122.6 (C-1), 114.8 (C-2), 53.3 (OCH3), 45.7 (NHCH), 41.8 (CH2CO), 20.6 
(CHCH3); m/z (ESI) 397 (55), 395 (MH
+
, 100), 393 (50), 321 (3), 319 (10), 317 (5), 280 (10), 
278 (20), 276 (10). 
 
3- (3, 5-Dibromoohenylamino)botanic acid (4.14) 
 
To a solution of the carbamate (0.46 g, 1.20 mmol) in MeOH (10 mL) was added 1M aq. 
KOH (12.0 mL, 12.0 mmol). The resultant solution was stirred at room temperature for 1 h 
and evaporated to dryness. H2O was added to the residue and the aqueous layer was extracted 
with Et2O (2 x 10 mL). The aqueous layer was then acidified to pH 4 by the addition of 1M 
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aq. HCl and extracted with EtOAc (3 x 10 mL). The combined organic extracts were washed 
with brine, dried over MgSO4 and evaporated to give the acid as a brown gum (0.30 g, 77%);  
δH (400 MHz, CDCl3) 7.00 (1H, t, J 1.6, H-1), 6.70 (2H, d, J 1.6, H-2), 3.97-3.85 (1H, m, 
CH), 2.65 (1H, dd, J 5.5, 15.6, CH2CO), 2.57 (1H, dd, J 6.2, 15.6, CH2CO ), 1.33 (3H, d, J 
6.5, CH3CH); δC (100 MHz, CDCl3) 176.4 (CO2H), 148.7 (C-3), 123.6 (C-Br), 122.9 (C-1), 
114.9 (C-2), 45.6 (CH), 40.2 (CH2CO), 20.3 (CH3); m/z (ESI) 337 (M
+
, 100%), 321 (5), 319 
(8), 317 (5), 280 (10), 278 (20), 276 (10).
 
 
 
5,7-Dibromo-2-methyl-2,3-dihydroquinolin-4(1H)-one (4.10) 
 
Polyphosphoric acid (2.00 g) was added to the acid (100 mg, 0.25 mmol) and the resultant 
slurry heated to 90 °C for 4 h. After cooling to 60 °C, an ice/H2O mixture was added and the 
reaction mixture was stirred for a further 15 min. The product was then extracted with EtOAc 
(3 x 5 mL). The combined organic extracts were basified to pH 14 using 1M aq. NaOH, 
washed with brine, dried over MgSO4, filtered and concentrated under vacuum. The crude 
product was purified by column chromatography, EtOAc/n-hexane 3:7, Rf = 0.35, to give the 
tetrahydroquinolone as a bright yellow solid (60.0 mg, 42%); [α]D
25
 -19.0° (c = 1, CHCl3); 
mp 157-159 ˚C; max/cm
-1
 3360, 1660, 1490; δH (400 MHz, CDCl3) 7.14 (1H, d, J 1.8, H-7), 
6.80 (1H, d, J 1.8, H-9), 4.42 (1H, br. s, H-1), 3.86-3.74 (1H, m, H-2), 2.70 (1H, dd, J 3.8, 
15.4, H-3), 2.53 (1H, dd, J 12.3, 15.4, H-3), 1.34 (3H, d, J 6.4, H-11); δC (100 MHz, CDCl3) 
153.1 (C-4), 128.4 (C-10), 128.4 (C-8), 127.0 (C-7), 123.3 (C-6), 117.7 (C-9), 115.0 (C-5), 
48.1 (C-2), 46.1 (C-3), 21.1 (C-11); m/z (EI) 319 (M
+
, 48%), 304 (100). 
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